PMID
Article Title
Citation
Organization
Download
View Data
Discovery of 7H-pyrrolo[2,3-d]pyrimidine derivatives as selective covalent irreversible inhibitors of interleukin-2-inducible T-cell kinase (Itk).
Eur J Med Chem 173: 167-183 (2019)
Peking University
Discovery of Pyrrolo[3,2- d]pyrimidin-4-one Derivatives as a New Class of Potent and Cell-Active Inhibitors of P300/CBP-Associated Factor Bromodomain.
J Med Chem 62: 4526-4542 (2019)
Sichuan University
Novel Deazaflavin Analogues Potently Inhibited Tyrosyl DNA Phosphodiesterase 2 (TDP2) and Strongly Sensitized Cancer Cells toward Treatment with Topoisomerase II (TOP2) Poison Etoposide.
J Med Chem 62: 4669-4682 (2019)
National Cancer Institute
Novel Tetrahydroquinazolinamines as Selective Histamine 3 Receptor Antagonists for the Treatment of Obesity.
J Med Chem 62: 4638-4655 (2019)
Academy of Scientific and Innovative Research (Acsir)
Design and Optimization Leading to an Orally Active TTK Protein Kinase Inhibitor with Robust Single Agent Efficacy.
J Med Chem 62: 4401-4410 (2019)
Celgene
Discovery of 3-(Indol-5-yl)-indazole Derivatives as Novel Myeloid Differentiation Protein 2/Toll-like Receptor 4 Antagonists for Treatment of Acute Lung Injury.
J Med Chem 62: 5453-5469 (2019)
Wenzhou Medical University
Exploiting Chemical Toolboxes for the Expedited Generation of Tetracyclic Quinolines as a Novel Class of PXR Agonists.
ACS Med Chem Lett 10: 677-681 (2019)
University of Perugia
Novel Sustainable-by-Design HDAC Inhibitors for the Treatment of Alzheimer's Disease.
ACS Med Chem Lett 10: 671-676 (2019)
University of Bras£Lia
?,?-Diketocarboxylic Acids and Their Esters Act as Carbonic Anhydrase IX and XII Selective Inhibitors.
ACS Med Chem Lett 10: 661-665 (2019)
University of Florence
Identification of Isoform 2 Acid-Sensing Ion Channel Inhibitors as Tool Compounds for Target Validation Studies in CNS.
ACS Med Chem Lett 10: 627-632 (2019)
Promidis
Identification of a Strigoterpenoid with Dual Nrf2 and Nf-?B Modulatory Activity.
ACS Med Chem Lett 10: 606-610 (2019)
University of Eastern Piedmont
Identification of the 2-Benzoxazol-2-yl-phenol Scaffold as New Hit for JMJD3 Inhibition.
ACS Med Chem Lett 10: 601-605 (2019)
Institute of Biomolecular Chemistry (Icb)
Polycyclic Maleimide-based Scaffold as New Privileged Structure for Navigating the Cannabinoid System Opportunities.
ACS Med Chem Lett 10: 596-600 (2019)
University of Bologna
EC18 as a Tool To Understand the Role of HCN4 Channels in Mediating Hyperpolarization-Activated Current in Tissues.
ACS Med Chem Lett 10: 584-589 (2019)
University of Florence
Novel Phenyldiazenyl Fibrate Analogues as PPAR ?/?/? Pan-Agonists for the Amelioration of Metabolic Syndrome.
ACS Med Chem Lett 10: 545-551 (2019)
University of Chieti "G. D.Annunzio
Discovery of Stereospecific PARP-1 Inhibitor Isoindolinone NMS-P515.
ACS Med Chem Lett 10: 534-538 (2019)
Nerviano Medical Sciences
SAR Studies and Biological Characterization of a Chromen-4-one Derivative as an Anti-
ACS Med Chem Lett 10: 528-533 (2019)
University of Modena and Reggio Emilia
Investigation around the Oxadiazole Core in the Discovery of a New Chemotype of Potent and Selective FXR Antagonists.
ACS Med Chem Lett 10: 504-510 (2019)
University of Naples "Federico Ii
Drug Design and Synthesis of First in Class PDZ1 Targeting NHERF1 Inhibitors as Anticancer Agents.
ACS Med Chem Lett 10: 499-503 (2019)
Sapienza University of Rome
Investigation on 2',3'-
ACS Med Chem Lett 10: 493-498 (2019)
University of Camerino
Discovering New Casein Kinase 1d Inhibitors with an Innovative Molecular Dynamics Enabled Virtual Screening Workflow.
ACS Med Chem Lett 10: 487-492 (2019)
Pfizer
Improved Selective Class I HDAC and Novel Selective HDAC3 Inhibitors: Beyond Hydroxamic Acids and Benzamides.
ACS Med Chem Lett 10: 481-486 (2019)
IRBM Science Park
First-of-its-kind STARD
ACS Med Chem Lett 10: 475-480 (2019)
University of Pisa
Discovery of the First-in-Class GSK-3?/HDAC Dual Inhibitor as Disease-Modifying Agent To Combat Alzheimer's Disease.
ACS Med Chem Lett 10: 469-474 (2019)
Alma Mater Studiorum-University of Bologna
Discovery of Pyrido[3',2':5,6]thiopyrano[4,3-
ACS Med Chem Lett 10: 457-462 (2019)
University of Pisa
Novel Cyclic Biphalin Analogues by Ruthenium-Catalyzed Ring Closing Metathesis:
ACS Med Chem Lett 10: 450-456 (2019)
D'Annunzio University of Chieti???Pescara
Bioisosteres of Indomethacin as Inhibitors of Aldo-Keto Reductase 1C3.
ACS Med Chem Lett 10: 437-443 (2019)
University of Turin
-Nitrosulfonamides as Carbonic Anhydrase Inhibitors: A Promising Chemotype for Targeting Chagas Disease and Leishmaniasis.
ACS Med Chem Lett 10: 413-418 (2019)
University of Florence
Novel Isoxazole Derivatives with Potent FXR Agonistic Activity Prevent Acetaminophen-Induced Liver Injury.
ACS Med Chem Lett 10: 407-412 (2019)
University of Naples "Federico Ii
Discovery of 1,4-Naphthoquinones as a New Class of Antiproliferative Agents Targeting GPR55.
ACS Med Chem Lett 10: 402-406 (2019)
University of Calabria
Comparative analysis of pyrimidine substituted aminoacyl-sulfamoyl nucleosides as potential inhibitors targeting class I aminoacyl-tRNA synthetases.
Eur J Med Chem 173: 154-166 (2019)
Ku Leuven
Synthetic approaches and pharmaceutical applications of chloro-containing molecules for drug discovery: A critical review.
Eur J Med Chem 173: 117-153 (2019)
Wuhan University of Technology
Structural Basis for E. coli Penicillin Binding Protein (PBP) 2 Inhibition, a Platform for Drug Design.
J Med Chem 62: 4742-4754 (2019)
Mutabilis
Design, Synthesis, and Preclinical Characterization of Selective Factor D Inhibitors Targeting the Alternative Complement Pathway.
J Med Chem 62: 4656-4668 (2019)
Novartis Institutes For Biomedical Research
Discovery of trans-3-(pyridin-3-yl)acrylamide-derived sulfamides as potent nicotinamide phosphoribosyltransferase (NAMPT) inhibitors for the potential treatment of cancer.
Bioorg Med Chem Lett 29: 1502-1506 (2019)
Chinese Academy of Sciences
Design, synthesis and biological activity of deuterium-based FFA1 agonists with improved pharmacokinetic profiles.
Bioorg Med Chem Lett 29: 1471-1475 (2019)
Guangdong Pharmaceutical University
Novel 7-formyl-naphthyridyl-ureas derivatives as potential selective FGFR4 inhibitors: Design, synthesis, and biological activity studies.
Bioorg Med Chem 27: 1932-1941 (2019)
Southeast University
New analogs of SYA013 as sigma-2 ligands with anticancer activity.
Bioorg Med Chem 27: 2629-2636 (2019)
Florida A&M University
Discovery of (R)-5-((5-(1-methyl-1H-pyrazol-4-yl)-4-(methylamino)pyrimidin-2-yl)amino)-3-(piperidin-3-yloxy)picolinonitrile, a novel CHK1 inhibitor for hematologic malignancies.
Eur J Med Chem 173: 44-62 (2019)
Zhejiang University
Structure Overhaul Affords a Potent Purine PI3K? Inhibitor with Improved Tolerability.
J Med Chem 62: 4370-4382 (2019)
TBA
Novel Lysine-Based Thioureas as Mechanism-Based Inhibitors of Sirtuin 2 (SIRT2) with Anticancer Activity in a Colorectal Cancer Murine Model.
J Med Chem 62: 4131-4141 (2019)
TBA
Inhibiting Hedgehog: An Update on Pharmacological Compounds and Targeting Strategies.
J Med Chem 62: 8392-8411 (2019)
Philipps University Marburg
Chemical synthesis, microbial transformation and biological evaluation of tetrahydroprotoberberines as dopamine D1/D2 receptor ligands.
Bioorg Med Chem 27: 2100-2111 (2019)
Huzhou University
Design, synthesis and structure-activity relationship study of aminopyridine derivatives as novel inhibitors of Janus kinase 2.
Bioorg Med Chem Lett 29: 1507-1513 (2019)
East China University of Science & Technology
Synthesis and evaluation of histamine H
Bioorg Med Chem Lett 29: 1492-1496 (2019)
Jiangsu Marine Resources Development Research Institute
Discovery of a class of highly potent Janus Kinase 1/2 (JAK1/2) inhibitors demonstrating effective cell-based blockade of IL-13 signaling.
Bioorg Med Chem Lett 29: 1522-1531 (2019)
Genentech
High affinity CXCR4 inhibitors generated by linking low affinity peptides.
Eur J Med Chem 172: 174-185 (2019)
University of California San Diego
Synthesis and biological evaluation of tryptophan-derived rhodanine derivatives as PTP1B inhibitors and anti-bacterial agents.
Eur J Med Chem 172: 163-173 (2019)
Yanbian University College of Pharmacy
Structure-based modification of carbonyl-diphenylpyrimidines (Car-DPPYs) as a novel focal adhesion kinase (FAK) inhibitor against various stubborn cancer cells.
Eur J Med Chem 172: 154-162 (2019)
The First Affiliated Hospital of Dalian Medical University
Third-generation CDK inhibitors: A review on the synthesis and binding modes of Palbociclib, Ribociclib and Abemaciclib.
Eur J Med Chem 172: 143-153 (2019)
University of Padova
A Selective and Brain Penetrant p38?MAPK Inhibitor Candidate for Neurologic and Neuropsychiatric Disorders That Attenuates Neuroinflammation and Cognitive Dysfunction.
J Med Chem 62: 5298-5311 (2019)
Northwestern University
Design and Synthesis of Type-IV Inhibitors of BRAF Kinase That Block Dimerization and Overcome Paradoxical MEK/ERK Activation.
J Med Chem 62: 3886-3897 (2019)
University of South Carolina
Discovery of 1,3-dihydro-2H-imidazo[4,5-c]quinolin-2-ones based novel, potent and PI3K? selective inhibitors.
Bioorg Med Chem Lett 29: 1313-1319 (2019)
Zydus Research Centre
Scaffold hopping of fused piperidine-type NK3 receptor antagonists to reduce environmental impact.
Bioorg Med Chem 27: 2019-2026 (2019)
Kyoto University
Discovery, synthesis, biological evaluation and molecular docking study of (R)-5-methylmellein and its analogs as selective monoamine oxidase A inhibitors.
Bioorg Med Chem 27: 2027-2040 (2019)
Fudan University
Design of a Cyclin G Associated Kinase (GAK)/Epidermal Growth Factor Receptor (EGFR) Inhibitor Set to Interrogate the Relationship of EGFR and GAK in Chordoma.
J Med Chem 62: 4772-4778 (2019)
University of North Carolina At Chapel Hill
Structure-Activity and Structure-Conformation Relationships of Aryl Propionic Acid Inhibitors of the Kelch-like ECH-Associated Protein 1/Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1/NRF2) Protein-Protein Interaction.
J Med Chem 62: 4683-4702 (2019)
Astex Pharmaceuticals
Identification of 5-Substituted 2-Acylaminothiazoles That Activate Tat-Mediated Transcription in HIV-1 Latency Models.
J Med Chem 62: 5148-5175 (2019)
The Walter and Eliza Hall Institute For Medical Research
Discovery of Conformational Control Inhibitors Switching off the Activated c-KIT and Targeting a Broad Range of Clinically Relevant c-KIT Mutants.
J Med Chem 62: 3940-3957 (2019)
National Health Research Institutes
Synthesis and characterization of hydrogen peroxide activated estrogen receptor beta ligands.
Bioorg Med Chem 27: 2075-2082 (2019)
University of Richmond
Kinase inhibitions in pyrido[4,3-h] and [3,4-g]quinazolines: Synthesis, SAR and molecular modeling studies.
Bioorg Med Chem 27: 2083-2089 (2019)
University of Clermont Auvergne
Design and Identification of a Novel, Functionally Subtype Selective GABA
J Med Chem 62: 5773-5796 (2019)
Pfizer
Development of Novel Epoxyketone-Based Proteasome Inhibitors as a Strategy To Overcome Cancer Resistance to Carfilzomib and Bortezomib.
J Med Chem 62: 4444-4455 (2019)
University of Kentucky
Galloyl Carbohydrates with Antiangiogenic Activity Mediated by Capillary Morphogenesis Gene 2 (CMG2) Protein Binding.
J Med Chem 62: 3958-3970 (2019)
Instituto De Qu£Mica M£Dica (Iqm)
Novel 15-Lipoxygenase-1 Inhibitor Protects Macrophages from Lipopolysaccharide-Induced Cytotoxicity.
J Med Chem 62: 4624-4637 (2019)
University of Groningen
Discovery and Characterization of XY101, a Potent, Selective, and Orally Bioavailable ROR? Inverse Agonist for Treatment of Castration-Resistant Prostate Cancer.
J Med Chem 62: 4716-4730 (2019)
Chinese Academy of Sciences
Difluoromethylene at the ?-Lactam ?-Position Improves 11-Deoxy-8-aza-PGE
J Med Chem 62: 4731-4741 (2019)
Cayman Chemical
Discovery of [1,2,4]Triazolo[4,3- a]pyridines as Potent Inhibitors Targeting the Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Interaction.
J Med Chem 62: 4703-4715 (2019)
Shenyang Pharmaceutical University
Selective Inhibition of Histone Deacetylase 10: Hydrogen Bonding to the Gatekeeper Residue is Implicated.
J Med Chem 62: 4426-4443 (2019)
European Molecular Biology Laboratory
Plasmodium Purine Metabolism and Its Inhibition by Nucleoside and Nucleotide Analogues.
J Med Chem 62: 8365-8391 (2019)
University of Montpellier
Structure-guided design of antibacterials that allosterically inhibit DNA gyrase.
Bioorg Med Chem Lett 29: 1407-1412 (2019)
Glaxosmithkline
Discovery of an EGFR tyrosine kinase inhibitor from Ilex latifolia in breast cancer therapy.
Bioorg Med Chem Lett 29: 1282-1290 (2019)
Wannan Medical College
Discovery and optimization of thienopyridine derivatives as novel urea transporter inhibitors.
Eur J Med Chem 172: 131-142 (2019)
Peking University
Probing structural requirements for human topoisomerase I inhibition by a novel N1-Biphenyl fluoroquinolone.
Eur J Med Chem 172: 109-130 (2019)
University of Iowa
Cu-mediated synthesis of differentially substituted diazepines as AChE inhibitors; validation through molecular docking and Lipinski's filter to develop novel anti-neurodegenerative drugs.
Bioorg Med Chem Lett 29: 1308-1312 (2019)
The South India Textile Research Association
Design, synthesis, evaluation and molecular modeling study of 4-N-phenylaminoquinolines for Alzheimer disease treatment.
Bioorg Med Chem Lett 29: 1325-1329 (2019)
Tianjin University of Technology
Nucleoside protein arginine methyltransferase 5 (PRMT5) inhibitors.
Bioorg Med Chem Lett 29: 1264-1269 (2019)
Prelude Therapeutics
Anticancer profile of newly synthesized BRAF inhibitors possess 5-(pyrimidin-4-yl)imidazo[2,1-b]thiazole scaffold.
Bioorg Med Chem 27: 2041-2051 (2019)
National Research Centre (Nrc)
PIM kinase inhibitors: Structural and pharmacological perspectives.
Eur J Med Chem 172: 95-108 (2019)
Nri Institute of Pharmacy
Peptide-based covalent inhibitors of MALT1 paracaspase.
Bioorg Med Chem Lett 29: 1336-1339 (2019)
Harvard Medical School
Design, synthesis, and biological evaluation of novel pyrrolo[1,2-a]pyrazine derivatives.
Bioorg Med Chem Lett 29: 1350-1356 (2019)
Yonsei University
Proline-based hydroxamates targeting the zinc-dependent deacetylase LpxC: Synthesis, antibacterial properties, and docking studies.
Bioorg Med Chem 27: 1997-2018 (2019)
University of Hamburg
Synthesis of ?-methylstilbenes using an aqueous Wittig methodology and application toward the development of potent human aromatase inhibitors.
Bioorg Med Chem Lett 29: 1395-1398 (2019)
Mcmaster University
Accelerating the discovery of DGAT1 inhibitors through the application of parallel medicinal chemistry (PMC).
Bioorg Med Chem Lett 29: 1380-1385 (2019)
Merck
Structural requirements of cholenamide derivatives as the LXR ligands.
Bioorg Med Chem Lett 29: 1330-1335 (2019)
Niigata University of Pharmacy and Applied Life Sciences
Benzothiophene derivatives as phosphodiesterase 10A (PDE10A) inhibitors: Hit-to-lead studies.
Bioorg Med Chem Lett 29: 1419-1422 (2019)
Asubio Pharma
Dispiropyrrolidinyl-piperidone embedded indeno[1,2-b]quinoxaline heterocyclic hybrids: Synthesis, cholinesterase inhibitory activity and their molecular docking simulation.
Bioorg Med Chem 27: 2621-2628 (2019)
King Saud University
Synthesis and Anti-HCV Activities of 4'-Fluoro-2'-Substituted Uridine Triphosphates and Nucleotide Prodrugs: Discovery of 4'-Fluoro-2'- C-methyluridine 5'-Phosphoramidate Prodrug (AL-335) for the Treatment of Hepatitis C Infection.
J Med Chem 62: 4555-4570 (2019)
Janssen Biopharma
Modulation of the spacer in N,N-bis(alkanol)amine aryl ester heterodimers led to the discovery of a series of highly potent P-glycoprotein-based multidrug resistance (MDR) modulators.
Eur J Med Chem 172: 71-94 (2019)
University of Florence
Structure- and Ligand-Based Discovery of Chromane Arylsulfonamide Na
J Med Chem 62: 4091-4109 (2019)
Genentech
Review of Transient Receptor Potential Canonical (TRPC5) Channel Modulators and Diseases.
J Med Chem 62: 7589-7602 (2019)
University of Nebraska Medical Center
3,5,7-Substituted Pyrazolo[4,3- d]pyrimidine Inhibitors of Cyclin-Dependent Kinases and Their Evaluation in Lymphoma Models.
J Med Chem 62: 4606-4623 (2019)
Palack£
Use of the 4-Hydroxytriazole Moiety as a Bioisosteric Tool in the Development of Ionotropic Glutamate Receptor Ligands.
J Med Chem 62: 4467-4482 (2019)
University of Turin
Identification and design of novel small molecule inhibitors against MERS-CoV papain-like protease via high-throughput screening and molecular modeling.
Bioorg Med Chem 27: 1981-1989 (2019)
University of Illinois At Chicago
Structure-activity relationship study of estrogen receptor down-regulators with a diphenylmethane skeleton.
Bioorg Med Chem 27: 1952-1961 (2019)
The University of Tokyo
Discovery of thiazolidin-4-one urea analogues as novel multikinase inhibitors that potently inhibit FLT3 and VEGFR2.
Bioorg Med Chem 27: 2127-2139 (2019)
Zhuhai Campus of Zunyi Medical University
Exploring the PROTAC degron candidates: OBHSA with different side chains as novel selective estrogen receptor degraders (SERDs).
Eur J Med Chem 172: 48-61 (2019)
Wuhan University
Anti-PqsR compounds as next-generation antibacterial agents against Pseudomonas aeruginosa: A review.
Eur J Med Chem 172: 26-35 (2019)
Mashhad University of Medical Sciences
Structural optimization on a virtual screening hit of smoothened receptor.
Eur J Med Chem 172: 1-15 (2019)
Soochow University
Discovery and Structure-Based Optimization of Next-Generation Reversible Methionine Aminopeptidase-2 (MetAP-2) Inhibitors.
J Med Chem 62: 5025-5039 (2019)
Merck Healthcare
Synthesis and Structure-Affinity Relationships of Spirocyclic Benzopyrans with Exocyclic Amino Moiety.
J Med Chem 62: 4204-4217 (2019)
Universit£T M£Nster
Identification of Pyrrolo[2,3- d]pyrimidine-Based Derivatives as Potent and Orally Effective Fms-like Tyrosine Receptor Kinase 3 (FLT3) Inhibitors for Treating Acute Myelogenous Leukemia.
J Med Chem 62: 4158-4173 (2019)
TBA
Synthetic Approaches to the New Drugs Approved During 2017.
J Med Chem 62: 7340-7382 (2019)
Seattle Genetics
Design, Synthesis, and Pharmacokinetic Evaluation of Phosphate and Amino Acid Ester Prodrugs for Improving the Oral Bioavailability of the HIV-1 Protease Inhibitor Atazanavir.
J Med Chem 62: 3553-3574 (2019)
TBA
Caprazamycins: Promising lead structures acting on a novel antibacterial target MraY.
Eur J Med Chem 171: 462-474 (2019)
Griffith University
Profiling withanolide A for therapeutic targets in neurodegenerative diseases.
Bioorg Med Chem 27: 2508-2520 (2019)
University of Basel
Novel Chemical Series of 5-Lipoxygenase-Activating Protein Inhibitors for Treatment of Coronary Artery Disease.
J Med Chem 62: 4325-4349 (2019)
TBA
Discovery of Potent Myeloid Cell Leukemia-1 (Mcl-1) Inhibitors That Demonstrate in Vivo Activity in Mouse Xenograft Models of Human Cancer.
J Med Chem 62: 3971-3988 (2019)
Vanderbilt University School of Medicine
GABA allosteric modulators: An overview of recent developments in non-benzodiazepine modulators.
Eur J Med Chem 171: 434-461 (2019)
The University of Sydney
Stereoselective synthesis and biological evaluation as inhibitors of hepatitis C virus RNA polymerase of GSK3082 analogues with structural diversity at the 5-position.
Eur J Med Chem 171: 401-419 (2019)
Csic - Universidad De Zaragoza
Novel benzenesulfonamide and 1,2-benzisothiazol-3(2H)-one-1,1-dioxide derivatives as potential selective COX-2 inhibitors.
Eur J Med Chem 171: 372-382 (2019)
Al-Azhar University
New pyrazole derivatives: Synthesis, anti-inflammatory activity, cycloxygenase inhibition assay and evaluation of mPGES.
Eur J Med Chem 171: 332-342 (2019)
Cairo University
Structural hybridization of pyrrolidine-based T-type calcium channel inhibitors and exploration of their analgesic effects in a neuropathic pain model.
Bioorg Med Chem Lett 29: 1168-1172 (2019)
Korea Institute of Science and Technology
Identification of ortho-hydroxy anilide as a novel scaffold for lysine demethylase 5 inhibitors.
Bioorg Med Chem Lett 29: 1173-1176 (2019)
Kyoto Prefectural University of Medicine
Discovery of novel mutant-combating ALK and ROS1 dual inhibitors bearing imidazolidin-2-one moiety with reasonable PK properties.
Eur J Med Chem 171: 297-309 (2019)
Shenyang Pharmaceutical University
Design, synthesis and biological evaluation of novel uracil derivatives bearing 1, 2, 3-triazole moiety as thymidylate synthase (TS) inhibitors and as potential antitumor drugs.
Eur J Med Chem 171: 282-296 (2019)
China Medical University
Discovery of potent anti-inflammatory 4-(4,5,6,7-tetrahydrofuro[3,2-c]pyridin-2-yl) pyrimidin-2-amines for use as Janus kinase inhibitors.
Bioorg Med Chem 27: 2592-2597 (2019)
Central China Normal University
Binding pocket-based design, synthesis and biological evaluation of novel selective BRD4-BD1 inhibitors.
Bioorg Med Chem 27: 1871-1881 (2019)
Central South University
Identification of highly potent and selective MMP2 inhibitors addressing the S1' subsite with d-proline-based compounds.
Bioorg Med Chem 27: 1891-1902 (2019)
University of Florence
Benzimidazole-based DGAT1 inhibitors with a [3.1.0] bicyclohexane carboxylic acid moiety.
Bioorg Med Chem Lett 29: 1182-1186 (2019)
Merck
Discovery and biological evaluation of novel androgen receptor antagonist for castration-resistant prostate cancer.
Eur J Med Chem 171: 265-281 (2019)
Sichuan University and Collaborative Innovation Center For Biotherapy
Synthesis and structure-bactericidal activity relationships of non-ketolides: 9-Oxime clarithromycin 11,12-cyclic carbonate featured with three-to eight-atom-length spacers at 3-OH.
Eur J Med Chem 171: 235-254 (2019)
Beijing Institute of Technology
Discovery of novel glycogen synthase kinase-3? inhibitors: Structure-based virtual screening, preliminary SAR and biological evaluation for treatment of acute myeloid leukemia.
Eur J Med Chem 171: 221-234 (2019)
Peking University
Discovery of novel bacterial FabH inhibitors (Pyrazol-Benzimidazole amide derivatives): Design, synthesis, bioassay, molecular docking and crystal structure determination.
Eur J Med Chem 171: 209-220 (2019)
Fudan University
Carbonic Anhydrase XII Inhibitors Overcome Temozolomide Resistance in Glioblastoma.
J Med Chem 62: 4174-4192 (2019)
Griffith University
Identification of Thienopyrimidine Scaffold as an Inhibitor of the ABC Transport Protein ABCC1 (MRP1) and Related Transporters Using a Combined Virtual Screening Approach.
J Med Chem 62: 4383-4400 (2019)
Rheinische Friedrich-Wilhelms-University of Bonn
Novel Pyrazolo[4,3- d]pyrimidine as Potent and Orally Active Inducible Nitric Oxide Synthase (iNOS) Dimerization Inhibitor with Efficacy in Rheumatoid Arthritis Mouse Model.
J Med Chem 62: 4013-4031 (2019)
Anhui Medical University
Structural Simplification of a Tetrahydroquinoline-Core Peptidomimetic ?-Opioid Receptor (MOR) Agonist/?-Opioid Receptor (DOR) Antagonist Produces Improved Metabolic Stability.
J Med Chem 62: 4142-4157 (2019)
University of Michigan
Neutral sphingomyelinase 2 inhibitors based on the 4-(1H-imidazol-2-yl)-2,6-dialkoxyphenol scaffold.
Eur J Med Chem 170: 276-289 (2019)
Johns Hopkins University
Bioactive Dimeric Acylphloroglucinols from the Mexican Fern Elaphoglossum paleaceum.
J Nat Prod 82: 785-791 (2019)
Universidad Aut£Noma Del Estado De Morelos
Dual Pharmacophores Explored via Structure-Activity Relationship (SAR) Matrix: Insights into Potent, Bifunctional Opioid Ligand Design.
J Med Chem 62: 4193-4203 (2019)
TBA
Discovery of Potent, Selective, and Orally Bioavailable Inhibitors against Phosphodiesterase-9, a Novel Target for the Treatment of Vascular Dementia.
J Med Chem 62: 4218-4224 (2019)
Sun Yat-Sen University
Discovery of 1,3-diphenyl-1H-pyrazole derivatives containing rhodanine-3-alkanoic acid groups as potential PTP1B inhibitors.
Bioorg Med Chem Lett 29: 1187-1193 (2019)
Yanbian University
Bioactivity-guided identification of flavonoids with cholinesterase and ?-amyloid peptide aggregation inhibitory effects from the seeds of Millettia pachycarpa.
Bioorg Med Chem Lett 29: 1194-1198 (2019)
Sichuan University
Surveying heterocycles as amide bioisosteres within a series of mGlu
Bioorg Med Chem Lett 29: 1211-1214 (2019)
Vanderbilt University
Insights into the chemistry and therapeutic potential of furanones: A versatile pharmacophore.
Eur J Med Chem 171: 66-92 (2019)
Jamia Hamdard
Enhancement of Benzothiazoles as Pteridine Reductase-1 Inhibitors for the Treatment of Trypanosomatidic Infections.
J Med Chem 62: 3989-4012 (2019)
University of Modena and Reggio Emilia
Concise Modular Synthesis of Thalassotalic Acids A-C.
J Nat Prod 82: 1045-1048 (2019)
TBA
Lead optimization and efficacy evaluation of quinazoline-based BET family inhibitors for potential treatment of cancer and inflammatory diseases.
Bioorg Med Chem Lett 29: 1220-1226 (2019)
National Institutes of Health
Fluorinated indole-imidazole conjugates: Selective orally bioavailable 5-HT
Eur J Med Chem 170: 261-275 (2019)
Polish Academy of Sciences
Multi-target compounds acting in cancer progression: Focus on thiosemicarbazone, thiazole and thiazolidinone analogues.
Eur J Med Chem 170: 237-260 (2019)
Universidade Federal De Pernambuco
Synthesis and biological evaluation of pyridazinone derivatives as selective COX-2 inhibitors and potential anti-inflammatory agents.
Eur J Med Chem 171: 25-37 (2019)
Cairo University
Discovery of a novel class of potent and selective tetrahydroindazole-based sigma-1 receptor ligands.
Bioorg Med Chem 27: 1824-1835 (2019)
Northwestern University
Synthesis and biological evaluation of 3-substituted 2-oxindole derivatives as new glycogen synthase kinase 3? inhibitors.
Bioorg Med Chem 27: 1804-1817 (2019)
Lomonosov Moscow State University
Synthesis and bioevaluation of diarylpyrazoles as antiproliferative agents.
Eur J Med Chem 171: 1-10 (2019)
Shenyang Pharmaceutical University
Discovery of Novel Janus Kinase (JAK) and Histone Deacetylase (HDAC) Dual Inhibitors for the Treatment of Hematological Malignancies.
J Med Chem 62: 3898-3923 (2019)
Shandong University
Discovery and Mechanistic Study of Tailor-Made Quinoline Derivatives as Topoisomerase 1 Poison with Potent Anticancer Activity.
J Med Chem 62: 3428-3446 (2019)
Csir-Indian Institute of Chemical Biology
Development of a Highly Potent Analogue and a Long-Acting Analogue of Oxytocin for the Treatment of Social Impairment-Like Behaviors.
J Med Chem 62: 3297-3310 (2019)
Tohoku University and Department of Pharmaceutical Sciences
Structure-Activity Relationships for Itraconazole-Based Triazolone Analogues as Hedgehog Pathway Inhibitors.
J Med Chem 62: 3873-3885 (2019)
University of Connecticut
Structure-Activity Relationship of Purine and Pyrimidine Nucleotides as Ecto-5'-Nucleotidase (CD73) Inhibitors.
J Med Chem 62: 3677-3695 (2019)
National Institute of Diabetes and Digestive and Kidney Diseases
Discovery of Branebrutinib (BMS-986195): A Strategy for Identifying a Highly Potent and Selective Covalent Inhibitor Providing Rapid in Vivo Inactivation of Bruton's Tyrosine Kinase (BTK).
J Med Chem 62: 3228-3250 (2019)
Bristol-Myers Squibb Research and Development
Dihydrophenanthrenes from Juncus effusus as Inhibitors of OAT1 and OAT3.
J Nat Prod 82: 832-839 (2019)
Tianjin University
Identification of Imidazo[1,2-
ACS Med Chem Lett 10: 383-388 (2019)
Bristol-Myers Squibb
Structure-based Discovery of Phenyl (3-Phenylpyrrolidin-3-yl)sulfones as Selective, Orally Active ROR?t Inverse Agonists.
ACS Med Chem Lett 10: 367-373 (2019)
Bristol-Myers Squibb
Antibacterial Strategy against
ACS Med Chem Lett 10: 363-366 (2019)
Texas A&M University
Structure-Activity Relationship Studies of 3- or 4-Pyridine Derivatives of DS-6930.
ACS Med Chem Lett 10: 358-362 (2019)
Daiichi Sankyo
Discovery of Soft-Drug Topical Tool Modulators of Sphingosine-1-phosphate Receptor 1 (S1PR1).
ACS Med Chem Lett 10: 341-347 (2019)
University of Dundee
Fragment-based Discovery of a Small-Molecule Protein Kinase C-iota Inhibitor Binding Post-kinase Domain Residues.
ACS Med Chem Lett 10: 318-323 (2019)
Astar
Identification and Preclinical Evaluation of the Bicyclic Pyrimidine ?-Secretase Modulator BMS-932481.
ACS Med Chem Lett 10: 312-317 (2019)
Bristol-Myers Squibb
Discovery of a JAK1/3 Inhibitor and Use of a Prodrug To Demonstrate Efficacy in a Model of Rheumatoid Arthritis.
ACS Med Chem Lett 10: 306-311 (2019)
Bristol-Myers Squibb
Use of a Conformational-Switching Mechanism to Modulate Exposed Polarity: Discovery of CCR2 Antagonist BMS-741672.
ACS Med Chem Lett 10: 300-305 (2019)
Bristol-Myers Squibb
PROTAC Molecules for the Treatment of Autoimmune Disorders.
ACS Med Chem Lett 10: 276-277 (2019)
Usona Institute
Discovery of Imidazo[1,2-
ACS Med Chem Lett 10: 267-272 (2019)
Sanford Burnham Prebys Medical Discovery Institute
Discovery of VU2957 (Valiglurax): An mGlu
ACS Med Chem Lett 10: 255-260 (2019)
Vanderbilt University
Di-aryl Sulfonamide Motif Adds ?-Stacking Bulk in Negative Allosteric Modulators of the NMDA Receptor.
ACS Med Chem Lett 10: 248-254 (2019)
Emory University
Modulation of AMPA Receptor Gating by the Anticonvulsant Drug, Perampanel.
ACS Med Chem Lett 10: 237-242 (2019)
Cornell University
Modulation of the NOD-like receptors NOD1 and NOD2: A chemist's perspective.
Bioorg Med Chem Lett 29: 1153-1161 (2019)
University of Delaware
Topographical Mapping of Isoform-Selectivity Determinants for J-Channel-Binding Inhibitors of Sphingosine Kinases 1 and 2.
J Med Chem 62: 3658-3676 (2019)
Heriot-Watt University
Fragment-Based Discovery of a Qualified Hit Targeting the Latency-Associated Nuclear Antigen of the Oncogenic Kaposi's Sarcoma-Associated Herpesvirus/Human Herpesvirus 8.
J Med Chem 62: 3924-3939 (2019)
Institute For Pharmaceutical Research Saarland (Hips)-Helmholtz Centre For Infection Research (Hzi
Validation of Phosphodiesterase-10 as a Novel Target for Pulmonary Arterial Hypertension via Highly Selective and Subnanomolar Inhibitors.
J Med Chem 62: 3707-3721 (2019)
Sun Yat-Sen University
Amino Acid Scanning at P5' within the Bowman-Birk Inhibitory Loop Reveals Specificity Trends for Diverse Serine Proteases.
J Med Chem 62: 3696-3706 (2019)
The University of Queensland
New SIRT2 inhibitors: Histidine-based bleomycin spin-off.
Bioorg Med Chem 27: 1767-1775 (2019)
Kumamoto University
Design, synthesis and bioevaluation of 3-oxo-6-aryl-2,3-dihydropyridazine-4-carbohydrazide derivatives as novel xanthine oxidase inhibitors.
Bioorg Med Chem 27: 1818-1823 (2019)
Shenyang Pharmaceutical University
Advancement of multi-target drug discoveries and promising applications in the field of Alzheimer's disease.
Eur J Med Chem 169: 200-223 (2019)
Jining Medical University
Discovery of Bisubstrate Inhibitors for Protein N-Terminal Methyltransferase 1.
J Med Chem 62: 3773-3779 (2019)
Purdue University
Discovery of Novel Spiroindoline Derivatives as Selective Tankyrase Inhibitors.
J Med Chem 62: 3407-3427 (2019)
Riken
Design, synthesis and activity evaluation of indole-based double - Branched HDAC1 inhibitors.
Bioorg Med Chem 27: 1595-1604 (2019)
Shandong University
Design and synthesis of a novel 1H-pyrrolo[3,2-b]pyridine-3-carboxamide derivative as an orally available ACC1 inhibitor.
Bioorg Med Chem 27: 2521-2530 (2019)
Takeda Pharmaceutical
N-Acyl pyrazoles: Effective and tunable inhibitors of serine hydrolases.
Bioorg Med Chem 27: 1693-1703 (2019)
The Scripps Research Institute
Chemical synthesis and biological activity of novel brominated 7-deazaadenosine-3',5'-cyclic monophosphate derivatives.
Bioorg Med Chem 27: 1704-1713 (2019)
University Hospital Jena
Potassium channel blocking 1,2-bis(aryl)ethane-1,2-diamines active as antiarrhythmic agents.
Bioorg Med Chem Lett 29: 1241-1245 (2019)
Astrazeneca
Recent advancements of 4-aminoquinazoline derivatives as kinase inhibitors and their applications in medicinal chemistry.
Eur J Med Chem 170: 55-72 (2019)
Arromax Pharmatech
N-Cinnamoylanthranilates as human TRPA1 modulators: Structure-activity relationships and channel binding sites.
Eur J Med Chem 170: 141-156 (2019)
University of Hull
Design, synthesis and biological evaluation of novel benzothiadiazine derivatives as potent PI3K?-selective inhibitors for treating B-cell-mediated malignancies.
Eur J Med Chem 170: 112-125 (2019)
Zhejiang University
Design, synthesis and evaluation of novel diaryl-1,5-diazoles derivatives bearing morpholine as potent dual COX-2/5-LOX inhibitors and antitumor agents.
Eur J Med Chem 169: 168-184 (2019)
Nanjing University
Design, synthesis and evaluation of novel 7H-pyrrolo[2,3-d]pyrimidin-4-amine derivatives as potent, selective and reversible Bruton's tyrosine kinase (BTK) inhibitors for the treatment of rheumatoid arthritis.
Eur J Med Chem 169: 121-143 (2019)
Sichuan University and Collaborative Innovation Center
Defining Structure-Functional Selectivity Relationships (SFSR) for a Class of Non-Catechol Dopamine D
J Med Chem 62: 3753-3772 (2019)
University of North Carolina At Chapel Hill
Tyrosinase inhibitory study of flavonolignans from the seeds of Silybum marianum (Milk thistle).
Bioorg Med Chem 27: 2499-2507 (2019)
Gyeongsang National University
Essential structure of orexin 1 receptor antagonist YNT-707, part III: Role of the 14-hydroxy and the 3-methoxy groups in antagonistic activity toward the orexin 1 receptor in YNT-707 derivatives lacking the 4,5-epoxy ring.
Bioorg Med Chem 27: 1747-1758 (2019)
University of Tsukuba
Development of Covalent Ligands for G Protein-Coupled Receptors: A Case for the Human Adenosine A
J Med Chem 62: 3539-3552 (2019)
Leiden University
Discovery and Early Clinical Development of an Inhibitor of 5-Lipoxygenase Activating Protein (AZD5718) for Treatment of Coronary Artery Disease.
J Med Chem 62: 4312-4324 (2019)
TBA
Selective Inhibitors of Helicobacter pylori Methylthioadenosine Nucleosidase and Human Methylthioadenosine Phosphorylase.
J Med Chem 62: 3286-3296 (2019)
Albert Einstein College of Medicine
FragLites-Minimal, Halogenated Fragments Displaying Pharmacophore Doublets. An Efficient Approach to Druggability Assessment and Hit Generation.
J Med Chem 62: 3741-3752 (2019)
Newcastle University
Jatrophane Diterpenoids from Euphorbia glomerulans.
J Nat Prod 82: 724-734 (2019)
Chinese Academy of Sciences
Design, synthesis and biological evaluation of 2,5-dimethylfuran-3-carboxylic acid derivatives as potential IDO1 inhibitors.
Bioorg Med Chem 27: 1605-1618 (2019)
China Pharmaceutical University
Designing of acyl sulphonamide based quinoxalinones as multifunctional aldose reductase inhibitors.
Bioorg Med Chem 27: 1658-1669 (2019)
Beijing Institute of Technology
The discovery of quinoline-3-carboxamides as hematopoietic prostaglandin D synthase (H-PGDS) inhibitors.
Bioorg Med Chem 27: 1456-1478 (2019)
Glaxosmithkline
Discovery of novel pyrazole derivatives as potential anticancer agents in MCL.
Bioorg Med Chem Lett 29: 1060-1064 (2019)
Shandong University
A potent seven-membered cyclic BTK (Bruton's tyrosine Kinase) chiral inhibitor conceived by structure-based drug design to lock its bioactive conformation.
Bioorg Med Chem Lett 29: 1074-1078 (2019)
Hoffmann-La Roche
Structural studies of the binding of an antagonistic cyclic peptide to the VEGFR1 domain 2.
Eur J Med Chem 169: 65-75 (2019)
Paris Descartes University
Optimization of Peptidomimetics as Selective Inhibitors for the ?-Catenin/T-Cell Factor Protein-Protein Interaction.
J Med Chem 62: 3617-3635 (2019)
H. Lee Moffitt Cancer Center and Research Institute
4-Aryl Pyrrolidines as a Novel Class of Orally Efficacious Antimalarial Agents. Part 1: Evaluation of 4-Aryl- N-benzylpyrrolidine-3-carboxamides.
J Med Chem 62: 3503-3512 (2019)
Saint Louis University
Structure-based design and synthesis of pyrimidine-4,6-diamine derivatives as Janus kinase 3 inhibitors.
Bioorg Med Chem 27: 1646-1657 (2019)
China Pharmaceutical University
C-6?- vs C-7?-Substituted Steroidal Aromatase Inhibitors: Which Is Better? Synthesis, Biochemical Evaluation, Docking Studies, and Structure-Activity Relationships.
J Med Chem 62: 3636-3657 (2019)
University of Coimbra
Synthesis of urea analogues bearing N-alkyl-N'-(thiophen-2-yl) scaffold and evaluation of their innate immune response to toll-like receptors.
Eur J Med Chem 169: 42-52 (2019)
Southern Medical University
Design, synthesis and structure-activity relationships of novel macrolones: Hybrids of 2-fluoro 9-oxime ketolides and carbamoyl quinolones with highly improved activity against resistant pathogens.
Eur J Med Chem 169: 1-20 (2019)
Beijing Institute of Technology
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
Bioorg Med Chem Lett 29: 1106-1112 (2019)
Indiana University School of Medicine
?-Carboline and N-hydroxycinnamamide hybrids as anticancer agents for drug-resistant hepatocellular carcinoma.
Eur J Med Chem 168: 515-526 (2019)
Nantong University
Novel tacrine-tryptophan hybrids: Multi-target directed ligands as potential treatment for Alzheimer's disease.
Eur J Med Chem 168: 491-514 (2019)
University of Hradec Kralove
Structural requirement of tunicamycin V for MraY inhibition.
Bioorg Med Chem 27: 1714-1719 (2019)
Hokkaido University
Inhibition of the FAD containing ER oxidoreductin 1 (Ero1) protein by EN-460 as a strategy for treatment of multiple myeloma.
Bioorg Med Chem 27: 1479-1488 (2019)
West Virginia University
Synthesis and biological evaluation of solubilized sulfonamide analogues of the phosphatidylinositol 3-kinase inhibitor ZSTK474.
Bioorg Med Chem 27: 1529-1545 (2019)
University of Auckland
Discovery of novel selective Janus kinase 2 (JAK2) inhibitors bearing a 1H-pyrazolo[3,4-d]pyrimidin-4-amino scaffold.
Bioorg Med Chem 27: 1562-1576 (2019)
China Pharmaceutical University
Discovery and development of novel rhodanine derivatives targeting enoyl-acyl carrier protein reductase.
Bioorg Med Chem 27: 1509-1516 (2019)
Nanjing University
Discovery of new ureido benzenesulfonamides incorporating 1,3,5-triazine moieties as carbonic anhydrase I, II, IX and XII inhibitors.
Bioorg Med Chem 27: 1588-1594 (2019)
Adiyaman University
Design, synthesis and biological evaluation of 1,4-dihydroxyanthraquinone derivatives as anticancer agents.
Bioorg Med Chem Lett 29: 1120-1126 (2019)
Guangxi University
Recent developments in the synthesis and applications of phosphinic peptide analogs.
Bioorg Med Chem Lett 29: 1031-1042 (2019)
Wroclaw University of Technology
Chemical manipulations on the 1,4-dioxane ring of 5-HT
Eur J Med Chem 168: 461-473 (2019)
University of Camerino
Discovery of Novel Bromophenol-Thiosemicarbazone Hybrids as Potent Selective Inhibitors of Poly(ADP-ribose) Polymerase-1 (PARP-1) for Use in Cancer.
J Med Chem 62: 3051-3067 (2019)
Chinese Academy of Sciences
Optimization of P2Y
J Med Chem 62: 3088-3106 (2019)
East China Normal University
Synthesis and Biological Studies of (+)-Liquiditerpenoic Acid A (Abietopinoic Acid) and Representative Analogues: SAR Studies.
J Nat Prod 82: 823-831 (2019)
Universitat Polit£Cnica De Valencia-Consejo Superior De Investigaciones Cient£Ficas
Inhibitory Properties of ATP-Competitive Coumestrol and Boldine Are Correlated to Different Modulations of CK2 Flexibility.
J Nat Prod 82: 1014-1018 (2019)
University of Padua and Institute of Biomolecular Chemistry
Optimization of Potent and Selective Ataxia Telangiectasia-Mutated Inhibitors Suitable for a Proof-of-Concept Study in Huntington's Disease Models.
J Med Chem 62: 2988-3008 (2019)
Chdi Management/Chdi Foundation
Fusicoccane Diterpenes from Hypoestes forsskaolii as Heat Shock Protein 90 (Hsp90) Modulators.
J Nat Prod 82: 539-549 (2019)
University of Salerno
Potent and Highly Selective Aldo-Keto Reductase 1C3 (AKR1C3) Inhibitors Act as Chemotherapeutic Potentiators in Acute Myeloid Leukemia and T-Cell Acute Lymphoblastic Leukemia.
J Med Chem 62: 3590-3616 (2019)
Texas Tech University Health Sciences Center
A
J Med Chem 62: 4032-4055 (2019)
Rheinische Friedrich-Wilhelms-Universitat Bonn
The impact of binding site waters on the activity/selectivity trade-off of Janus kinase 2 (JAK2) inhibitors.
Bioorg Med Chem 27: 1497-1508 (2019)
Hungarian Academy of Sciences
Discovery of NR2B-selective antagonists via scaffold hopping and pharmacokinetic profile optimization.
Bioorg Med Chem Lett 29: 1143-1147 (2019)
Shionogi
Discovery of novel 2,3-dihydro-1H-inden-1-amine derivatives as selective monoamine oxidase B inhibitors.
Bioorg Med Chem Lett 29: 1090-1093 (2019)
Hefei University of Technology
3-Acyltetramic acids as a novel class of inhibitors for human kallikreins 5 and 7.
Bioorg Med Chem Lett 29: 1094-1098 (2019)
Universidade Federal Fluminense
Potential Anticancer Agents Characterized from Selected Tropical Plants.
J Nat Prod 82: 657-679 (2019)
The Ohio State University
Discovery of Irreversible p97 Inhibitors.
J Med Chem 62: 2814-2829 (2019)
University of Minnesota
Development of 5-Aminopyrazole-4-carboxamide-based Bumped-Kinase Inhibitors for Cryptosporidiosis Therapy.
J Med Chem 62: 3135-3146 (2019)
University of Washington
Structural Basis of TLR2/TLR1 Activation by the Synthetic Agonist Diprovocim.
J Med Chem 62: 2938-2949 (2019)
University of Pittsburgh
Expansion of a novel lead targeting M. tuberculosis DHFR as antitubercular agents.
Bioorg Med Chem 27: 1421-1429 (2019)
Jamia Hamdard
Discovery of Isaindigotone Derivatives as Novel Bloom's Syndrome Protein (BLM) Helicase Inhibitors That Disrupt the BLM/DNA Interactions and Regulate the Homologous Recombination Repair.
J Med Chem 62: 3147-3162 (2019)
Sun Yat-Sen University
Fluorination of Photoswitchable Muscarinic Agonists Tunes Receptor Pharmacology and Photochromic Properties.
J Med Chem 62: 3009-3020 (2019)
Julius Maximilian University of W£Rzburg
Comprehensive review on the anti-bacterial activity of 1,2,3-triazole hybrids.
Eur J Med Chem 168: 357-372 (2019)
Anshan Normal University
Inhibiting A? toxicity in Alzheimer's disease by a pyridine amine derivative.
Eur J Med Chem 168: 330-339 (2019)
Nanjing University
Design, synthesis and docking study of novel picolinamide derivatives as anticancer agents and VEGFR-2 inhibitors.
Eur J Med Chem 168: 315-329 (2019)
Mansoura University
Pyridazinone-substituted benzenesulfonamides display potent inhibition of membrane-bound human carbonic anhydrase IX and promising antiproliferative activity against cancer cell lines.
Eur J Med Chem 168: 301-314 (2019)
Saint Petersburg State University
Thieno[2,3-d]pyrimidine as a promising scaffold in medicinal chemistry: Recent advances.
Bioorg Med Chem 27: 1159-1194 (2019)
University of Science & Technology (Ust)
Discovery of a small molecule RXFP3/4 agonist that increases food intake in rats upon acute central administration.
Bioorg Med Chem Lett 29: 991-994 (2019)
Novartis Institutes For Biomedical Research
Design, synthesis and biological evaluation of imidazo[1,5-a]pyrazin-8(7H)-one derivatives as BRD9 inhibitors.
Bioorg Med Chem 27: 1391-1404 (2019)
China Pharmaceutical University
Design, synthesis and biological evaluation of pyridone-aminal derivatives as MNK1/2 inhibitors.
Bioorg Med Chem 27: 1211-1225 (2019)
China Pharmaceutical University
Rational design of allosteric modulators of the aromatase enzyme: An unprecedented therapeutic strategy to fight breast cancer.
Eur J Med Chem 168: 253-262 (2019)
Cnr-Iom-Democritos C/O International School For Advanced Studies (Sissa)
Discovery of arylbenzylamines as PDE4 inhibitors with potential neuroprotective effect.
Eur J Med Chem 168: 221-231 (2019)
Southern Medical University
Design, synthesis, and evaluation of isoflavone analogs as multifunctional agents for the treatment of Alzheimer's disease.
Eur J Med Chem 168: 207-220 (2019)
Chinese Academy of Medical Sciences and Peking Union Medical College
(2S)-N-2-methoxy-2-phenylethyl-6,7-benzomorphan compound (2S-LP2): Discovery of a biased mu/delta opioid receptor agonist.
Eur J Med Chem 168: 189-198 (2019)
University of Catania
Advances in inhibition of protein-protein interactions targeting hypoxia-inducible factor-1 for cancer therapy.
Bioorg Med Chem 27: 1145-1158 (2019)
China Pharmaceutical University
Discovery of (S)-6-methoxy-chroman-3-carboxylic acid (4-pyridin-4-yl-phenyl)-amide as potent and isoform selective ROCK2 inhibitors.
Bioorg Med Chem 27: 1382-1390 (2019)
Shanghai Institute of Technology
Shooting three inflammatory targets with a single bullet: Novel multi-targeting anti-inflammatory glitazones.
Eur J Med Chem 167: 562-582 (2019)
Alexandria University
Synthesis of new arylsulfonylspiroimidazolidine-2',4'-diones and study of their effect on stimulation of insulin release from MIN6 cell line, inhibition of human aldose reductase, sorbitol accumulations in various tissues and oxidative stress.
Eur J Med Chem 168: 154-175 (2019)
Quaid-I-Azam University
Allosteric Modulator Discovery: From Serendipity to Structure-Based Design.
J Med Chem 62: 6405-6421 (2019)
Shanghai Jiao-Tong University School of Medicine
Plant-Based Modulators of Endocannabinoid Signaling.
J Nat Prod 82: 636-646 (2019)
Concordia University Wisconsin
Novel multi-target directed ligands based on annelated xanthine scaffold with aromatic substituents acting on adenosine receptor and monoamine oxidase B. Synthesis, in vitro and in silico studies.
Bioorg Med Chem 27: 1195-1210 (2019)
Jagiellonian University Medical College
Electrostatic Complementarity as a Fast and Effective Tool to Optimize Binding and Selectivity of Protein-Ligand Complexes.
J Med Chem 62: 3036-3050 (2019)
Cresset
Discovery and optimization of novel piperazines as potent inhibitors of fatty acid synthase (FASN).
Bioorg Med Chem Lett 29: 1001-1006 (2019)
Forma Therapeutics
3,5-Dialkoxypyridine analogues of bedaquiline are potent antituberculosis agents with minimal inhibition of the hERG channel.
Bioorg Med Chem 27: 1292-1307 (2019)
Auckland Cancer Society Research Centre
Development of Highly Potent, Selective, and Cellular Active Triazolo[1,5- a]pyrimidine-Based Inhibitors Targeting the DCN1-UBC12 Protein-Protein Interaction.
J Med Chem 62: 2772-2797 (2019)
Zhengzhou University
Discovery of novel triazolo[4,3-b]pyridazin-3-yl-quinoline derivatives as PIM inhibitors.
Eur J Med Chem 168: 87-109 (2019)
Spanish National Cancer Research Centre (Cnio)
Design, synthesis and biological evaluation of novel isoindolinone derivatives as potent histone deacetylase inhibitors.
Eur J Med Chem 168: 110-122 (2019)
Northwest A&F University
Optimization of Blood-Brain Barrier Permeability with Potent and Selective Human Neuronal Nitric Oxide Synthase Inhibitors Having a 2-Aminopyridine Scaffold.
J Med Chem 62: 2690-2707 (2019)
Northwestern University
?-Lactones: A Novel Class of Ca
J Med Chem 62: 2916-2927 (2019)
National and Kapodistrian University of Athens
Design, biological evaluation and X-ray crystallography of nanomolar multifunctional ligands targeting simultaneously acetylcholinesterase and glycogen synthase kinase-3.
Eur J Med Chem 168: 58-77 (2019)
Cnrs
Synthesis and biological evaluation of anthraquinone derivatives as allosteric phosphoglycerate mutase 1 inhibitors for cancer treatment.
Eur J Med Chem 168: 45-57 (2019)
Fudan University
Lead optimization and biological evaluation of fragment-based cN-II inhibitors.
Eur J Med Chem 168: 28-44 (2019)
University of Montpellier
Design and development of novel N-(pyrimidin-2-yl)-1,3,4-oxadiazole hybrids to treat cognitive dysfunctions.
Bioorg Med Chem 27: 1327-1340 (2019)
Indian Institute of Technology (Banaras Hindu University)
Modulation of autophagy by the novel mitochondrial complex I inhibitor Authipyrin.
Bioorg Med Chem 27: 2444-2448 (2019)
Tu Dortmund University
Bialternacins A-F, Aromatic Polyketide Dimers from an Endophytic Alternaria sp.
J Nat Prod 82: 792-797 (2019)
Nanjing University
Alkyl derivatives of 1,3,5-triazine as histamine H
Bioorg Med Chem 27: 1254-1262 (2019)
Jagiellonian University Medical College
Ketamine esters and amides as short-acting anaesthetics: Structure-activity relationships for the side-chain.
Bioorg Med Chem 27: 1226-1231 (2019)
University of Auckland
Structure-activity relationships for unit C pyridyl analogues of the tuberculosis drug bedaquiline.
Bioorg Med Chem 27: 1283-1291 (2019)
University of Auckland
Specificity of extended O-aryloxycarbonyl hydroxamates as inhibitors of a class C ?-lactamase.
Bioorg Med Chem 27: 1430-1436 (2019)
Wesleyan University
Semisynthesis of epoxy-pimarane diterpenoids from kirenol and their FXa inhibition activities.
Bioorg Med Chem 27: 1320-1326 (2019)
Peking University
Design and molecular modeling of novel P38? MAPK inhibitors targeting breast cancer, synthesized from oxygen heterocyclic natural compounds.
Bioorg Med Chem 27: 1308-1319 (2019)
National Research Centre
Design, synthesis and biological evaluation of novel human monoamine oxidase B inhibitors based on a fragment in an X-ray crystal structure.
Bioorg Med Chem Lett 29: 1012-1018 (2019)
Hefei University of Technology
Discovery and lead optimisation of a potent, selective and orally bioavailable RAR? agonist for the potential treatment of nerve injury.
Bioorg Med Chem Lett 29: 995-1000 (2019)
King'S College
Designing Dual Inhibitors of Anaplastic Lymphoma Kinase (ALK) and Bromodomain-4 (BRD4) by Tuning Kinase Selectivity.
J Med Chem 62: 2618-2637 (2019)
The Institute of Cancer Research
DPD-Inspired Discovery of Novel LsrK Kinase Inhibitors: An Opportunity To Fight Antimicrobial Resistance.
J Med Chem 62: 2720-2737 (2019)
University of Pavia
Identification and Preclinical Pharmacology of ((1 R,3 S)-1-Amino-3-(( S)-6-(2-methoxyphenethyl)-5,6,7,8-tetrahydronaphthalen-2-yl)cyclopentyl)methanol (BMS-986166): A Differentiated Sphingosine-1-phosphate Receptor 1 (S1P
J Med Chem 62: 2265-2285 (2019)
Bristol-Myers Squibb Research and Development
Synthesis, in vitro and in vivo biological evaluation of substituted 3-(5-imidazo[2,1-b]thiazolylmethylene)-2-indolinones as new potent anticancer agents.
Eur J Med Chem 166: 514-530 (2019)
University of Bologna
Design and development of multitarget-directed N-Benzylpiperidine analogs as potential candidates for the treatment of Alzheimer's disease.
Eur J Med Chem 167: 510-524 (2019)
Indian Institute of Technology (Banaras Hindu University)
Design, synthesis, and biological evaluation of truncated deguelin derivatives as Hsp90 inhibitors.
Eur J Med Chem 167: 485-498 (2019)
China Pharmaceutical University
Efficient click chemistry towards novel 1H-1,2,3-triazole-tethered 4H-chromene-d-glucose conjugates: Design, synthesis and evaluation of in vitro antibacterial, MRSA and antifungal activities.
Eur J Med Chem 167: 454-471 (2019)
Vnu University of Science (Vietnam National University)
Progress in the development of selective heme oxygenase-1 inhibitors and their potential therapeutic application.
Eur J Med Chem 167: 439-453 (2019)
University of Catania
An Isoquinoline Scaffold as a Novel Class of Allosteric HIV-1 Integrase Inhibitors.
ACS Med Chem Lett 10: 215-220 (2019)
The Ohio State University
Computer-Assisted Discovery and Structural Optimization of a Novel Retinoid X Receptor Agonist Chemotype.
ACS Med Chem Lett 10: 203-208 (2019)
Goethe-University Frankfurt
Aryl Substituted Benzimidazolones as Potent HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors.
ACS Med Chem Lett 10: 196-202 (2019)
Stellenbosch University
Cytosine-Based TET Enzyme Inhibitors.
ACS Med Chem Lett 10: 180-185 (2019)
Bates College
Discovery of Nonstandard Macrocyclic Peptides as Noncompetitive Inhibitors of the Zika Virus NS2B-NS3 Protease.
ACS Med Chem Lett 10: 168-174 (2019)
Australian National University
Novel Bis-heteroaryl Derivatives To Modulate Protein Aggregation for the Treatment of Neurodegenerative Diseases.
ACS Med Chem Lett 10: (2019)
Drexel University
Imidazoquinolines as Novel Inhibitors of LRRK2 Kinase Activity.
ACS Med Chem Lett 10: 148-149 (2019)
Drexel University
Diazaspirononane Inhibitors of O-GlcNAc Hydrolase for the Treatment of Central Nervous System Diseases.
ACS Med Chem Lett 10: (2019)
Drexel University
TRPV1 Modulators for the Treatment of Pain and Inflammation.
ACS Med Chem Lett 10: 143-144 (2019)
Usona Institute
Synthesis, structure-activity relationship studies and biological characterization of new [1,2,4]triazolo[1,5-a]pyrimidine-based LSD1/KDM1A inhibitors.
Eur J Med Chem 167: 388-401 (2019)
Zhengzhou University
Binding to an Unusual Inactive Kinase Conformation by Highly Selective Inhibitors of Inositol-Requiring Enzyme 1? Kinase-Endoribonuclease.
J Med Chem 62: 2447-2465 (2019)
University of Leicester
Design and synthesis of potent myostatin inhibitory cyclic peptides.
Bioorg Med Chem 27: 1437-1443 (2019)
Tokyo University of Pharmacy and Life Sciences
Screening oxime libraries by means of mass spectrometry (MS) binding assays: Identification of new highly potent inhibitors to optimized inhibitors ?-aminobutyric acid transporter 1.
Bioorg Med Chem 27: 1232-1245 (2019)
Ludwig-Maximilians-University M£Nchen
Discovery of 3,6-diaryl-1H-pyrazolo[3,4-b]pyridines as potent anaplastic lymphoma kinase (ALK) inhibitors.
Bioorg Med Chem Lett 29: 912-916 (2019)
Zhejiang University
Ligand-based design, synthesis and biochemical evaluation of potent and selective inhibitors of Schistosoma mansoni dihydroorotate dehydrogenase.
Eur J Med Chem 167: 357-366 (2019)
Universidade De S£O Paulo
Revealing quinquennial anticancer journey of morpholine: A SAR based review.
Eur J Med Chem 167: 324-356 (2019)
Jamia Hamdard
The in vivo antinociceptive and ?-opioid receptor activating effects of the combination of N-phenyl-2',4'-dimethyl-4,5'-bi-1,3-thiazol-2-amines and naloxone.
Eur J Med Chem 167: 312-323 (2019)
National Health Research Institutes
Another look at phenolic compounds in cancer therapy the effect of polyphenols on ubiquitin-proteasome system.
Eur J Med Chem 167: 291-311 (2019)
Institute of Agricultural and Food Biotechnology
An optimised series of substituted N-phenylpyrrolamides as DNA gyrase B inhibitors.
Eur J Med Chem 167: 269-290 (2019)
University of Ljubljana
Identification and Characterization of AES-135, a Hydroxamic Acid-Based HDAC Inhibitor That Prolongs Survival in an Orthotopic Mouse Model of Pancreatic Cancer.
J Med Chem 62: 2651-2665 (2019)
University of Toronto Mississauga
Discovery of Second Generation ROR? Inhibitors Composed of an Azole Scaffold.
J Med Chem 62: 2837-2842 (2019)
Kyoto Prefectural University of Medicine
Development of a novel NURR1/NOT agonist from hit to lead and candidate for the potential treatment of Parkinson's disease.
Bioorg Med Chem Lett 29: 929-932 (2019)
Sanofi
Structure-based design, synthesis and biological evaluation of a novel series of isoquinolone and pyrazolo[4,3-c]pyridine inhibitors of fascin 1 as potential anti-metastatic agents.
Bioorg Med Chem Lett 29: 1023-1029 (2019)
Cruk Beatson Institute
4,6-Substituted-1H-Indazoles as potent IDO1/TDO dual inhibitors.
Bioorg Med Chem 27: 1087-1098 (2019)
Xihua University
Design, synthesis and biological evaluation of inhibitors of cathepsin K on dedifferentiated chondrocytes.
Bioorg Med Chem 27: 1034-1042 (2019)
Jilin University
A novel, potent, and orally bioavailable thiazole HCV NS5A inhibitor for the treatment of hepatitis C virus.
Eur J Med Chem 167: 245-268 (2019)
National Health Research Institutes
Synthesis and evaluation of novel GSK-3? inhibitors as multifunctional agents against Alzheimer's disease.
Eur J Med Chem 167: 211-225 (2019)
Shandong University
Discovery of 4'-OH-flurbiprofen Mannich base derivatives as potential Alzheimer's disease treatment with multiple inhibitory activities.
Bioorg Med Chem 27: 991-1001 (2019)
Sichuan University
Design, synthesis and biological evaluation of low molecular weight CXCR4 ligands.
Bioorg Med Chem 27: 1130-1138 (2019)
Tokyo Medical and Dental University (Tmdu)
Tackling neuroinflammation and cholinergic deficit in Alzheimer's disease: Multi-target inhibitors of cholinesterases, cyclooxygenase-2 and 15-lipoxygenase.
Eur J Med Chem 167: 161-186 (2019)
Alexandria University
Discovery of a new class of MTH1 inhibitor by X-ray crystallographic screening.
Eur J Med Chem 167: 153-160 (2019)
University of Toyama
Synthesis and evaluation of tetrahydroisoquinoline-benzimidazole hybrids as multifunctional agents for the treatment of Alzheimer's disease.
Eur J Med Chem 167: 133-145 (2019)
Sun Yat-Sen University
Binding of thiazolidinediones to the endoplasmic reticulum protein nutrient-deprivation autophagy factor-1.
Bioorg Med Chem Lett 29: 901-904 (2019)
West Virginia University
Clinical candidates modulating protein-protein interactions: The fragment-based experience.
Eur J Med Chem 167: 76-95 (2019)
Taros Chemicals
First-in-class allosteric inhibitors of bacterial IMPDHs.
Eur J Med Chem 167: 124-132 (2019)
France
Design and synthesis of aminothiazolyl norfloxacin analogues as potential antimicrobial agents and their biological evaluation.
Eur J Med Chem 167: 105-123 (2019)
Southwest University
Pharmacological urate-lowering approaches in chronic kidney disease.
Eur J Med Chem 166: 186-196 (2019)
West China Hospital of Sichuan University
Targeting the MKK7-JNK (Mitogen-Activated Protein Kinase Kinase 7-c-Jun N-Terminal Kinase) Pathway with Covalent Inhibitors.
J Med Chem 62: 2843-2848 (2019)
Tu Dortmund University
SGC-GAK-1: A Chemical Probe for Cyclin G Associated Kinase (GAK).
J Med Chem 62: 2830-2836 (2019)
Johann Wolfgang Goethe University
Highly potent and selective aryl-1,2,3-triazolyl benzylpiperidine inhibitors toward butyrylcholinesterase in Alzheimer's disease.
Bioorg Med Chem 27: 931-943 (2019)
University of S£O Paulo
Identification of an indol-based multi-target kinase inhibitor through phenotype screening and target fishing using inverse virtual screening approach.
Eur J Med Chem 167: 61-75 (2019)
University of Naples Federico Ii
Design of N-Benzoxaborole Benzofuran GSK8175-Optimization of Human Pharmacokinetics Inspired by Metabolites of a Failed Clinical HCV Inhibitor.
J Med Chem 62: 3254-3267 (2019)
Glaxosmithkline
Discovery of 2-(Imidazo[1,2- b]pyridazin-2-yl)acetic Acid as a New Class of Ligands Selective for the ?-Hydroxybutyric Acid (GHB) High-Affinity Binding Sites.
J Med Chem 62: 2798-2813 (2019)
University of Copenhagen
Design, Synthesis, and Biological Evaluation of Novel Allosteric Protein Disulfide Isomerase Inhibitors.
J Med Chem 62: 3447-3474 (2019)
University of Michigan
Optimization of 5,6,7,8-tetrahydropyrido[4,3-d]pyrimidines to generate a highly selective PI3K? inhibitor.
Bioorg Med Chem 27: 1056-1064 (2019)
Astellas Pharma
Optimization of an azetidine series as inhibitors of colony stimulating factor-1 receptor (CSF-1R) Type II to lead to the clinical candidate JTE-952.
Bioorg Med Chem Lett 29: 873-877 (2019)
Japan Tobacco
Discovery of a Novel Chemotype of Histone Lysine Methyltransferase EHMT1/2 (GLP/G9a) Inhibitors: Rational Design, Synthesis, Biological Evaluation, and Co-crystal Structure.
J Med Chem 62: 2666-2689 (2019)
The University of Texas M.D. Anderson Cancer Center
Identification of novel lysine demethylase 5-selective inhibitors by inhibitor-based fragment merging strategy.
Bioorg Med Chem 27: 1119-1129 (2019)
Kyoto Prefectural University of Medicine
Discovery of novel thienoquinoline-2-carboxamide chalcone derivatives as antiproliferative EGFR tyrosine kinase inhibitors.
Bioorg Med Chem 27: 1076-1086 (2019)
Al-Azhar University
Anti-cholinesterase hybrids as multi-target-directed ligands against Alzheimer's disease (1998-2018).
Bioorg Med Chem 27: 895-930 (2019)
Csir-Central Drug Research Institute
Discovery of N-indanyl benzamides as potent ROR?t inverse agonists.
Eur J Med Chem 167: 37-48 (2019)
Fudan University
Toward the discovery and development of effective modulators of ?-synuclein amyloid aggregation.
Eur J Med Chem 167: 10-36 (2019)
University of Catania
Virtual Screening Identifies Irreversible FMS-like Tyrosine Kinase 3 Inhibitors with Activity toward Resistance-Conferring Mutations.
J Med Chem 62: 2428-2446 (2019)
Technische Universit£T Darmstadt
Discovery of Polypharmacological Melanocortin-3 and -4 Receptor Probes and Identification of a 100-Fold Selective nM MC3R Agonist versus a ?M MC4R Partial Agonist.
J Med Chem 62: 2738-2749 (2019)
University of Minnesota
Experience-based discovery (EBD) of aryl hydrazines as new scaffolds for the development of LSD1/KDM1A inhibitors.
Eur J Med Chem 166: 432-444 (2019)
Zhengzhou University
Aurone: A biologically attractive scaffold as anticancer agent.
Eur J Med Chem 166: 417-431 (2019)
King Khalid University
An overview of grayanane diterpenoids and their biological activities from the Ericaceae family in the last seven years.
Eur J Med Chem 166: 400-416 (2019)
Northwest A & F University
Pharmacophore-based design of novel 3-hydroxypyrimidine-2,4-dione subtypes as inhibitors of HIV reverse transcriptase-associated RNase H: Tolerance of a nonflexible linker.
Eur J Med Chem 166: 390-399 (2019)
University of Minnesota
Tacrines for Alzheimer's disease therapy. III. The PyridoTacrines.
Eur J Med Chem 166: 381-389 (2019)
Hospital Universitario De La Princesa
Highly Selective PTK2 Proteolysis Targeting Chimeras to Probe Focal Adhesion Kinase Scaffolding Functions.
J Med Chem 62: 2508-2520 (2019)
Boehringer Ingelheim Rcv
Synthesis of 2-,4,-6-, and/or 7-substituted quinoline derivatives as human dihydroorotate dehydrogenase (hDHODH) inhibitors and anticancer agents: 3D QSAR-assisted design.
Bioorg Med Chem Lett 29: 917-922 (2019)
Nirma University
Synthesis and urease inhibitory potential of benzophenone sulfonamide hybrid in vitro and in silico.
Bioorg Med Chem 27: 1009-1022 (2019)
University of Karachi
Inhibition of a viral prolyl hydroxylase.
Bioorg Med Chem 27: 2405-2412 (2019)
University of Oxford
SYA 013 analogs as moderately selective sigma-2 (?
Bioorg Med Chem 27: 2421-2426 (2019)
Florida A&M University
Leucine ureido derivatives as aminopeptidase N inhibitors using click chemistry. Part II.
Bioorg Med Chem 27: 978-990 (2019)
Shandong University
Synthesis, biological evaluation, and molecular docking study of novel allyl-retrochalcones as a new class of protein tyrosine phosphatase 1B inhibitors.
Bioorg Med Chem 27: 963-977 (2019)
Wenzhou Medical University
Histone deacetylase 3 inhibitors in learning and memory processes with special emphasis on benzamides.
Eur J Med Chem 166: 369-380 (2019)
Jadavpur University
Histone methyl transferases: A class of epigenetic opportunities to counter uncontrolled cell proliferation.
Eur J Med Chem 166: 351-368 (2019)
Punjabi University
Discovery of an SSTR2-Targeting Maytansinoid Conjugate (PEN-221) with Potent Activity in Vitro and in Vivo.
J Med Chem 62: 2708-2719 (2019)
Tarveda Therapeutics
Structure-Based Design of N-(5-Phenylthiazol-2-yl)acrylamides as Novel and Potent Glutathione S-Transferase Omega 1 Inhibitors.
J Med Chem 62: 3068-3087 (2019)
Sichuan University
A review on flavones targeting serine/threonine protein kinases for potential anticancer drugs.
Bioorg Med Chem 27: 677-685 (2019)
China Pharmaceutical University
Unexpected equivalent potency of a constrained chromene enantiomeric pair rationalized by co-crystal structures in complex with estrogen receptor alpha.
Bioorg Med Chem Lett 29: 905-911 (2019)
Genentech
Design and synthesis of novel dual-cyclic RGD peptides for ?
Bioorg Med Chem Lett 29: 896-900 (2019)
Nanchang University
New pyrido[3,4-g]quinazoline derivatives as CLK1 and DYRK1A inhibitors: synthesis, biological evaluation and binding mode analysis.
Eur J Med Chem 166: 304-317 (2019)
University of Clermont Auvergne
Structure-based drug design, synthesis, In vitro, and In vivo biological evaluation of indole-based biomimetic analogs targeting estrogen receptor-? inhibition.
Eur J Med Chem 166: 281-290 (2019)
The British University In Egypt
Discovery of Lipophilic Bisphosphonates That Target Bacterial Cell Wall and Quinone Biosynthesis.
J Med Chem 62: 2564-2581 (2019)
Chinese Academy of Sciences
Fragment-based screening of programmed death ligand 1 (PD-L1).
Bioorg Med Chem Lett 29: 786-790 (2019)
Vanderbilt University
Design, synthesis, and screening of novel ursolic acid derivatives as potential anti-cancer agents that target the HIF-1? pathway.
Bioorg Med Chem Lett 29: 853-858 (2019)
Yanbian University College of Pharmacy
Synthesis and biological evaluation of nitroxide labeled pyrimidines as Aurora kinase inhibitors.
Bioorg Med Chem Lett 29: 694-699 (2019)
Lanzhou University
Pyrrolinone derivatives as a new class of P2X3 receptor antagonists Part 2: Discovery of orally bioavailable compounds.
Bioorg Med Chem Lett 29: 688-693 (2019)
Shionogi
Synthesis and biological evaluation of new long-chain squaramides as anti-chagasic agents in the BALB/c mouse model.
Bioorg Med Chem 27: 865-879 (2019)
Hospitales Universitarios De Granada/University of Granada
DDX3X Helicase Inhibitors as a New Strategy To Fight the West Nile Virus Infection.
J Med Chem 62: 2333-2347 (2019)
University of Siena
Exploiting the Tolerant Region I of the Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) Binding Pocket: Discovery of Potent Diarylpyrimidine-Typed HIV-1 NNRTIs against Wild-Type and E138K Mutant Virus with Significantly Improved Water Solubility and Favorable Safety Profiles.
J Med Chem 62: 2083-2098 (2019)
Shandong University
Novel Aryloxyethyl Derivatives of 1-(1-Benzoylpiperidin-4-yl)methanamine as the Extracellular Regulated Kinases 1/2 (ERK1/2) Phosphorylation-Preferring Serotonin 5-HT
J Med Chem 62: 2750-2771 (2019)
Jagiellonian University Medical College
3,17?-Bis-sulfamoyloxy-2-methoxyestra-1,3,5(10)-triene and Nonsteroidal Sulfamate Derivatives Inhibit Carbonic Anhydrase IX: Structure-Activity Optimization for Isoform Selectivity.
J Med Chem 62: 2202-2212 (2019)
University of Florida
Discovery and Optimization of Selective and in Vivo Active Inhibitors of the Lysophosphatidylserine Lipase ?/?-Hydrolase Domain-Containing 12 (ABHD12).
J Med Chem 62: 1643-1656 (2019)
The Scripps Research Institute
Propolis Components from Stingless Bees Collected on South Sulawesi, Indonesia, and Their Xanthine Oxidase Inhibitory Activity.
J Nat Prod 82: 205-210 (2019)
University of Shizuoka
Discovery, synthesis and characterization of a series of (1-alkyl-3-methyl-1H-pyrazol-5-yl)-2-(5-aryl-2H-tetrazol-2-yl)acetamides as novel GIRK1/2 potassium channel activators.
Bioorg Med Chem Lett 29: 791-796 (2019)
University of Nebraska Medical Center
Synthesis and biological evaluation of novel N-substituted nipecotic acid derivatives with a cis-alkene spacer as GABA uptake inhibitors.
Bioorg Med Chem 27: 822-831 (2019)
Ludwig-Maximilians-Universit£T M£Nchen
Development of bioactive gemcitabine-D-Lys
Eur J Med Chem 166: 256-266 (2019)
University of Ioannina
Optimization of Pan-Pim Kinase Activity and Oral Bioavailability Leading to Diaminopyrazole (GDC-0339) for the Treatment of Multiple Myeloma.
J Med Chem 62: 2140-2153 (2019)
Genentech
Optimization of a Benzoylpiperidine Class Identifies a Highly Potent and Selective Reversible Monoacylglycerol Lipase (MAGL) Inhibitor.
J Med Chem 62: 1932-1958 (2019)
University of Pisa
New Quinolylnitrones for Stroke Therapy: Antioxidant and Neuroprotective ( Z)- N- tert-Butyl-1-(2-chloro-6-methoxyquinolin-3-yl)methanimine Oxide as a New Lead-Compound for Ischemic Stroke Treatment.
J Med Chem 62: 2184-2201 (2019)
Iqog, Csic
Corrected Structure of Natural Hyacinthacine C
J Nat Prod 82: 358-367 (2019)
University of Wollongong
Development of an N-Acyl Amino Acid That Selectively Inhibits the Glycine Transporter 2 To Produce Analgesia in a Rat Model of Chronic Pain.
J Med Chem 62: 2466-2484 (2019)
University of Sydney
Tranylcypromine and 6-trifluoroethyl thienopyrimidine hybrid as LSD1 inhibitor.
Bioorg Med Chem Lett 29: 844-847 (2019)
Liaoning Shihua University
Rational drug design for androgen receptor and glucocorticoids receptor dual antagonist.
Eur J Med Chem 166: 232-242 (2019)
Zhejiang Normal University
Toward a treatment of diabesity: In vitro and in vivo evaluation of uncharged bromophenol derivatives as a new series of PTP1B inhibitors.
Eur J Med Chem 166: 178-185 (2019)
Chinese Academy of Sciences
Discovery of novel pan-genotypic HCV NS5A inhibitors containing a novel tetracyclic core.
Bioorg Med Chem Lett 29: 700-706 (2019)
Merck
Design, synthesis and algicides activities of thiourea derivatives as the novel scaffold aldolase inhibitors.
Bioorg Med Chem 27: 805-812 (2019)
International Cooperation Base of Pesticide and Green Synthesis (Hubei)
Pyrrolomycins as antimicrobial agents. Microwave-assisted organic synthesis and insights into their antimicrobial mechanism of action.
Bioorg Med Chem 27: 721-728 (2019)
University of Palermo
New evolutions in the BACE1 inhibitor field from 2014 to 2018.
Bioorg Med Chem Lett 29: 761-777 (2019)
Janssen Research & Development
Optimizing TRPM4 inhibitors in the MHFP6 chemical space.
Eur J Med Chem 166: 167-177 (2019)
University of Berne
Suppression of Tumor Growth and Metastases by Targeted Intervention in Urokinase Activity with Cyclic Peptides.
J Med Chem 62: 2172-2183 (2019)
Chinese Academy of Sciences
Chemical Control of Mammalian Circadian Behavior through Dual Inhibition of Casein Kinase I? and ?.
J Med Chem 62: 1989-1998 (2019)
Korea Institute of Science and Technology
Design and Synthesis of a Novel and Selective Kappa Opioid Receptor (KOR) Antagonist (BTRX-335140).
J Med Chem 62: 1761-1780 (2019)
The Scripps Research Institute
Identification of a Benzimidazolecarboxylic Acid Derivative (BAY 1316957) as a Potent and Selective Human Prostaglandin E2 Receptor Subtype 4 (hEP4-R) Antagonist for the Treatment of Endometriosis.
J Med Chem 62: 2541-2563 (2019)
Bayer
Discovery of 2,4-diamino-5-cyanopyrimidine derivatives as protein kinase C theta inhibitors with mitigated time-dependent drug-drug interactions.
Bioorg Med Chem 27: 790-799 (2019)
Astellas Pharma
Synthesis of NSC 106084 and NSC 14778 and evaluation of their DNMT inhibitory activity.
Bioorg Med Chem Lett 29: 826-831 (2019)
University of Montreal
Calixarene-based phosphinic acids as inhibitors of protein tyrosine phosphatases.
Bioorg Med Chem Lett 29: 797-801 (2019)
V.P. Kukhar Institute of Bioorganic Chemistry and Petrochemistry of The National Academy of Sciences of Ukraine
1,2,4-Triazolo[1,5-a]pyrimidines in drug design.
Eur J Med Chem 165: 332-346 (2019)
University of California
Synthesis of novel pyrido[1,2-c]pyrimidine derivatives with rigidized tryptamine moiety as potential SSRI and 5-HT
Eur J Med Chem 166: 144-158 (2019)
Medical University of Warsaw
Tuning Nuclear Receptor Selectivity of Wy14,643 towards Selective Retinoid X Receptor Modulation.
J Med Chem 62: 2112-2126 (2019)
Goethe University Frankfurt
Isoquinoline Alkaloids from Berberis vulgaris as Potential Lead Compounds for the Treatment of Alzheimer's Disease.
J Nat Prod 82: 239-248 (2019)
Charles University
Design, Synthesis, and Biological Evaluation of Novel DNA Gyrase-Inhibiting Spiropyrimidinetriones as Potent Antibiotics for Treatment of Infections Caused by Multidrug-Resistant Gram-Positive Bacteria.
J Med Chem 62: 2950-2973 (2019)
Chinese Academy of Sciences
Lycopodium Alkaloids: Lycoplatyrine A, an Unusual Lycodine-Piperidine Adduct from Lycopodium platyrhizoma and the Absolute Configurations of Lycoplanine D and Lycogladine H.
J Nat Prod 82: 324-329 (2019)
University of Malaya
Discovery of a Natural-Product-Derived Preclinical Candidate for Once-Weekly Treatment of Type 2 Diabetes.
J Med Chem 62: 2348-2361 (2019)
East China University of Science and Technology
Amides and Flavonoids from the Fruit and Leaf Extracts of Melodorum siamensis.
J Nat Prod 82: 283-292 (2019)
University of Wollongong
Identification of the Metabolic Profile of the ?-Tubulin-Binding Natural Product (-)-Pironetin.
J Med Chem 62: 1684-1689 (2019)
University of Minnesota
Di- and heptavalent nicotinic analogues to interfere with ?7 nicotinic acetylcholine receptors.
Bioorg Med Chem 27: 700-707 (2019)
University of Nantes
Kallikrein 5 inhibitors identified through structure based drug design in search for a treatment for Netherton Syndrome.
Bioorg Med Chem Lett 29: 821-825 (2019)
Glaxosmithkline R&D
Plasma kallikrein cleaves and inactivates apelin-17: Palmitoyl- and PEG-extended apelin-17 analogs as metabolically stable blood pressure-lowering agents.
Eur J Med Chem 166: 119-124 (2019)
University of Alberta
2-Aminothiazole Derivatives as Selective Allosteric Modulators of the Protein Kinase CK2. 1. Identification of an Allosteric Binding Site.
J Med Chem 62: 1803-1816 (2019)
Saarland University
2-Aminothiazole Derivatives as Selective Allosteric Modulators of the Protein Kinase CK2. 2. Structure-Based Optimization and Investigation of Effects Specific to the Allosteric Mode of Action.
J Med Chem 62: 1817-1836 (2019)
University of Lyon
Identification and Optimization of Novel Small c-Abl Kinase Activators Using Fragment and HTS Methodologies.
J Med Chem 62: 2154-2171 (2019)
Glaxosmithkline R&D
Absolute Binding Free Energy Calculation and Design of a Subnanomolar Inhibitor of Phosphodiesterase-10.
J Med Chem 62: 2099-2111 (2019)
Sun Yat-Sen University
Optimization of Fused Bicyclic Allosteric SHP2 Inhibitors.
J Med Chem 62: 1781-1792 (2019)
Novartis Pharmaceuticals
6-Amino-3-methylpyrimidinones as Potent, Selective, and Orally Efficacious SHP2 Inhibitors.
J Med Chem 62: 1793-1802 (2019)
TBA
Crown Ethers as Transthyretin Amyloidogenesis Inhibitors.
J Med Chem 62: 2076-2082 (2019)
University of Toyama
Synthesis and Structural/Functional Characterization of Selective M14 Metallocarboxypeptidase Inhibitors Based on Phosphinic Pseudopeptide Scaffold: Implications on the Design of Specific Optical Probes.
J Med Chem 62: 1917-1931 (2019)
Universitat Aut£Noma De Barcelona
Osthenol, a prenylated coumarin, as a monoamine oxidase A inhibitor with high selectivity.
Bioorg Med Chem Lett 29: 839-843 (2019)
Sunchon National University
Indazolylketones as new multitarget cannabinoid drugs.
Eur J Med Chem 166: 90-107 (2019)
Instituto De Qu£Mica M£Dica (Csic)
Marine natural products as potential anti-tubercular agents.
Eur J Med Chem 165: 273-292 (2019)
Ocean University of China
Pros and cons of virtual screening based on public "Big Data": In silico mining for new bromodomain inhibitors.
Eur J Med Chem 165: 258-272 (2019)
University of Strasbourg
Benzimidazolone-based selective ?
Eur J Med Chem 165: 250-257 (2019)
University of Florida
Synthesis and biological evaluation of novel potent FFA1 agonists containing 2,3-dihydrobenzo[b][1,4]dioxine.
Bioorg Med Chem Lett 29: 848-852 (2019)
East China Normal University
Discovery of a potent tyrosine kinase AXL inhibitor bearing the 3-((2,3,4,5-tetrahydro-1H-benzo[d]azepin-7-yl)amino)pyrazine core.
Bioorg Med Chem Lett 29: 836-838 (2019)
Shanghai University
Hydrophobicity-oriented drug design (HODD) of new human 4-hydroxyphenylpyruvate dioxygenase inhibitors.
Eur J Med Chem 166: 22-31 (2019)
Central China Normal University
Medicinal chemistry approaches of poly ADP-Ribose polymerase 1 (PARP1) inhibitors as anticancer agents - A recent update.
Eur J Med Chem 165: 198-215 (2019)
Nirma University
Medicinal chemistry of metal chelating fragments in metalloenzyme active sites: A perspective.
Eur J Med Chem 165: 172-197 (2019)
China Pharmaceutical University
Synthesis, spectroscopic characterization, molecular docking and theoretical studies (DFT) of N-(4-aminophenylsulfonyl)-2-(4-isobutylphenyl) propanamide having potential enzyme inhibition applications.
Bioorg Med Chem 27: 2397-2404 (2019)
University of Education
Small-Molecule Modulators of the Hypoxia-Inducible Factor Pathway: Development and Therapeutic Applications.
J Med Chem 62: 5725-5749 (2019)
China Pharmaceutical University
Targeted Treatments for Chronic Obstructive Pulmonary Disease (COPD) Using Low-Molecular-Weight Drugs (LMWDs).
J Med Chem 62: 5944-5978 (2019)
School of Pharmaceutical Sciences & The Fifth Affiliated Hospital
New Rigid Nicotine Analogues, Carrying a Norbornane Moiety, Are Potent Agonists of ?7 and ?3* Nicotinic Receptors.
J Med Chem 62: 1887-1901 (2019)
University of Florence
Structural Basis of Altered Potency and Efficacy Displayed by a Major in Vivo Metabolite of the Antidiabetic PPAR? Drug Pioglitazone.
J Med Chem 62: 2008-2023 (2019)
The Scripps Research Institute
Inhibitor of Apoptosis Protein (IAP) Antagonists in Anticancer Agent Discovery: Current Status and Perspectives.
J Med Chem 62: 5750-5772 (2019)
Ningxia Medical University
Adiponectin-Secretion-Promoting Phenylethylchromones from the Agarwood of Aquilaria malaccensis.
J Nat Prod 82: 259-264 (2019)
Seoul National University
Soluble-type small-molecule CD4 mimics as HIV entry inhibitors.
Bioorg Med Chem Lett 29: 719-723 (2019)
Tokyo Medical and Dental University
Cink4T, a quinazolinone-based dual inhibitor of Cdk4 and tubulin polymerization, identified via ligand-based virtual screening, for efficient anticancer therapy.
Eur J Med Chem 165: 115-132 (2019)
De Montfort University
Comprehensive structure-activity-relationship of azaindoles as highly potent FLT3 inhibitors.
Bioorg Med Chem 27: 692-699 (2019)
Leiden University
Rad51/BRCA2 disruptors inhibit homologous recombination and synergize with olaparib in pancreatic cancer cells.
Eur J Med Chem 165: 80-92 (2019)
University of Bologna
Quinolone hybrids and their anti-cancer activities: An overview.
Eur J Med Chem 165: 59-79 (2019)
Qilu University of Technology (Shandong Academy of Sciences)
Discovery of highly potent V600E-B-RAF kinase inhibitors: Molecular modeling study.
Bioorg Med Chem 27: 655-663 (2019)
University of Sharjah
Selective Targeting of Integrin ?v?8 by a Highly Active Cyclic Peptide.
J Med Chem 62: 2024-2037 (2019)
Technische Universit£T M£Nchen
Structure-Based Design of Inhibitors Selective for Human Proteasome ?2c or ?2i Subunits.
J Med Chem 62: 1626-1642 (2019)
Leiden Institute of Chemistry and Netherlands Proteomics Centre
Discovery of Potent, Selective, and Orally Bioavailable Estrogen-Related Receptor-? Inverse Agonists To Restore the Sodium Iodide Symporter Function in Anaplastic Thyroid Cancer.
J Med Chem 62: 1837-1858 (2019)
Daegu-Gyeongbuk Medical Innovation Foundation
Identification of Human Toll-like Receptor 2-Agonistic Activity in Dihydropyridine-Quinolone Carboxamides.
ACS Med Chem Lett 10: 132-136 (2019)
University of Minnesota
Design and Evaluation of Heterobivalent PAR1-PAR2 Ligands as Antagonists of Calcium Mobilization.
ACS Med Chem Lett 10: 121-126 (2019)
Marquette University
Synthesis of a 6-Aza-Isoindolinone-Based Inhibitor of Phosphoinositide 3-Kinase ? via Ruthenium-Catalyzed [2 + 2 + 2] Cyclotrimerization.
ACS Med Chem Lett 10: 117-120 (2019)
Vertex Pharmaceuticals
Optimizing the Pharmacological Profile of New Bifunctional Antihyperlipidemic/Antioxidant Morpholine Derivatives.
ACS Med Chem Lett 10: 98-104 (2019)
University of Athens
Discovery of a Novel cGAMP Competitive Ligand of the Inactive Form of STING.
ACS Med Chem Lett 10: 92-97 (2019)
Merck
Discovery of TD-0212, an Orally Active Dual Pharmacology AT
ACS Med Chem Lett 10: 86-91 (2019)
Theravance Biopharma Us
Aminopyrazole Carboxamide Bruton's Tyrosine Kinase Inhibitors. Irreversible to Reversible Covalent Reactive Group Tuning.
ACS Med Chem Lett 10: 80-85 (2019)
Pfizer
Rational Design of Cell-Active Inhibitors of PARP10.
ACS Med Chem Lett 10: 74-79 (2019)
Oregon Health and Science University
Tetrahydroisoquinoline CXCR4 Antagonists Adopt a Hybrid Binding Mode within the Peptide Subpocket of the CXCR4 Receptor.
ACS Med Chem Lett 10: 67-73 (2019)
Emory University
Synthesis, Biological Evaluation and Structure-Activity Relationships of Diflapolin Analogues as Dual sEH/FLAP Inhibitors.
ACS Med Chem Lett 10: 62-66 (2019)
University of Innsbruck
Maximizing ER-? Degradation Maximizes Activity in a Tamoxifen-Resistant Breast Cancer Model: Identification of GDC-0927.
ACS Med Chem Lett 10: 50-55 (2019)
Seragon Pharmaceuticals
Discovery of Novel Retigabine Derivatives as Potent KCNQ4 and KCNQ5 Channel Agonists with Improved Specificity.
ACS Med Chem Lett 10: 27-33 (2019)
Chinese Academy of Sciences
Acrylamide Functional Group Incorporation Improves Drug-like Properties: An Example with EGFR Inhibitors.
ACS Med Chem Lett 10: 22-26 (2019)
National Taiwan University
Discovery of a GPR40 Superagonist: The Impact of Aryl Propionic Acid ?-Fluorination.
ACS Med Chem Lett 10: 16-21 (2019)
Janssen Research & Development
Treatment of Diabetes, Obesity, Dyslipidemia, and Related Disorders with GPR119 Agonists.
ACS Med Chem Lett 10: 14-15 (2019)
Therachem Research Medilab
ASK1: A Therapeutic Target for the Treatment of Multiple Diseases.
ACS Med Chem Lett 10: 12-13 (2019)
Therachem Research Medilab
Inhibitors of G12C Mutant Ras Proteins for the Treatment of Cancers.
ACS Med Chem Lett 10: 10-11 (2019)
Usona Institute
Tricyclic Inhibitors of ?-Secretase and Their Methods of Use for the Treatment of Alzheimer's Disease.
ACS Med Chem Lett 10: 8-9 (2019)
Temple University
Bridged Piperidine Derivatives Useful as ?-Secretase Inhibitors for the Treatment of Alzheimer's Disease.
ACS Med Chem Lett 10: 6-7 (2019)
Temple University
Discovery of Macrocyclic Inhibitors of Apurinic/Apyrimidinic Endonuclease 1.
J Med Chem 62: 1971-1988 (2019)
Boston University
Discovery of a Series of 2'-?-Fluoro,2'-?-bromo-ribonucleosides and Their Phosphoramidate Prodrugs as Potent Pan-Genotypic Inhibitors of Hepatitis C Virus.
J Med Chem 62: 1859-1874 (2019)
Emory University School of Medicine
Design, Synthesis, and Biological Evaluation of Retinoic Acid-Related Orphan Receptor ?t (ROR?t) Agonist Structure-Based Functionality Switching Approach from In House ROR?t Inverse Agonist to ROR?t Agonist.
J Med Chem 62: 1167-1179 (2019)
Takeda Pharmaceutical
Conversion of Quinazoline Modulators from Inhibitors to Activators of ?-Glucocerebrosidase.
J Med Chem 62: 1218-1230 (2019)
Northwestern University
Synthesis and Biological Investigation of Phenothiazine-Based Benzhydroxamic Acids as Selective Histone Deacetylase 6 Inhibitors.
J Med Chem 62: 1138-1166 (2019)
Ludwig-Maximilians University Munich
Targeted Endocrine Therapy: Design, Synthesis, and Proof-of-Principle of 17?-Hydroxysteroid Dehydrogenase Type 2 Inhibitors in Bone Fracture Healing.
J Med Chem 62: 1362-1372 (2019)
Elexopharm
Identification of novel uracil derivatives incorporating benzoic acid moieties as highly potent Dipeptidyl Peptidase-IV inhibitors.
Bioorg Med Chem 27: 644-654 (2019)
Guangxi Medical University
Antiproliferative and Antimigratory Effects of a Novel YAP-TEAD Interaction Inhibitor Identified Using in Silico Molecular Docking.
J Med Chem 62: 1291-1305 (2019)
University of Bristol
Tricyclic Indazoles-A Novel Class of Selective Estrogen Receptor Degrader Antagonists.
J Med Chem 62: 1593-1608 (2019)
Astrazeneca
Recent development of CDK inhibitors: An overview of CDK/inhibitor co-crystal structures.
Eur J Med Chem 164: 615-639 (2019)
The First Affiliated Hospital of Zhengzhou University
Covalent docking modelling-based discovery of tripeptidyl epoxyketone proteasome inhibitors composed of aliphatic-heterocycles.
Eur J Med Chem 164: 602-614 (2019)
Hangzhou Institute of Innovative Medicine
A review on HCV inhibitors: Significance of non-structural polyproteins.
Eur J Med Chem 164: 576-601 (2019)
Institute of Pharmaceutical Education and Research
Design, synthesis and identification of novel coumaperine derivatives for inhibition of human 5-LOX: Antioxidant, pseudoperoxidase and docking studies.
Bioorg Med Chem 27: 604-619 (2019)
Vellore Institute of Technology
Novel human adenosine receptor antagonists based on the 7-amino-thiazolo[5,4-d]pyrimidine scaffold. Structural investigations at the 2-, 5- and 7-positions to enhance affinity and tune selectivity.
Bioorg Med Chem Lett 29: 563-569 (2019)
Universita Degli Studi Di Firenze
Discovery of new indole-based acylsulfonamide Na
Bioorg Med Chem Lett 29: 659-663 (2019)
Bristol-Myers Squibb Research and Development
Design, synthesis and biological evaluation of tetrazole-containing RXR? ligands as anticancer agents.
Eur J Med Chem 164: 562-575 (2019)
Xiamen University
Design, Synthesis, and Biological Evaluation of 6-Substituted Thieno[3,2- d]pyrimidine Analogues as Dual Epidermal Growth Factor Receptor Kinase and Microtubule Inhibitors.
J Med Chem 62: 1274-1290 (2019)
University of Ferrara
Shape-based virtual screen for the discovery of novel CDK8 inhibitor chemotypes.
Bioorg Med Chem Lett 29: 549-555 (2019)
Wannan Medical College
Discovery of 2-phenylthiazole-4-carboxylic acid, a novel and potent scaffold as xanthine oxidase inhibitors.
Bioorg Med Chem Lett 29: 525-528 (2019)
Guangzhou General Pharmaceutical Research Institute
Design, synthesis, and in vitro evaluation of N-(3-(3-alkyl-1H-pyrazol-5-yl) phenyl)-aryl amide for selective RAF inhibition.
Bioorg Med Chem Lett 29: 534-538 (2019)
Hanyang University
Discovery of Novel Transient Receptor Potential Vanilloid 4 (TRPV4) Agonists as Regulators of Chondrogenic Differentiation: Identification of Quinazolin-4(3 H)-ones and in Vivo Studies on a Surgically Induced Rat Model of Osteoarthritis.
J Med Chem 62: 1468-1483 (2019)
Asahi Kasei Medical
Discovery of ARD-69 as a Highly Potent Proteolysis Targeting Chimera (PROTAC) Degrader of Androgen Receptor (AR) for the Treatment of Prostate Cancer.
J Med Chem 62: 941-964 (2019)
TBA
Discovery and Development of N-[4-(1-Cyclobutylpiperidin-4-yloxy)phenyl]-2-(morpholin-4-yl)acetamide Dihydrochloride (SUVN-G3031): A Novel, Potent, Selective, and Orally Active Histamine H
J Med Chem 62: 1203-1217 (2019)
Suven Life Sciences
Discovery of Novel Dual Histone Deacetylase and Mammalian Target of Rapamycin Target Inhibitors as a Promising Strategy for Cancer Therapy.
J Med Chem 62: 1577-1592 (2019)
TBA
Metal-Binding Pharmacophore Library Yields the Discovery of a Glyoxalase 1 Inhibitor.
J Med Chem 62: 1609-1625 (2019)
TBA
5-Keto-3-cyano-2,4-diaminothiophenes as selective maternal embryonic leucine zipper kinase inhibitors.
Bioorg Med Chem Lett 29: 607-613 (2019)
Selvita
The identification of novel small-molecule inhibitors targeting WDR5-MLL1 interaction through fluorescence polarization based high-throughput screening.
Bioorg Med Chem Lett 29: 638-645 (2019)
Zhejiang Sci-Tech University
Synthesis of amide and sulfonamide substituted N-aryl 6-aminoquinoxalines as PFKFB3 inhibitors with improved physicochemical properties.
Bioorg Med Chem Lett 29: 646-653 (2019)
Selvita
Discovery of a crystalline sulforaphane analog with good solid-state stability and engagement of the Nrf2 pathway in vitro and in vivo.
Bioorg Med Chem 27: 579-588 (2019)
Glaxosmithkline
Discovery of two novel branched peptidomimetics containing endomorphin-2 and RF9 pharmacophores: Synthesis and neuropharmacological evaluation.
Bioorg Med Chem 27: 630-643 (2019)
Lanzhou University
Discovery of ( R)-8-(6-Methyl-4-oxo-1,4,5,6-tetrahydropyrrolo[3,4- b]pyrrol-2-yl)-3-(1-methylcyclopropyl)-2-((1-methylcyclopropyl)amino)quinazolin-4(3 H)-one, a Potent and Selective Pim-1/2 Kinase Inhibitor for Hematological Malignancies.
J Med Chem 62: 1523-1540 (2019)
TBA
Identification of Dihydrofuro[3,4- d]pyrimidine Derivatives as Novel HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors with Promising Antiviral Activities and Desirable Physicochemical Properties.
J Med Chem 62: 1484-1501 (2019)
Shandong University
Inhibition of Inositol Polyphosphate Kinases by Quercetin and Related Flavonoids: A Structure-Activity Analysis.
J Med Chem 62: 1443-1454 (2019)
National Institute of Environmental Health Sciences
Discovery of Selective Toxoplasma gondii Dihydrofolate Reductase Inhibitors for the Treatment of Toxoplasmosis.
J Med Chem 62: 1562-1576 (2019)
Vyera Pharmaceuticals
Evaluation of Amides, Carbamates, Sulfonamides, and Ureas of 4-Prop-2-ynylidenecycloalkylamine as Potent, Selective, and Bioavailable Negative Allosteric Modulators of Metabotropic Glutamate Receptor 5.
J Med Chem 62: 1246-1273 (2019)
Recordati
Structure-Activity Relationships and Characterization of Highly Selective, Long-Acting, Peptide-Based Cholecystokinin 1 Receptor Agonists.
J Med Chem 62: 1407-1419 (2019)
TBA
Discovery of Novel Pyruvate Dehydrogenase Kinase 4 Inhibitors for Potential Oral Treatment of Metabolic Diseases.
J Med Chem 62: 575-588 (2019)
Gwangju Institute of Science and Technology
Recent applications of hydantoin and thiohydantoin in medicinal chemistry.
Eur J Med Chem 164: 517-545 (2019)
College of Pharmacy and Gachon Institute of Pharmaceutical Science
Identification of dual role of piperazine-linked phenyl cyclopropyl methanone as positive allosteric modulator of 5-HT
Eur J Med Chem 164: 499-516 (2019)
Csir-Central Drug Research Institute (Csir-Cdri)
Investigation of the structural requirements for N-methyl-D-aspartate receptor positive and negative allosteric modulators based on 2-naphthoic acid.
Eur J Med Chem 164: 471-498 (2019)
University of Bristol
Bifunctional Duocarmycin Analogues as Inhibitors of Protein Tyrosine Kinases.
J Nat Prod 82: 16-26 (2019)
Albert Ludwigs University Freiburg
Structure-Based Discovery of a Subtype-Selective Inhibitor Targeting a Transient Receptor Potential Vanilloid Channel.
J Med Chem 62: 1373-1384 (2019)
Chinese Academy of Sciences
Fluoromethylcyclopropylamine derivatives as potential in vivo toxicophores - A cautionary disclosure.
Bioorg Med Chem Lett 29: 560-562 (2019)
The University of Manchester
Structure-activity relationship (SAR) studies of synthetic glycogen synthase kinase-3? inhibitors: A critical review.
Eur J Med Chem 164: 448-470 (2019)
Wuhan Institute of Technology
Discovery of novel anti-angiogenesis agents. Part 9: Multiplex inhibitors suppressing compensatory activations of RTKs.
Eur J Med Chem 164: 440-447 (2019)
The First Affiliated Hospital of Xi'An Jiaotong University
Functional Selectivity Revealed by N-Methylation Scanning of Human Urotensin II and Related Peptides.
J Med Chem 62: 1455-1467 (2019)
University of Naples "Federico Ii
Design of Novel Inhibitors of Human Thymidine Phosphorylase: Synthesis, Enzyme Inhibition, in Vitro Toxicity, and Impact on Human Glioblastoma Cancer.
J Med Chem 62: 1231-1245 (2019)
Universidade Federal Do Pampa
Discovery of an Orally Available Janus Kinase 3 Selective Covalent Inhibitor.
J Med Chem 62: 1054-1066 (2019)
Peking University
Substrate-Specific Inhibition Constants for Phospholipase A
J Med Chem 62: 1999-2007 (2019)
University of California
Design, Synthesis, and Biological Evaluation of New 1-(Aryl-1 H-pyrrolyl)(phenyl)methyl-1 H-imidazole Derivatives as Antiprotozoal Agents.
J Med Chem 62: 1330-1347 (2019)
"Sapienza" Universit£
Molecular Basis for the Selective Inhibition of Histone Deacetylase 6 by a Mercaptoacetamide Inhibitor.
ACS Med Chem Lett 9: 1301-1305 (2018)
University of Pennsylvania
Novel Fluorescence Competition Assay for Retinoic Acid Binding Proteins.
ACS Med Chem Lett 9: 1297-1300 (2018)
Durham University
Discovery of 12-Thiazole Abietanes as Selective Inhibitors of the Human Metabolic Serine Hydrolase hABHD16A.
ACS Med Chem Lett 9: 1269-1273 (2018)
University of Helsinki
Sulfonylated Benzothiazoles as Inhibitors of Endothelial Lipase.
ACS Med Chem Lett 9: 1263-1268 (2018)
Bristol-Myers Squibb
Potent, Selective, and Cell-Penetrating Inhibitors of Kallikrein-Related Peptidase 4 Based on the Cyclic Peptide MCoTI-II.
ACS Med Chem Lett 9: 1258-1262 (2018)
The University of Queensland
Adaptable Small Ligand of CYP1 Enzymes for Use in Understanding the Structural Features Determining Isoform Selectivity.
ACS Med Chem Lett 9: 1247-1252 (2018)
Seoul National University
Modification of the Thioglycosyl-Naphthalimides as Potent and Selective Human O-GlcNAcase Inhibitors.
ACS Med Chem Lett 9: 1241-1246 (2018)
China Agricultural University
Hybrid Inhibitors of Malarial Dihydrofolate Reductase with Dual Binding Modes That Can Forestall Resistance.
ACS Med Chem Lett 9: 1235-1240 (2018)
National Center For Genetic Engineering and Biotechnology At Thailand
Discovery of Tetrahydropyridopyrimidines as Irreversible Covalent Inhibitors of KRAS-G12C with In Vivo Activity.
ACS Med Chem Lett 9: 1230-1234 (2018)
Array Biopharma
Structure-Property Basis for Solving Transporter-Mediated Efflux and Pan-Genotypic Inhibition in HCV NS5B Inhibitors.
ACS Med Chem Lett 9: 1217-1222 (2018)
Bristol-Myers Squibb Research and Development
Privileged Structures and Polypharmacology within and between Protein Families.
ACS Med Chem Lett 9: 1199-1204 (2018)
The Institute of Cancer Research
Discovery of Orally Bioavailable and Liver-Targeted Hypoxia-Inducible Factor Prolyl Hydroxylase (HIF-PHD) Inhibitors for the Treatment of Anemia.
ACS Med Chem Lett 9: 1193-1198 (2018)
Merck
Restoring Let-7 microRNA Biogenesis Using a Small-Molecule Inhibitor of the Protein-RNA Interaction.
ACS Med Chem Lett 9: 1181-1185 (2018)
Seoul National University
Potent Triazolopyridine Myeloperoxidase Inhibitors.
ACS Med Chem Lett 9: 1175-1180 (2018)
Bristol-Myers Squibb Research and Development
Discovery of Clinical Candidate BMS-823778 as an Inhibitor of Human 11?-Hydroxysteroid Dehydrogenase Type 1 (11?-HSD-1).
ACS Med Chem Lett 9: 1170-1174 (2018)
Bristol-Myers Squibb
3,5-Disubstituted-indole-7-carboxamides as IKK? Inhibitors: Optimization of Oral Activity via the C3 Substituent.
ACS Med Chem Lett 9: 1164-1169 (2018)
Glaxosmithkline
Heterocyclic Amides as Kinase Inhibitors.
ACS Med Chem Lett 9: 1160-1161 (2018)
Usona Institute
Exploration of novel macrocyclic dipeptide N-benzyl amides as proteasome inhibitors.
Eur J Med Chem 164: 423-439 (2019)
Zhejiang University
Investigation of stereoisomeric bisarylethenesulfonic acid esters for discovering potent and selective PTP1B inhibitors.
Eur J Med Chem 164: 408-422 (2019)
Shanghai Jiao Tong University (Sjtu)
Synthesis and SAR of 5-aryl-furan-2-carboxamide derivatives as potent urotensin-II receptor antagonists.
Bioorg Med Chem Lett 29: 577-580 (2019)
Korea Research Institute of Chemical Technology
Identification of selective and reversible LSD1 inhibitors with anti-metastasis activity by high-throughput docking.
Bioorg Med Chem Lett 29: 544-548 (2019)
Taizhou People'S Hospital
Identification of a novel DGK? inhibitor for XLP-1 therapy by virtual screening.
Eur J Med Chem 164: 378-390 (2019)
University of Piemonte Orientale
Design, Synthesis, and Biological Evaluation of the Third Generation 17-Cyclopropylmethyl-3,14?-dihydroxy-4,5?-epoxy-6?-[(4'-pyridyl)carboxamido]morphinan (NAP) Derivatives as ?/? Opioid Receptor Dual Selective Ligands.
J Med Chem 62: 561-574 (2019)
Virginia Commonwealth University
Discovery of an Orally Bioavailable and Central Nervous System (CNS) Penetrant mGlu
J Med Chem 62: 1690-1695 (2019)
Vanderbilt University School of Medicine
Structure-guided discovery of a novel, potent, and orally bioavailable 3,5-dimethylisoxazole aryl-benzimidazole BET bromodomain inhibitor.
Bioorg Med Chem 27: 457-469 (2019)
Gilead Sciences
Harzianoic acids A and B, new natural scaffolds with inhibitory effects against hepatitis C virus.
Bioorg Med Chem 27: 560-567 (2019)
Peking University
Discovery of a new class of valosine containing protein (VCP/P97) inhibitors for the treatment of non-small cell lung cancer.
Bioorg Med Chem 27: 533-544 (2019)
Nanjing Normal University
Design, synthesis and biological evaluation of novel acetamide-substituted doravirine and its prodrugs as potent HIV-1 NNRTIs.
Bioorg Med Chem 27: 447-456 (2019)
Shandong University
Discovery of first-in-class thiazole-based dual FFA1/PPAR? agonists as potential anti-diabetic agents.
Eur J Med Chem 164: 352-365 (2019)
Guangdong Pharmaceutical University
Discovery of potent, orally bioavailable ERK1/2 inhibitors with isoindolin-1-one structure by structure-based drug design.
Eur J Med Chem 164: 334-341 (2019)
China Pharmaceutical University
Discovery of 2-substituted-N-(3-(3,4-dihydroisoquinolin-2(1H)-yl)-2-hydroxypropyl)-1,2,3,4-tetrahydroisoquinoline-6-carboxamide as potent and selective protein arginine methyltransferases 5 inhibitors: Design, synthesis and biological evaluation.
Eur J Med Chem 164: 317-333 (2019)
Shanghai Institute of Materia Medica
Optimization of novel benzofuro[3,2-b]pyridin-2(1H)-one derivatives as dual inhibitors of BTK and PI3K?.
Eur J Med Chem 164: 304-316 (2019)
China Pharmaceutical University
Triazole-Based Inhibitors of the Wnt/?-Catenin Signaling Pathway Improve Glucose and Lipid Metabolisms in Diet-Induced Obese Mice.
J Med Chem 62: 727-741 (2019)
University of Maryland
Design and in Vivo Characterization of A
J Med Chem 62: 1502-1522 (2019)
Medical College of Wisconsin
Secondary Metabolites from the Fungus Dictyosporium sp. and Their MALT1 Inhibitory Activities.
J Nat Prod 82: 154-162 (2019)
National Cancer Institute
Discovery of new quinazoline derivatives as irreversible dual EGFR/HER2 inhibitors and their anticancer activities - Part 1.
Bioorg Med Chem Lett 29: 591-596 (2019)
Arromax Pharmatech
Discovery of an isocoumarin analogue that modulates neuronal functions via neurotrophin receptor TrkB.
Bioorg Med Chem Lett 29: 585-590 (2019)
Indian Institute of Technology Madras
The association between anti-tumor potency and structure-activity of protein-kinases inhibitors based on quinazoline molecular skeleton.
Bioorg Med Chem 27: 568-577 (2019)
University of South China
Synthesis and biological evaluation of 3-aryl-4-indolyl-maleimides as potent mutant isocitrate dehydrogenase-1 inhibitors.
Bioorg Med Chem 27: 589-603 (2019)
Zhejiang University
A new class of pentapeptide KISS1 receptor agonists with hypothalamic-pituitary-gonadal axis activation.
Bioorg Med Chem Lett 29: 654-658 (2019)
Takeda Pharmaceutical
N,N'-diaryl-bishydrazones in a biphenyl platform: Broad spectrum antifungal agents.
Eur J Med Chem 164: 273-281 (2019)
University of Kentucky
A novel class of anthraquinone-based HDAC6 inhibitors.
Eur J Med Chem 164: 263-272 (2019)
Keimyung University
High-throughput screening of novel pyruvate dehydrogenase kinases inhibitors and biological evaluation of their in vitro and in vivo antiproliferative activity.
Eur J Med Chem 164: 252-262 (2019)
Jiangsu Normal University
Synthesis of spiro-2,6-dioxopiperazine and spiro-2,6-dioxopyrazine scaffolds using amino acids in a three-component reaction to generate potential Sigma-1 (?
Eur J Med Chem 164: 241-251 (2019)
Memorial Sloan Kettering Cancer Center
Identification of Mineralocorticoid Receptor Modulators with Low Impact on Electrolyte Homeostasis but Maintained Organ Protection.
J Med Chem 62: 1385-1406 (2019)
Pharmaron-Beijing
Identification of novel azaindazole CCR1 antagonist clinical candidates.
Bioorg Med Chem Lett 29: 441-448 (2019)
Boehringer Ingelheim Pharmaceuticals
Histone deacetylase 8 (HDAC8) and its inhibitors with selectivity to other isoforms: An overview.
Eur J Med Chem 164: 214-240 (2019)
Jadavpur University
Novel chalcone and flavone derivatives as selective and dual inhibitors of the transport proteins ABCB1 and ABCG2.
Eur J Med Chem 164: 193-213 (2019)
Rheinische Friedrich-Wilhelms-University of Bonn
?-Glucosidase inhibition activity and in silico study of 2-(benzo[d][1,3]dioxol-5-yl)-4H-chromen-4-one, a synthetic derivative of flavone.
Bioorg Med Chem 27: 2340-2344 (2019)
Goa University
Design, synthesis, and bioactivity evaluation of novel Bcl-2/HDAC dual-target inhibitors for the treatment of multiple myeloma.
Bioorg Med Chem Lett 29: 349-352 (2019)
Wuhan Polytechnic University
Discovery of potent and selective PPAR?/? dual antagonists and initial biological studies.
Bioorg Med Chem Lett 29: 503-508 (2019)
Inception Sciences
Identification of BR101549 as a lead candidate of non-TZD PPAR? agonist for the treatment of type 2 diabetes: Proof-of-concept evaluation and SAR.
Bioorg Med Chem Lett 29: 631-637 (2019)
Boryung Pharmaceuticals
Continued exploration of 1,2,4-oxadiazole periphery for carbonic anhydrase-targeting primary arene sulfonamides: Discovery of subnanomolar inhibitors of membrane-bound hCA IX isoform that selectively kill cancer cells in hypoxic environment.
Eur J Med Chem 164: 92-105 (2019)
Saint Petersburg State University
CDK8 as a therapeutic target for cancers and recent developments in discovery of CDK8 inhibitors.
Eur J Med Chem 164: 77-91 (2019)
Shaoxing University
Translational impact of novel widely pharmacological characterized mofezolac-derived COX-1 inhibitors combined with bortezomib on human multiple myeloma cell lines viability.
Eur J Med Chem 164: 59-76 (2019)
University of Bari "Aldo Moro
Selective estrogen receptor degraders with novel structural motifs induce regression in a tamoxifen-resistant breast cancer xenograft.
Bioorg Med Chem Lett 29: 367-372 (2019)
Seragon Pharmaceuticals
Lead generation and optimization of novel GPR119 agonists with a spirocyclic cyclohexane structure.
Bioorg Med Chem Lett 29: 373-379 (2019)
Japan Tobacco
Novel, potent, selective, and brain penetrant phosphodiesterase 10A inhibitors.
Bioorg Med Chem Lett 29: 406-412 (2019)
Abbvie Deutschland
Analysis of chain length, substitution patterns, and unsaturation of AM-404 derivatives as 20S proteasome stimulators.
Bioorg Med Chem Lett 29: 420-423 (2019)
Purdue University
Development of novel liver?X?receptor modulators based on a 1,2,4-triazole scaffold.
Bioorg Med Chem Lett 29: 449-453 (2019)
Benha University
An irreversible inhibitor of peptidyl-prolyl cis/trans isomerase Pin1 and evaluation of cytotoxicity.
Bioorg Med Chem Lett 29: 353-356 (2019)
Nagoya Citi University
Design, Biological Evaluation, and Molecular Modeling of Tetrahydroisoquinoline Derivatives: Discovery of A Potent P-Glycoprotein Ligand Overcoming Multidrug Resistance in Cancer Stem Cells.
J Med Chem 62: 974-986 (2019)
University of Turin
Benzo[d]thiazol-2(3H)-ones as new potent selective CB
Eur J Med Chem 165: 347-362 (2019)
Univ. Lille
Recent advances in the discovery of small molecules targeting glioblastoma.
Eur J Med Chem 164: 8-26 (2019)
S£O Paulo State University (Unesp)
New polyamine drugs as more effective antichagas agents than benznidazole in both the acute and chronic phases.
Eur J Med Chem 164: 27-46 (2019)
Hospitales Universitarios De Granada/University of Granada
Evolution of PI3K? and ? Inhibitors for Inflammatory and Autoimmune Diseases.
J Med Chem 62: 4783-4814 (2019)
Astrazeneca
Class 1 PI3K Clinical Candidates and Recent Inhibitor Design Strategies: A Medicinal Chemistry Perspective.
J Med Chem 62: 4815-4850 (2019)
University Park Nottingham
Tripeptide analogues of MG132 as protease inhibitors.
Bioorg Med Chem 27: 436-441 (2019)
University of Adelaide
Design, synthesis and biological evaluation of novel HIV-1 protease inhibitors with pentacyclic triterpenoids as P2-ligands.
Bioorg Med Chem Lett 29: 357-361 (2019)
Chinese Academy of Medical Science and Peking Union Medical College
A class of novel tubulin polymerization inhibitors exert effective anti-tumor activity via mitotic catastrophe.
Eur J Med Chem 163: 896-910 (2019)
Nanjing University
Discovery, synthesis and anti-atherosclerotic activities of a novel selective sphingomyelin synthase 2 inhibitor.
Eur J Med Chem 163: 864-882 (2019)
Fudan University
Leucoflavonine, a new bioactive racemic flavoalkaloid from the leaves of Leucosceptrum canum.
Bioorg Med Chem 27: 442-446 (2019)
Chinese Academy of Sciences
Discovery of potent, low-absorbable sodium-dependent glucose cotransporter 1 (SGLT1) inhibitor SGL5213 for type 2 diabetes treatment.
Bioorg Med Chem 27: 394-409 (2019)
Taisho Pharmaceutical
Synthesis, biological evaluation and 3D-QSAR studies of 1,2,4-triazole-5-substituted carboxylic acid bioisosteres as uric acid transporter 1 (URAT1) inhibitors for the treatment of hyperuricemia associated with gout.
Bioorg Med Chem Lett 29: 383-388 (2019)
Tianjin Medical University
The role of N-terminal heterocycles in hydrogen bonding to ?-chymotrypsin.
Bioorg Med Chem Lett 29: 396-399 (2019)
The University of Adelaide
Multiple weak intercalation as a strategy for the inhibition of polymerases.
Bioorg Med Chem Lett 29: 424-429 (2019)
University of Missouri-Kansas City
Design and development of Isatin-triazole hydrazones as potential inhibitors of microtubule affinity-regulating kinase 4 for the therapeutic management of cell proliferation and metastasis.
Eur J Med Chem 163: 840-852 (2019)
Jamia Millia Islamia
In silico, NMR and pharmacological evaluation of an hydroxyoxindole cholinesterase inhibitor.
Bioorg Med Chem 27: 354-363 (2019)
Universidade De £Vora
Cyclic tripeptide-based potent human SIRT7 inhibitors.
Bioorg Med Chem Lett 29: 461-465 (2019)
Jiangsu University
Novel non-xanthine antagonist of the A
Eur J Med Chem 163: 763-778 (2019)
Bayer Pharmaceuticals
Boronate, trifluoroborate, sulfone, sulfinate and sulfonate congeners of oseltamivir carboxylic acid: Synthesis and anti-influenza activity.
Eur J Med Chem 163: 710-721 (2019)
National Taiwan University
Synthesis and anti-tumor activity of imidazopyrazines as TAK1 inhibitors.
Eur J Med Chem 163: 660-670 (2019)
Chung-Ang University
Discovery of Indole- and Indazole-acylsulfonamides as Potent and Selective Na
J Med Chem 62: 831-856 (2019)
Bristol-Myers Squibb Research and Development
Discovery and optimization of a series of 3-substituted indazole derivatives as multi-target kinase inhibitors for the treatment of lung squamous cell carcinoma.
Eur J Med Chem 163: 671-689 (2019)
Chinese Academy of Sciences
Synthesis, Biological, and Structural Explorations of New Zwitterionic Derivatives of 14- O-Methyloxymorphone, as Potent ?/? Opioid Agonists and Peripherally Selective Antinociceptives.
J Med Chem 62: 641-653 (2019)
TBA
?-Amino Diphenyl Phosphonates as Novel Inhibitors of Escherichia coli ClpP Protease.
J Med Chem 62: 774-797 (2019)
University of Antwerp
Discovery of Selective Matriptase and Hepsin Serine Protease Inhibitors: Useful Chemical Tools for Cancer Cell Biology.
J Med Chem 62: 480-490 (2019)
Washington University School of Medicine
Identification of GSK3186899/DDD853651 as a Preclinical Development Candidate for the Treatment of Visceral Leishmaniasis.
J Med Chem 62: 1180-1202 (2019)
University of Dundee
Discovery of N-(4-(6-Acetamidopyrimidin-4-yloxy)phenyl)-2-(2-(trifluoromethyl)phenyl)acetamide (CHMFL-FLT3-335) as a Potent FMS-like Tyrosine Kinase 3 Internal Tandem Duplication (FLT3-ITD) Mutant Selective Inhibitor for Acute Myeloid Leukemia.
J Med Chem 62: 875-892 (2019)
Hefei Institutes of Physical Science
Emerging and Re-Emerging Warheads for Targeted Covalent Inhibitors: Applications in Medicinal Chemistry and Chemical Biology.
J Med Chem 62: 5673-5724 (2019)
Eberhard Karls University T£Bingen
Discovery and Characterization of the Potent and Highly Selective (Piperidin-4-yl)pyrido[3,2- d]pyrimidine Based in Vitro Probe BAY-885 for the Kinase ERK5.
J Med Chem 62: 928-940 (2019)
Bayer
The p53 stabilizing agent CP-31398 and multi-kinase inhibitors. Designing, synthesizing and screening of styrylquinazoline series.
Eur J Med Chem 163: 610-625 (2019)
University of Silesia In Katowice
Fragment-based drug discovery of triazole inhibitors to block PDE?-RAS protein-protein interaction.
Eur J Med Chem 163: 597-609 (2019)
Chinese Academy of Sciences
Structure-Activity Relationship Studies and Plasmodium Life Cycle Profiling Identifies Pan-Active N-Aryl-3-trifluoromethyl Pyrido[1,2- a]benzimidazoles Which Are Efficacious in an in Vivo Mouse Model of Malaria.
J Med Chem 62: 1022-1035 (2019)
University of Cape Town
Discovery of a Bioactive Inhibitor with a New Scaffold for Cystathionine ?-Lyase.
J Med Chem 62: 1677-1683 (2019)
Shanghai Jiao Tong University
Unravel a neuroactive sHA sulfation pattern with neurogenesis activity by a library of defined oligosaccharides.
Eur J Med Chem 163: 583-596 (2019)
Peking University
Synthesis and Structure-Activity Relationships of Inhibitors That Target the C-Terminal MEEVD on Heat Shock Protein 90.
ACS Med Chem Lett 9: 73-77 (2018)
University of New South Wales
Muscarinic agonist, (±)-quinuclidin-3-yl-(4-fluorophenethyl)(phenyl)carbamate: High affinity, but low subtype selectivity for human M
Bioorg Med Chem Lett 29: 471-476 (2019)
University of Kentucky
Discovery of potent and selective 5-azaindazole inhibitors of leucine-rich repeat kinase 2 (LRRK2) - Part 1.
Bioorg Med Chem Lett 29: 668-673 (2019)
Lifearc
Design, synthesis of novel purin-6-one derivatives as phosphodiesterase 2 (PDE2) inhibitors: The neuroprotective and anxiolytic-like effects.
Bioorg Med Chem Lett 29: 481-486 (2019)
Changzhou University
Click chemistry for improvement in selectivity of quinazoline-based kinase inhibitors for mutant epidermal growth factor receptors.
Bioorg Med Chem Lett 29: 477-480 (2019)
Chung-Ang University
Synthesis, structure activity relationship and in vitro anti-influenza virus activity of novel polyphenol-pentacyclic triterpene conjugates.
Eur J Med Chem 163: 560-568 (2019)
Peking University
Discovery of N-substituted 7-azaindoles as Pan-PIM kinases inhibitors - Lead optimization - Part III.
Bioorg Med Chem Lett 29: 491-495 (2019)
Sanofi
Pyrrolidinone-bearing methylated and halogenated benzenesulfonamides as inhibitors of carbonic anhydrases.
Bioorg Med Chem 27: 322-337 (2019)
Kaunas University of Technology
Design and synthesis of selective CYP1B1 inhibitor via dearomatization of ?-naphthoflavone.
Bioorg Med Chem 27: 285-304 (2019)
Showa Pharmaceutical University
Synthesis and evaluation of clioquinol-rolipram/roflumilast hybrids as multitarget-directed ligands for the treatment of Alzheimer's disease.
Eur J Med Chem 163: 512-526 (2019)
Sun Yat-Sen University
Structural and computational basis for potent inhibition of glutamate carboxypeptidase II by carbamate-based inhibitors.
Bioorg Med Chem 27: 255-264 (2019)
Institute of Biotechnology of The Czech Academy of Sciences
Flavone-based natural product agents as new lysine-specific demethylase 1 inhibitors exhibiting cytotoxicity against breast cancer cells in vitro.
Bioorg Med Chem 27: 370-374 (2019)
China Pharmaceutical University
Synthesis, biological evaluation and molecular docking study of 1,2,3-1H-triazoles having 4H-pyrano[2,3-d]pyrimidine as potential Mycobacterium tuberculosis protein tyrosine phosphatase B inhibitors.
Bioorg Med Chem Lett 29: 164-171 (2019)
Vnu University of Science
Identification of fluorinated (R)-(-)-aporphine derivatives as potent and selective ligands at serotonin 5-HT
Bioorg Med Chem Lett 29: 230-233 (2019)
Harvard Medical School
Cyclin-Dependent Kinase 2 Inhibitors in Cancer Therapy: An Update.
J Med Chem 62: 4233-4251 (2019)
University of South Australia Cancer Research Institute
N-Terminal Liver-Expressed Antimicrobial Peptide 2 (LEAP2) Region Exhibits Inverse Agonist Activity toward the Ghrelin Receptor.
J Med Chem 62: 965-973 (2019)
University of Montpellier
Development of Novel Quinoxaline-Based ?-Opioid Receptor Agonists for the Treatment of Neuroinflammation.
J Med Chem 62: 893-907 (2019)
Universit£T M£Nster
Novel 1,3,4-Selenadiazole-Containing Kidney-Type Glutaminase Inhibitors Showed Improved Cellular Uptake and Antitumor Activity.
J Med Chem 62: 589-603 (2019)
Zhejiang University
Benzophenone: a ubiquitous scaffold in medicinal chemistry.
Medchemcomm 9: 1803-1817 (2018)
National Institute of Pharmaceutical Education and Research
Biphenyl Gal and GalNAc FmlH Lectin Antagonists of Uropathogenic E. coli (UPEC): Optimization through Iterative Rational Drug Design.
J Med Chem 62: 467-479 (2019)
Washington University School of Medicine
Iterative Design and Optimization of Initially Inactive Proteolysis Targeting Chimeras (PROTACs) Identify VZ185 as a Potent, Fast, and Selective von Hippel-Lindau (VHL) Based Dual Degrader Probe of BRD9 and BRD7.
J Med Chem 62: 699-726 (2019)
University of Dundee
Optimization of Vinyl Sulfone Derivatives as Potent Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) Activators for Parkinson's Disease Therapy.
J Med Chem 62: 811-830 (2019)
Korea Institute of Science & Technology (Kist)
Design, synthesis and characterization of novel N-heterocyclic-1-benzyl-1H-benzo[d]imidazole-2-amines as selective TRPC5 inhibitors leading to the identification of the selective compound, AC1903.
Bioorg Med Chem Lett 29: 155-159 (2019)
University of Nebraska Medical Center
The discovery and optimization of benzimidazoles as selective Na
Bioorg Med Chem 27: 230-239 (2019)
Pfizer
Hydroxamic Acid Inhibitors Provide Cross-Species Inhibition of Plasmodium M1 and M17 Aminopeptidases.
J Med Chem 62: 622-640 (2019)
Monash University
Discovery of Potent, Efficient, and Selective Inhibitors of Phosphoinositide 3-Kinase ? through a Deconstruction and Regrowth Approach.
J Med Chem 61: 11061-11073 (2018)
Glaxosmithkline R&D
Chemistry-oriented synthesis (ChOS) and target deconvolution on neuroprotective effect of a novel scaffold, oxaza spiroquinone.
Eur J Med Chem 163: 453-480 (2019)
Gachon University
Exploring structural properties of potent human carbonic anhydrase inhibitors bearing a 4-(cycloalkylamino-1-carbonyl)benzenesulfonamide moiety.
Eur J Med Chem 163: 443-452 (2019)
University of Messina
Design, synthesis and biological evaluation of quinoline-indole derivatives as anti-tubulin agents targeting the colchicine binding site.
Eur J Med Chem 163: 428-442 (2019)
China Pharmaceutical University
Targeting the immunity protein kinases for immuno-oncology.
Eur J Med Chem 163: 413-427 (2019)
China Pharmaceutical University
Recent advances of tetrazole derivatives as potential anti-tubercular and anti-malarial agents.
Eur J Med Chem 163: 404-412 (2019)
Wuxi Apptec
Polycyclic maleimide-based derivatives as first dual modulators of neuronal calcium channels and GSK-3? for Alzheimer's disease treatment.
Eur J Med Chem 163: 394-402 (2019)
Alma Mater Studiorum-University of Bologna
Design, synthesis and biological evaluation of AZD9291 derivatives as selective and potent EGFR
Eur J Med Chem 163: 367-380 (2019)
Jiangxi Science & Technology Normal University
Peptidomimetic plasmepsin inhibitors with potent anti-malarial activity and selectivity against cathepsin D.
Eur J Med Chem 163: 344-352 (2019)
Latvian Institute of Organic Synthesis
Development of posaconazole-based analogues as hedgehog signaling pathway inhibitors.
Eur J Med Chem 163: 320-332 (2019)
University of Connecticut
Synthesis and evaluation of isoprenylation-resveratrol dimer derivatives against Alzheimer's disease.
Eur J Med Chem 163: 307-319 (2019)
School of Traditional Chinese Pharmacy
Rational design of 5-((1H-imidazol-1-yl)methyl)quinolin-8-ol derivatives as novel bromodomain-containing protein 4 inhibitors.
Eur J Med Chem 163: 281-294 (2019)
Chinese Academy of Sciences
Hydroxyazole scaffold-based Plasmodium falciparum dihydroorotate dehydrogenase inhibitors: Synthesis, biological evaluation and X-ray structural studies.
Eur J Med Chem 163: 266-280 (2019)
University of Turin
Cyclin G-associated kinase (GAK) affinity and antiviral activity studies of a series of 3-C-substituted isothiazolo[4,3-b]pyridines.
Eur J Med Chem 163: 256-265 (2019)
Ku Leuven
Discovery of potent Pan-Raf inhibitors with increased solubility to overcome drug resistance.
Eur J Med Chem 163: 243-255 (2019)
China Pharmaceutical University
The development and characterization of a chemical probe targeting PRMT1 over PRMT5.
Bioorg Med Chem 27: 224-229 (2019)
University of North Florida
Isoform selective PLD inhibition by novel, chiral 2,8-diazaspiro[4.5]decan-1-one derivatives.
Bioorg Med Chem Lett 28: 3670-3673 (2018)
Vanderbilt University Medical Center
Dual inhibition of Kif15 by oxindole and quinazolinedione chemical probes.
Bioorg Med Chem Lett 29: 148-154 (2019)
Vanderbilt University
8-Hydroxy-2-(1H-1,2,3-triazol-1-yl)-1,4-naphtoquinone derivatives inhibited P2X7 Receptor-Induced dye uptake into murine Macrophages.
Bioorg Med Chem 27: 1449-1455 (2019)
Fluminense Federal University
Ganocapenoids A-D: Four new aromatic meroterpenoids from Ganoderma capense.
Bioorg Med Chem Lett 29: 143-147 (2019)
Guangxi University of Chinese Medicine
Melonoside B and Melonosins A and B, Lipids Containing Multifunctionalized ?-Hydroxy Fatty Acid Amides from the Far Eastern Marine Sponge Melonanchora kobjakovae.
J Nat Prod 81: 2763-2767 (2018)
Far Eastern Branch of The Russian Academy of Sciences
New Generation of Selective Androgen Receptor Degraders: Our Initial Design, Synthesis, and Biological Evaluation of New Compounds with Enzalutamide-Resistant Prostate Cancer Activity.
J Med Chem 62: 491-511 (2019)
University of Tennessee Health Science Center
Discovery of 3-Ethyl-4-(3-isopropyl-4-(4-(1-methyl-1 H-pyrazol-4-yl)-1 H-imidazol-1-yl)-1 H-pyrazolo[3,4- b]pyridin-1-yl)benzamide (TAS-116) as a Potent, Selective, and Orally Available HSP90 Inhibitor.
J Med Chem 62: 531-551 (2019)
Taiho Pharmaceutical
Discovery of MD-224 as a First-in-Class, Highly Potent, and Efficacious Proteolysis Targeting Chimera Murine Double Minute 2 Degrader Capable of Achieving Complete and Durable Tumor Regression.
J Med Chem 62: 448-466 (2019)
TBA
Novel Strategies To Activate the Dopamine D
J Med Chem 62: 128-140 (2019)
Ucb Pharma
Celastrol Promotes Weight Loss in Diet-Induced Obesity by Inhibiting the Protein Tyrosine Phosphatases PTP1B and TCPTP in the Hypothalamus.
J Med Chem 61: 11144-11157 (2018)
Helmholtz Zentrum M�Nchen
Quinazolin-2,4-dione-Based Hydroxamic Acids as Selective Histone Deacetylase-6 Inhibitors for Treatment of Non-Small Cell Lung Cancer.
J Med Chem 62: 857-874 (2019)
Annji Pharmaceutical
Discovery of Novel Quinoline-Chalcone Derivatives as Potent Antitumor Agents with Microtubule Polymerization Inhibitory Activity.
J Med Chem 62: 993-1013 (2019)
China Pharmaceutical University
Molecular Mechanism of Inhibition of Acid Ceramidase by Carmofur.
J Med Chem 62: 987-992 (2019)
Argonne National Laboratory
Synthesis and evaluation of thieno[3,2-d]pyrimidine derivatives as novel FMS inhibitors.
Bioorg Med Chem Lett 29: 271-275 (2019)
Chung-Ang University
Triazolopyrimidine and triazolopyridine scaffolds as TDP2 inhibitors.
Bioorg Med Chem Lett 29: 257-261 (2019)
University of Minnesota
Synthesis and biological evaluation of novel 1-substituted 3-(3-phenoxyprop-1-yn-1-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amines as potent Bruton's tyrosine kinase (BTK) inhibitors.
Bioorg Med Chem Lett 29: 225-229 (2019)
Shanghai Institute of Pharmaceutical Industry
Discovery of potent azaindazole leucine-rich repeat kinase 2 (LRRK2) inhibitors possessing a key intramolecular hydrogen bond - Part 2.
Bioorg Med Chem Lett 29: 674-680 (2019)
Genentech
5-Substituted-N-pyridazinylbenzamides as potent and selective LRRK2 inhibitors: Improved brain unbound fraction enables efficacy.
Bioorg Med Chem Lett 29: 212-215 (2019)
Gsk Pharmaceuticals R&D
Discovery and structure-activity relationship of imidazolinylindole derivatives as kallikrein 7 inhibitors.
Bioorg Med Chem Lett 29: 334-338 (2019)
Asubio Pharma
Design, synthesis and biological evaluation of bifunctional inhibitors of membrane type 1 matrix metalloproteinase (MT1-MMP).
Bioorg Med Chem 27: 196-207 (2019)
University of Pisa
Design, synthesis, biological evaluation, structure-activity relationship, and toxicity of clinafloxacin-azole conjugates as novel antitubercular agents.
Bioorg Med Chem 27: 175-187 (2019)
Southwest University
(Pyrrolo-pyridin-5-yl)benzamides: BBB permeable monoamine oxidase B inhibitors with neuroprotective effect on cortical neurons.
Eur J Med Chem 162: 793-809 (2019)
Ntz Lab
Discovery and development of small molecule modulators targeting glutamine metabolism.
Eur J Med Chem 163: 215-242 (2019)
China Pharmaceutical University
Highly Potent and Selective Plasmin Inhibitors Based on the Sunflower Trypsin Inhibitor-1 Scaffold Attenuate Fibrinolysis in Plasma.
J Med Chem 62: 552-560 (2019)
The University of Queensland
The Journey of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) from Lab to Clinic.
J Med Chem 62: 4851-4883 (2019)
University of Bonn
Spirostaphylotrichin X from a Marine-Derived Fungus as an Anti-influenza Agent Targeting RNA Polymerase PB2.
J Nat Prod 81: 2722-2730 (2018)
Chinese Academy of Sciences
Design, synthesis and evaluation of N
Bioorg Med Chem Lett 29: 267-270 (2019)
Kasetsart University
Discovery of a highly selective FLT3 inhibitor with specific proliferation inhibition against AML cells harboring FLT3-ITD mutation.
Eur J Med Chem 163: 195-206 (2019)
China Pharmaceutical University
Design and Evaluation of Potent EGFR Inhibitors through the Incorporation of Macrocyclic Polyamine Moieties into the 4-Anilinoquinazoline Scaffold.
J Med Chem 61: 11372-11383 (2018)
Beijing University of Chemical Technology
Designing de Novo Small Molecules That Control Heat Shock Protein 70 (Hsp70) and Heat Shock Organizing Protein (HOP) within the Chaperone Protein-Folding Machinery.
J Med Chem 62: 742-761 (2019)
University of New South Wales
Onydecalins, Fungal Polyketides with Anti- Histoplasma and Anti-TRP Activity.
J Nat Prod 81: 2605-2611 (2018)
University of Utah
Design, synthesis and evaluation of pentacycloundecane and hexacycloundecane propargylamine derivatives as multifunctional neuroprotective agents.
Eur J Med Chem 163: 83-94 (2019)
University of The Western Cape
Synthesis and mechanistic studies of diketo acids and their bioisosteres as potential antibacterial agents.
Eur J Med Chem 163: 67-82 (2019)
Tm Bhagalpur University
Type IIA - Type IIB protein tyrosine kinase inhibitors hybridization as an efficient approach for potent multikinase inhibitor development: Design, synthesis, anti-proliferative activity, multikinase inhibitory activity and molecular modeling of novel indolinone-based ureides and amides.
Eur J Med Chem 163: 37-53 (2019)
Kafrelsheikh University
Phytoestrogens and their synthetic analogues as substrate mimic inhibitors of CYP1B1.
Eur J Med Chem 163: 28-36 (2019)
Birla Institute of Technology
Ligand design for somatostatin receptor isoforms 4 and 5.
Eur J Med Chem 163: 148-159 (2019)
National University of Ireland Galway
Antitumoral activity of quinoxaline derivatives: A systematic review.
Eur J Med Chem 163: 136-147 (2019)
Cnrs
Design and development of some phenyl benzoxazole derivatives as a potent acetylcholinesterase inhibitor with antioxidant property to enhance learning and memory.
Eur J Med Chem 163: 116-135 (2019)
Indian Institute of Technology (Banaras Hindu University)
Discovery of N
Eur J Med Chem 163: 10-27 (2019)
Zhuhai Campus of Zunyi Medical University
Discovery of novel anti-angiogenesis agents. Part 10: Multi-target inhibitors of VEGFR-2, Tie-2 and EphB4 incorporated with 1,2,3-triazol.
Eur J Med Chem 163: 1-9 (2019)
Xi'An Jiaotong University
Discovery and evaluation of novel FAAH inhibitors in neuropathic pain model.
Bioorg Med Chem Lett 29: 238-243 (2019)
Advinus Therapeutics
The discovery of VU0652957 (VU2957, Valiglurax): SAR and DMPK challenges en route to an mGlu
Bioorg Med Chem Lett 29: 342-346 (2019)
Vanderbilt University
Generation and screening of pseudostatic hydrazone libraries derived from 5-substituted nipecotic acid derivatives at the GABA transporter mGAT4.
Bioorg Med Chem 27: 144-152 (2019)
Ludwig-Maximilians-Universit£T M£Nchen
An insight into medicinal chemistry of anticancer quinoxalines.
Bioorg Med Chem 27: 16-35 (2019)
India
Synthesis and identification of 2,4-bisanilinopyrimidines bearing 2,2,6,6-tetramethylpiperidine-N-oxyl as potential Aurora A inhibitors.
Bioorg Med Chem 27: 65-78 (2019)
Lanzhou University
BH3 mimetics derived from Bim-BH3 domain core region show PTP1B inhibitory activity.
Bioorg Med Chem Lett 29: 244-247 (2019)
Ocean University of China
Improving the Selectivity of PACE4 Inhibitors through Modifications of the P1 Residue.
J Med Chem 61: 11250-11260 (2018)
TBA
Design and Optimization of Sulfone Pyrrolidine Sulfonamide Antagonists of Transient Receptor Potential Vanilloid-4 with in Vivo Activity in a Pulmonary Edema Model.
J Med Chem 61: 11209-11220 (2018)
TBA
Identification and Profiling of Hydantoins-A Novel Class of Potent Antimycobacterial DprE1 Inhibitors.
J Med Chem 61: 11221-11249 (2018)
University of Antwerp
Identification of Selective Acyl Sulfonamide-Cycloalkylether Inhibitors of the Voltage-Gated Sodium Channel (Na
J Med Chem 62: 908-927 (2019)
Xenon Pharmaceuticals
Pharmaceutical and medicinal significance of sulfur (S
Eur J Med Chem 162: 679-734 (2019)
Wuhan University of Technology
Discovery of 2-(1H-imidazo-2-yl)piperazines as a new class of potent and non-cytotoxic inhibitors of Trypanosoma brucei growth in vitro.
Bioorg Med Chem Lett 28: 3689-3692 (2018)
Irbm Science Park
Discovery of N-(piperidin-3-yl)-N-(pyridin-2-yl)piperidine/piperazine-1-carboxamides as small molecule inhibitors of PCSK9.
Bioorg Med Chem Lett 28: 3685-3688 (2018)
Pfizer
Synthesis and biological evaluation of arylpiperazine derivatives as potential anti-prostate cancer agents.
Bioorg Med Chem 27: 133-143 (2019)
Southern Medical University
Design and synthesis of rosiglitazone-ferulic acid-nitric oxide donor trihybrids for improving glucose tolerance.
Eur J Med Chem 162: 650-665 (2019)
China Pharmaceutical University
Novel Tetrazole-Containing Analogues of Itraconazole as Potent Antiangiogenic Agents with Reduced Cytochrome P450 3A4 Inhibition.
J Med Chem 61: 11158-11168 (2018)
TBA
Identification of 5-(2,3-Dihydro-1 H-indol-5-yl)-7 H-pyrrolo[2,3- d]pyrimidin-4-amine Derivatives as a New Class of Receptor-Interacting Protein Kinase 1 (RIPK1) Inhibitors, Which Showed Potent Activity in a Tumor Metastasis Model.
J Med Chem 61: 11398-11414 (2018)
Sichuan University/Collaborative Innovation Center of Biotherapy
Highly Potent 17?-HSD2 Inhibitors with a Promising Pharmacokinetic Profile for Targeted Osteoporosis Therapy.
J Med Chem 61: 10724-10738 (2018)
Pharmbiotec
Evaluation of neomycin analogues for HIV-1 RRE RNA recognition identifies enhanced activity simplified neamine analogues.
Bioorg Med Chem Lett 29: 339-341 (2019)
The University of Manchester
Structure-based exploration and pharmacological evaluation of N-substituted piperidin-4-yl-methanamine CXCR4 chemokine receptor antagonists.
Eur J Med Chem 162: 631-649 (2019)
Griffin Discoveries
1-Arylsulfonyl indoline-benzamides as a new antitubulin agents, with inhibition of histone deacetylase.
Eur J Med Chem 162: 612-630 (2019)
Taipei Medical University
Cathepsin B: Active site mapping with peptidic substrates and inhibitors.
Bioorg Med Chem 27: 1-15 (2019)
University of Bonn
Optimization of a 1,3,4-oxadiazole series for inhibition of Ca
Eur J Med Chem 162: 568-585 (2019)
Purdue University
Ligand-based design, synthesis and biological evaluation of xanthine derivatives as LSD1/KDM1A inhibitors.
Eur J Med Chem 162: 555-567 (2019)
Zhengzhou University
A novel series of napabucasin derivatives as orally active inhibitors of signal transducer and activator of transcription 3 (STAT3).
Eur J Med Chem 162: 543-554 (2019)
Sichuan University
Synthesis, biological evaluation, and molecular docking investigation of 3-amidoindoles as potent tubulin polymerization inhibitors.
Eur J Med Chem 162: 525-533 (2019)
Southern Medical University
Balancing reactivity and antitumor activity: heteroarylthioacetamide derivatives as potent and time-dependent inhibitors of EGFR.
Eur J Med Chem 162: 507-524 (2019)
University of Parma
The synthesis of 4-arylamido-2-arylaminoprimidines as potent EGFR T790M/L858R inhibitors for NSCLC.
Bioorg Med Chem 26: 6087-6095 (2018)
Shenyang Pharmaceutical University
Synthesis and evaluation of third generation vitamin D3 analogues as inhibitors of Hedgehog signaling.
Eur J Med Chem 162: 495-506 (2019)
University of Connecticut
Discovery of novel 2,5-dihydroxyterephthalamide derivatives as multifunctional agents for the treatment of Alzheimer's disease.
Bioorg Med Chem 26: 6115-6127 (2018)
Sichuan University
Resorcinol alkyl glucosides as potent tyrosinase inhibitors.
Bioorg Med Chem Lett 29: 313-316 (2019)
Utsunomiya University
Discovery of novel pyruvate dehydrogenase kinases inhibitors by screening of an in-house small molecule library for anti-lung cancer therapeutics.
Bioorg Med Chem Lett 29: 291-296 (2019)
Shaanxi Province Tuberculosis Prevention and Treatment Institute
Pharmaceutical significance of azepane based motifs for drug discovery: A critical review.
Eur J Med Chem 162: 465-494 (2019)
Wuhan Institute of Technology
Diaryl hydroxylamines as pan or dual inhibitors of indoleamine 2,3-dioxygenase-1, indoleamine 2,3-dioxygenase-2 and tryptophan dioxygenase.
Eur J Med Chem 162: 455-464 (2019)
Bryn Mawr College
Anti-inflammatory activity of triazine derivatives: A systematic review.
Eur J Med Chem 162: 435-447 (2019)
Universidad Tecnol£Gica De Pereira
The development of myeloperoxidase inhibitors.
Bioorg Med Chem Lett 29: 1-7 (2019)
University Sarajevo School of Science and Technology
Development and characterization of a CNS-penetrant benzhydryl hydroxamic acid class IIa histone deacetylase inhibitor.
Bioorg Med Chem Lett 29: 83-88 (2019)
Charles River Discovery (Previously Biofocus)
Fragment-to-Lead Medicinal Chemistry Publications in 2017.
J Med Chem 62: 3857-3872 (2019)
Astex Pharmaceuticals
Application of Sequential Palladium Catalysis for the Discovery of Janus Kinase Inhibitors in the Benzo[ c]pyrrolo[2,3- h][1,6]naphthyridin-5-one (BPN) Series.
J Med Chem 61: 10440-10462 (2018)
Purdue University
Selective Inhibitors of Human Neuraminidase 1 (NEU1).
J Med Chem 61: 11261-11279 (2018)
University of Alberta
Easy-To-Synthesize Spirocyclic Compounds Possess Remarkable in Vivo Activity against Mycobacterium tuberculosis.
J Med Chem 61: 11327-11340 (2018)
Glaxosmithkline
Small Molecule Inhibitor that Stabilizes the Autoinhibited Conformation of the Oncogenic Tyrosine Phosphatase SHP2.
J Med Chem 62: 1125-1137 (2019)
Emory University School of Medicine
Polyheteroaryl Oxazole/Pyridine-Based Compounds Selected in Vitro as G-Quadruplex Ligands Inhibit Rock Kinase and Exhibit Antiproliferative Activity.
J Med Chem 61: 10502-10518 (2018)
University Paris-Sud
Development of hydroxamate-based histone deacetylase inhibitors containing 1,2,4-oxadiazole moiety core with antitumor activities.
Bioorg Med Chem Lett 29: 15-21 (2019)
University of Jinan
Tetradehydrohalicyclamine B, a new proteasome inhibitor from the marine sponge Acanthostrongylophora ingens.
Bioorg Med Chem Lett 29: 8-10 (2019)
Kumamoto University
Novel monoamine oxidase inhibitors based on the privileged 2-imidazoline molecular framework.
Bioorg Med Chem Lett 29: 40-46 (2019)
Ushinsky Yaroslavl State Pedagogical University
Discovery of covalent enzyme inhibitors using virtual docking of covalent fragments.
Bioorg Med Chem Lett 29: 36-39 (2019)
University of Houston
Discovery and optimization of pyrazole amides as antagonists of CCR1.
Bioorg Med Chem Lett 29: 435-440 (2019)
Boehringer Ingelheim Pharmaceuticals
Synthesis and biological evaluation of thielocin B1 analogues as protein-protein interaction inhibitors of PAC3 homodimer.
Bioorg Med Chem 26: 6023-6034 (2018)
Tohoku University
Design, synthesis and biological evaluation of novel 1-phenyl phenanthridin-6(5H)-one derivatives as anti-tumor agents targeting TOPK.
Eur J Med Chem 162: 407-422 (2019)
Sichuan University
Proline- and Arginine-Rich Peptides as Flexible Allosteric Modulators of Human Proteasome Activity.
J Med Chem 62: 359-370 (2019)
University of Gdansk
Sterol 14?-Demethylase Structure-Based Optimization of Drug Candidates for Human Infections with the Protozoan Trypanosomatidae.
J Med Chem 61: 10910-10921 (2018)
Vanderbilt University School of Medicine
Highly fluorescent and HDAC6 selective scriptaid analogues.
Eur J Med Chem 162: 321-333 (2019)
Deakin University
Benzofuran derivatives and their anti-tubercular, anti-bacterial activities.
Eur J Med Chem 162: 266-276 (2019)
Huanghuai University
Design, synthesis and biological evaluation of novel, orally bioavailable pyrimidine-fused heterocycles as influenza PB2 inhibitors.
Eur J Med Chem 162: 249-265 (2019)
Fudan University
Small molecules as inhibitors of PCSK9: Current status and future challenges.
Eur J Med Chem 162: 212-233 (2019)
China Pharmaceutical University
Optimization and preclinical evaluation of novel histamine H
Bioorg Med Chem 26: 6056-6066 (2018)
Jagiellonian University Medical College
Design, synthesis and in vitro evaluation of stilbene derivatives as novel LSD1 inhibitors for AML therapy.
Bioorg Med Chem 26: 6000-6014 (2018)
Xinxiang Medical University
Furanoflavones pongapin and lanceolatin B blocks the cell cycle and induce senescence in CYP1A1-overexpressing breast cancer cells.
Bioorg Med Chem 26: 6076-6086 (2018)
Csir-Indian Institute of Integrative Medicine
Towards lead compounds as anti-cancer agents via new phaeosphaeride A derivatives.
Bioorg Med Chem Lett 29: 59-61 (2019)
Federal Medical Biological Agency
Novel multitarget-directed ligands targeting acetylcholinesterase and ?
Eur J Med Chem 162: 234-248 (2019)
Normandie Univ
Dimeric cinnamoylamide analogues for regulation of tyrosinase activity in melanoma cells: A role of diamide-link chain length.
Bioorg Med Chem 26: 6015-6022 (2018)
Seoul National University of Science and Technology
Synthesis and evaluation of potent and selective MGL inhibitors as a glaucoma treatment.
Bioorg Med Chem 27: 55-64 (2019)
Mak Scientific
Design, synthesis and biological evaluation of anthranilamide derivatives as potential factor Xa (fXa) inhibitors.
Bioorg Med Chem 26: 5987-5999 (2018)
China Pharmaceutical University
Structural development of non-secosteroidal vitamin D receptor (VDR) ligands without any asymmetric carbon.
Bioorg Med Chem 26: 6146-6152 (2018)
National Institute of Health Sciences
Synthesis and tyrosinase inhibitory activities of 4-oxobutanoate derivatives of carvacrol and thymol.
Bioorg Med Chem Lett 29: 56-58 (2019)
Susquehanna University
Discovery of naldemedine: A potent and orally available opioid receptor antagonist for treatment of opioid-induced adverse effects.
Bioorg Med Chem Lett 29: 73-77 (2019)
Shionogi
Discovery of 4-alkoxy-6-methylpicolinamide negative allosteric modulators of metabotropic glutamate receptor subtype 5.
Bioorg Med Chem Lett 29: 47-50 (2019)
Vanderbilt University Medical Center
First-in-class DAPK1/CSF1R dual inhibitors: Discovery of 3,5-dimethoxy-N-(4-(4-methoxyphenoxy)-2-((6-morpholinopyridin-3-yl)amino)pyrimidin-5-yl)benzamide as a potential anti-tauopathies agent.
Eur J Med Chem 162: 161-175 (2019)
Korea Institute of Science & Technology (Kist)
Enhancement of the tail hydrophobic interactions within the carbonic anhydrase IX active site via structural extension: Design and synthesis of novel N-substituted isatins-SLC-0111 hybrids as carbonic anhydrase inhibitors and antitumor agents.
Eur J Med Chem 162: 147-160 (2019)
Kafrelsheikh University
Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) Inhibition: An Emerging Strategy in Cancer Therapy.
J Med Chem 62: 3840-3856 (2019)
China Pharmaceutical University
Design, synthesis and evaluation of the osimertinib analogue (C-005) as potent EGFR inhibitor against NSCLC.
Bioorg Med Chem 26: 6135-6145 (2018)
Wuxi Shuangliang Biotechnology
Synthesis and biological evaluation of novel N-substituted nipecotic acid derivatives with a trans-alkene spacer as potent GABA uptake inhibitors.
Bioorg Med Chem 26: 5944-5961 (2018)
Ludwig-Maximilians-Universit£T M£Nchen
Discovery of a novel azetidine scaffold for colony stimulating factor-1 receptor (CSF-1R) Type II inhibitors by the use of docking models.
Bioorg Med Chem Lett 29: 115-118 (2019)
Central Pharmaceutical Research Institute
4-Hydroxy-3-nitro-5-ureido-benzenesulfonamides Selectively Target the Tumor-Associated Carbonic Anhydrase Isoforms IX and XII Showing Hypoxia-Enhanced Antiproliferative Profiles.
J Med Chem 61: 10860-10874 (2018)
Universita Degli Studi Di Firenze
Discovery of Clinical Candidate 2-(4-(2-((1 H-Benzo[ d]imidazol-2-yl)thio)ethyl)piperazin-1-yl)- N-(6-methyl-2,4-bis(methylthio)pyridin-3-yl)acetamide Hydrochloride [K-604], an Aqueous-Soluble Acyl-CoA:Cholesterol O-Acyltransferase-1 Inhibitor.
J Med Chem 61: 10635-10650 (2018)
Kowa
Discovery and Lead Optimization of Atropisomer D1 Agonists with Reduced Desensitization.
J Med Chem 61: 11384-11397 (2018)
Pfizer
Discovery of JND3229 as a New EGFR
ACS Med Chem Lett 9: 1123-1127 (2018)
Jinan University
Discovery of 4-Azaindole Inhibitors of TGF?RI as Immuno-oncology Agents.
ACS Med Chem Lett 9: 1117-1122 (2018)
Bristol-Myers Squibb Research and Development
2-Aminoadipic Acid-C(O)-Glutamate Based Prostate-Specific Membrane Antigen Ligands for Potential Use as Theranostics.
ACS Med Chem Lett 9: 1099-1104 (2018)
University of Illinois At Chicago
Optimization of Preclinical Metabolism for Somatostatin Receptor Subtype 5-Selective Antagonists.
ACS Med Chem Lett 9: 1088-1093 (2018)
Merck
Discovery and Pharmacology of a Novel Somatostatin Subtype 5 (SSTR5) Antagonist: Synergy with DPP-4 Inhibition.
ACS Med Chem Lett 9: 1082-1087 (2018)
Merck
Optimization of Phenyl Indole Inhibitors of the AAA+ ATPase p97.
ACS Med Chem Lett 9: 1075-1081 (2018)
University of Pittsburgh Chemical Diversity Center
Screening, synthesis, crystal structure, and molecular basis of 6-amino-4-phenyl-1,4-dihydropyrano[2,3-c]pyrazole-5-carbonitriles as novel AKR1C3 inhibitors.
Bioorg Med Chem 26: 5934-5943 (2018)
Guangzhou Medical University
Matrix metalloproteinase-12 inhibitors: synthesis, structure-activity relationships and intestinal absorption of novel sugar-based biphenylsulfonamide carboxylates.
Bioorg Med Chem 26: 5804-5815 (2018)
University of Pisa
PPAR?-sparing thiazolidinediones as insulin sensitizers. Design, synthesis and selection of compounds for clinical development.
Bioorg Med Chem 26: 5870-5884 (2018)
Sptanis Pharmachem Consulting
Probing the ligand preferences of the three types of bacterial pantothenate kinase.
Bioorg Med Chem 26: 5896-5902 (2018)
Mcgill University
Identification of Cyanamide-Based Janus Kinase 3 (JAK3) Covalent Inhibitors.
J Med Chem 61: 10665-10699 (2018)
Pfizer
Asymmetric synthesis and biological evaluation of imidazole- and oxazole-containing synthetic lipoxin A
Eur J Med Chem 162: 80-108 (2019)
University College Dublin
Kinase and Histone Deacetylase Hybrid Inhibitors for Cancer Therapy.
J Med Chem 62: 3171-3183 (2019)
Qingdao University
Discovery and structure-activity-relationship study of novel imidazole cyclopropyl amine analogues for mutant isocitric dehydrogenase 1 (IDH1) inhibitors.
Bioorg Med Chem Lett 28: 3808-3812 (2018)
Shanghai Haihe Pharmaceutical
Novel Symmetrical Benzazolyl Derivatives Endowed with Potent Anti-Heparanase Activity.
J Med Chem 61: 10834-10859 (2018)
"Sapienza" Universit£
Diterpenoids from Euphorbia dulcis with Potassium Ion Channel Inhibitory Activity with Selective G Protein-Activated Inwardly Rectifying Ion Channel (GIRK) Blocking Effect.
J Nat Prod 81: 2483-2492 (2018)
Rytmion
Design, synthesis, and ex vivo evaluation of a selective inhibitor for retinaldehyde dehydrogenase enzymes.
Bioorg Med Chem 26: 5766-5779 (2018)
University of Oklahoma Health Sciences Center
Structure-based design and discovery of potent and selective lysine-specific demethylase 1 (LSD1) inhibitors.
Bioorg Med Chem Lett 29: 103-106 (2019)
Celgene
An update on sphingosine-1-phosphate receptor 1 modulators.
Bioorg Med Chem Lett 28: 3585-3591 (2018)
The University of Arizona
Antileishmanial activity of new hybrid tetrahydroquinoline and quinoline derivatives with phosphorus substituents.
Eur J Med Chem 162: 18-31 (2019)
Universidad De Le£N
Discovery of Small Molecule Splicing Modulators of Survival Motor Neuron-2 (SMN2) for the Treatment of Spinal Muscular Atrophy (SMA).
J Med Chem 61: 11021-11036 (2018)
Novartis Institutes For Biomedical Research
Structure-Based Approach toward Identification of Inhibitory Fragments for Eleven-Nineteen-Leukemia Protein (ENL).
J Med Chem 61: 10929-10934 (2018)
Goethe-University Frankfurt
First Report of Plant-Derived ?-Sitosterol with Antithrombotic, in Vivo Anticoagulant, and Thrombus-Preventing Activities in a Mouse Model.
J Nat Prod 81: 2521-2530 (2018)
Institute of Medicinal and Aromatic Plants
4-tert-Pentylphenoxyalkyl derivatives - Histamine H
Bioorg Med Chem Lett 28: 3596-3600 (2018)
Jagiellonian University Medical College
Fibroblast Growth Factor Receptor 4 (FGFR4) Selective Inhibitors as Hepatocellular Carcinoma Therapy: Advances and Prospects.
J Med Chem 62: 2905-2915 (2019)
Jinan University
Potent Antiglioblastoma Agents by Hybridizing the Onium-Alkyloxy-Stilbene Based Structures of an ?7-nAChR, ?9-nAChR Antagonist and of a Pro-Oxidant Mitocan.
J Med Chem 61: 10531-10544 (2018)
University of Milan
Cell-Active Small Molecule Inhibitors of the DNA-Damage Repair Enzyme Poly(ADP-ribose) Glycohydrolase (PARG): Discovery and Optimization of Orally Bioavailable Quinazolinedione Sulfonamides.
J Med Chem 61: 10767-10792 (2018)
The University of Manchester
Novel tyrosyl-DNA phosphodiesterase 1 inhibitors enhance the therapeutic impact of topote?an on in vivo tumor models.
Eur J Med Chem 161: 581-593 (2019)
Siberian Branch of The Russian Academy of Sciences
Medicinal chemistry of vicinal diaryl scaffold: A mini review.
Eur J Med Chem 162: 1-17 (2019)
The M.S University of Baroda
Structural Basis of Sirtuin 6 Inhibition by the Hydroxamate Trichostatin A: Implications for Protein Deacylase Drug Development.
J Med Chem 61: 10922-10928 (2018)
University of Bayreuth
Receptor-Ligand Interaction Measured by Inductively Coupled Plasma Mass Spectrometry and Selenium Labeling.
J Med Chem 61: 10173-10184 (2018)
University of Montpellier
Design and optimization of 2,3-dihydrobenzo[b][1,4]dioxine propanoic acids as novel GPR40 agonists with improved pharmacokinetic and safety profiles.
Bioorg Med Chem 26: 5780-5791 (2018)
Chinese Academy of Sciences
Design, synthesis and biological evaluation of 5-(2-amino-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one derivatives as potent ?
Bioorg Med Chem 27: 2306-2314 (2019)
Shenyang Pharmaceutical University
Synthesis and SAR studies of novel benzodiazepinedione-based inhibitors of Clostridium difficile (C. difficile) toxin B (TcdB).
Bioorg Med Chem Lett 28: 3601-3605 (2018)
Venenum Biodesign
Hydroxybiphenylamide GroEL/ES Inhibitors Are Potent Antibacterials against Planktonic and Biofilm Forms of Staphylococcus aureus.
J Med Chem 61: 10651-10664 (2018)
Indiana University School of Medicine
Structure-Based Engineering of Irreversible Inhibitors against Histone Lysine Demethylase KDM5A.
J Med Chem 61: 10588-10601 (2018)
The University of Texas M.D. Anderson Cancer Center
Design, synthesis, and biological evaluation of novel phenol ether derivatives as non-covalent proteasome inhibitors.
Eur J Med Chem 161: 543-558 (2019)
Zhejiang University
Investigation of the molecular characteristics of bisindole inhibitors as HIV-1 glycoprotein-41 fusion inhibitors.
Eur J Med Chem 161: 533-542 (2019)
Touro University-California
Non-chelating p-phenylidene-linked bis-imidazoline analogs of known influenza virus endonuclease inhibitors: Synthesis and anti-influenza activity.
Eur J Med Chem 161: 526-532 (2019)
Saint Petersburg State University
Synthesis and biological evaluation of quinazoline derivatives - A SAR study of novel inhibitors of ABCG2.
Eur J Med Chem 161: 506-525 (2019)
University of Bonn
Synthetic thiosemicarbazones as a new class of Mycobacterium tuberculosis protein tyrosine phosphatase A inhibitors.
Bioorg Med Chem 26: 5742-5750 (2018)
Universidade Federal De Santa Catarina
Triazole-linked transition state analogs as selective inhibitors against V. cholerae sialidase.
Bioorg Med Chem 26: 5751-5757 (2018)
University of California-Davis
Design and evaluation of novel tetracyclic benzofurans as palm site allosteric inhibitors of HCV NS5B polymerase.
Bioorg Med Chem Lett 29: (2019)
Merck
Analogs of penfluridol as chemotherapeutic agents with reduced central nervous system activity.
Bioorg Med Chem Lett 28: 3652-3657 (2018)
Texas Tech University Health Sciences Center
Optimization of substituted cinnamic acyl sulfonamide derivatives as tubulin polymerization inhibitors with anticancer activity.
Bioorg Med Chem Lett 28: 3634-3638 (2018)
Second Military Medical University
Computer-aided design, synthesis and biological characterization of novel inhibitors for PKMYT1.
Eur J Med Chem 161: 479-492 (2019)
Martin-Luther-University Halle-Wittenberg
Overcoming Time-Dependent Inhibition (TDI) of Cytochrome P450 3A4 (CYP3A4) Resulting from Bioactivation of a Fluoropyrimidine Moiety.
J Med Chem 61: 10700-10708 (2018)
TBA
Total Synthesis of Xanthoangelol B and Its Various Fragments: Toward Inhibition of Virulence Factor Production of Staphylococcus aureus.
J Med Chem 61: 10473-10487 (2018)
University of Southampton
Design, synthesis, and biological evaluation of histone deacetylase inhibitors possessing glutathione peroxidase-like and antioxidant activities against Alzheimer's disease.
Bioorg Med Chem 26: 5718-5729 (2018)
Sun Yat-Sen University
Novel 5,6-disubstituted pyrrolo[2,3-d]pyrimidine derivatives as broad spectrum antiproliferative agents: Synthesis, cell based assays, kinase profile and molecular docking study.
Bioorg Med Chem 26: 5596-5611 (2018)
Korea Institute of Science and Technology
1H-pyrrolo[2,3-b]pyridine: A new scaffold for human neutrophil elastase (HNE) inhibitors.
Bioorg Med Chem 26: 5583-5595 (2018)
University of Florence
6'-Fluoro-3-deazaneplanocin: Synthesis and antiviral properties, including Ebola.
Bioorg Med Chem Lett 28: 3674-3675 (2018)
Auburn University
Design and synthesis of histamine H
Bioorg Med Chem Lett 28: 3630-3633 (2018)
Hokkaido University
Decreasing the CYP2D6 contribution to metabolism of a CK1? inhibitor.
Bioorg Med Chem Lett 28: 3681-3684 (2018)
Sanofi Us
Identification of Selective Dual ROCK1 and ROCK2 Inhibitors Using Structure-Based Drug Design.
J Med Chem 61: 11074-11100 (2018)
Abbvie Bioresearch Center
ASR352, A potent anticancer agent: Synthesis, preliminary SAR, and biological activities against colorectal cancer bulk, 5-fluorouracil/oxaliplatin resistant and stem cells.
Eur J Med Chem 161: 456-467 (2019)
University of Florida
Synthesis and biological evaluation of 3-aryl-quinolin derivatives as anti-breast cancer agents targeting ER? and VEGFR-2.
Eur J Med Chem 161: 445-455 (2019)
China Pharmaceutical University
1,2,3,4-Tetrahydroisoquinoline/2H-chromen-2-one conjugates as nanomolar P-glycoprotein inhibitors: Molecular determinants for affinity and selectivity over multidrug resistance associated protein 1.
Eur J Med Chem 161: 433-444 (2019)
University of Bari Aldo Moro
Design, synthesis and antitubercular activity of 4-alkoxy-triazoloquinolones able to inhibit the M. tuberculosis DNA gyrase.
Eur J Med Chem 161: 399-415 (2019)
University of Sassari
Peptide-based and small synthetic molecule inhibitors on PD-1/PD-L1 pathway: A new choice for immunotherapy?
Eur J Med Chem 161: 378-398 (2019)
China Pharmaceutical University
Synthesis and biological evaluation of novel H6 analogues as drug resistance reversal agents.
Eur J Med Chem 161: 364-377 (2019)
Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University)
Discovery of a subnanomolar and selective spirocyclic agonist of the glucocorticoid receptor.
Eur J Med Chem 161: 354-363 (2019)
European Institute of Chemistry and Biology (Iecb)
Pyridinium Oximes with Ortho-Positioned Chlorine Moiety Exhibit Improved Physicochemical Properties and Efficient Reactivation of Human Acetylcholinesterase Inhibited by Several Nerve Agents.
J Med Chem 61: 10753-10766 (2018)
Institute For Medical Research and Occupational Health
Synthesis and Biological Evaluation of Fused Tricyclic Heterocycle Piperazine (Piperidine) Derivatives As Potential Multireceptor Atypical Antipsychotics.
J Med Chem 61: 10017-10039 (2018)
Huazhong University of Science and Technology
Neolymphostin A Is a Covalent Phosphoinositide 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Dual Inhibitor That Employs an Unusual Electrophilic Vinylogous Ester.
J Med Chem 61: 10463-10472 (2018)
University of California San Diego
Required Immunoproteasome Subunit Inhibition Profile for Anti-Inflammatory Efficacy and Clinical Candidate KZR-616 ((2 S,3 R)- N-(( S)-3-(Cyclopent-1-en-1-yl)-1-(( R)-2-methyloxiran-2-yl)-1-oxopropan-2-yl)-3-hydroxy-3-(4-methoxyphenyl)-2-(( S)-2-(2-morpholinoacetamido)propanamido)propenamide).
J Med Chem 61: 11127-11143 (2018)
Kezar Life Sciences
Novel Allosteric Ligands of ?-Aminobutyric Acid Transporter 1 (GAT1) by MS Based Screening of Pseudostatic Hydrazone Libraries.
J Med Chem 61: 10310-10332 (2018)
Ludwig-Maximilians-Universit£T M£Nchen
Target Validation and Identification of Novel Boronate Inhibitors of the Plasmodium falciparum Proteasome.
J Med Chem 61: 10053-10066 (2018)
The University of Melbourne
Molecular Basis for Multiple Omapatrilat Binding Sites within the ACE C-Domain: Implications for Drug Design.
J Med Chem 61: 10141-10154 (2018)
University of Bath
Optimization of a fragment linking hit toward Dengue and Zika virus NS5 methyltransferases inhibitors.
Eur J Med Chem 161: 323-333 (2019)
Cnrs Umr7258
Design, synthesis, and effects of novel phenylpyrimidines as glucagon receptor antagonists.
Bioorg Med Chem 26: 5701-5710 (2018)
Gachon University
Discovery of new potent protein arginine methyltransferase 5 (PRMT5) inhibitors by assembly of key pharmacophores from known inhibitors.
Bioorg Med Chem Lett 28: 3693-3699 (2018)
University of Jinan
Investigating alkyl nitrates as nitric oxide releasing precursors of multitarget acetylcholinesterase-monoamine oxidase B inhibitors.
Eur J Med Chem 161: 292-309 (2019)
University of Bari Aldo Moro
Identification of novel quinazoline derivatives as potent antiplasmodial agents.
Eur J Med Chem 161: 277-291 (2019)
University of Lille
Naphthalene, a versatile platform in medicinal chemistry: Sky-high perspective.
Eur J Med Chem 161: 252-276 (2019)
Indian Institute of Technology (Bhu)
Discovery of the First-in-Class Dual Histone Deacetylase-Proteasome Inhibitor.
J Med Chem 61: 10299-10309 (2018)
Heinrich Heine University D£Sseldorf
Structure-Based Optimization of N-Substituted Oseltamivir Derivatives as Potent Anti-Influenza A Virus Agents with Significantly Improved Potency against Oseltamivir-Resistant N1-H274Y Variant.
J Med Chem 61: 9976-9999 (2018)
Shandong University
4-Iminooxazolidin-2-one as a Bioisostere of the Cyanohydrin Moiety: Inhibitors of Enterovirus 71 3C Protease.
J Med Chem 61: 10333-10339 (2018)
Nankai University
Structural Basis for ( S)-3,4-Dicarboxyphenylglycine (DCPG) As a Potent and Subtype Selective Agonist of the mGlu
J Med Chem 61: 10040-10052 (2018)
TBA
Stereoselective Synthesis of the Isomers of Notoincisol A: Assigment of the Absolute Configuration of this Natural Product and Biological Evaluation.
J Nat Prod 81: 2419-2428 (2018)
Vienna University of Technology
Resveratrol-maltol hybrids as multi-target-directed agents for Alzheimer's disease.
Bioorg Med Chem 26: 5759-5765 (2018)
Zhejiang University
Synthesis of novel 2-(1-adamantanylcarboxamido)thiophene derivatives. Selective cannabinoid type 2 (CB2) receptor agonists as potential agents for the treatment of skin inflammatory disease.
Eur J Med Chem 161: 239-251 (2019)
University of Siena
Quantitative and systems pharmacology 4. Network-based analysis of drug pleiotropy on coronary artery disease.
Eur J Med Chem 161: 192-204 (2019)
Guangzhou University of Chinese Medicine
Discovery and Preclinical Characterization of 5-[4,6-Bis({3-oxa-8-azabicyclo[3.2.1]octan-8-yl})-1,3,5-triazin-2-yl]-4-(difluoromethyl)pyridin-2-amine (PQR620), a Highly Potent and Selective mTORC1/2 Inhibitor for Cancer and Neurological Disorders.
J Med Chem 61: 10084-10105 (2018)
University of Basel
Design, Synthesis, Molecular Dynamics Simulation, and Functional Evaluation of a Novel Series of 26RFa Peptide Analogues Containing a Mono- or Polyalkyl Guanidino Arginine Derivative.
J Med Chem 61: 10185-10197 (2018)
Normandy University
Targeting of N-Type Calcium Channels via GABA
J Med Chem 61: 10198-10205 (2018)
Beijing Institute of Biotechnology
Design and Synthesis of Potent HIV-1 Protease Inhibitors Containing Bicyclic Oxazolidinone Scaffold as the P2 Ligands: Structure-Activity Studies and Biological and X-ray Structural Studies.
J Med Chem 61: 9722-9737 (2018)
Purdue University
NMR-Based Investigation of Hydrogen Bonding in a Dihydroanthracen-1(4 H)one from Rubia philippinensis and Its Soluble Epoxide Hydrolase Inhibitory Potential.
J Nat Prod 81: 2429-2435 (2018)
Yale University
Kojyl cinnamate esters are peroxisome proliferator-activated receptor ?/? dual agonists.
Bioorg Med Chem 26: 5654-5663 (2018)
Seoul National University
Discovery of Novel Flavonoid Dimers To Reverse Multidrug Resistance Protein 1 (MRP1, ABCC1) Mediated Drug Resistance in Cancers Using a High Throughput Platform with "Click Chemistry".
J Med Chem 61: 9931-9951 (2018)
Hong Kong Polytechnic University
Development of Dihydrodibenzooxepine Peroxisome Proliferator-Activated Receptor (PPAR) Gamma Ligands of a Novel Binding Mode as Anticancer Agents: Effective Mimicry of Chiral Structures by Olefinic E/ Z-Isomers.
J Med Chem 61: 10067-10083 (2018)
Fuji Research Park, R&D Division
Potent, Irreversible Inhibition of Human Carboxylesterases by Tanshinone Anhydrides Isolated from Salvia miltiorrhiza ("Danshen").
J Nat Prod 81: 2410-2418 (2018)
St. Jude Children'S Research Hospital
Biodegradable Amphipathic Peptide Hydrogels as Extended-Release System for Opioid Peptides.
J Med Chem 61: 9784-9789 (2018)
Vrije Universiteit Brussel
Discovery of a Potent Grp94 Selective Inhibitor with Anti-Inflammatory Efficacy in a Mouse Model of Ulcerative Colitis.
J Med Chem 61: 9513-9533 (2018)
China Pharmaceutical University
Discovery of a Novel Inhaled PI3K? Inhibitor for the Treatment of Respiratory Diseases.
J Med Chem 61: 9551-9567 (2018)
TBA
Synthesis, Receptor Affinity, and Antiallodynic Activity of Spirocyclic ? Receptor Ligands with Exocyclic Amino Moiety.
J Med Chem 61: 9666-9690 (2018)
Universit£T M£Nster
Triterpenoid Hydroxamates as HIF Prolyl Hydrolase Inhibitors.
J Nat Prod 81: 2235-2243 (2018)
University of Eastern Piedmont
Discovery of Novel Central Nervous System Penetrant Metabotropic Glutamate Receptor Subtype 2 (mGlu
J Med Chem 62: 378-384 (2019)
Vanderbilt University School of Medicine
Discovery and synthesis of tetrahydropyrimidinedione-4-carboxamides as endothelial lipase inhibitors.
Bioorg Med Chem Lett 28: 3721-3725 (2018)
Bristol-Myers Squibb
Synthesis of cinnamic amide derivatives and their anti-melanogenic effect in ?-MSH-stimulated B16F10 melanoma cells.
Eur J Med Chem 161: 78-92 (2019)
Pusan National University
Synthesis, biological evaluation, and molecular modeling of 11H-indeno[1,2-b]quinoxalin-11-one derivatives and tryptanthrin-6-oxime as c-Jun N-terminal kinase inhibitors.
Eur J Med Chem 161: 179-191 (2019)
Montana State University
Synthetic small molecules as anti-biofilm agents in the struggle against antibiotic resistance.
Eur J Med Chem 161: 154-178 (2019)
University of Palermo
Design, synthesis, and discovery of ocotillol-type amide derivatives as orally available modulators of P-glycoprotein-mediated multidrug resistance.
Eur J Med Chem 161: 118-130 (2019)
Universities of Shandong
Synthesis and biological evaluation of novel Ani9 derivatives as potent and selective ANO1 inhibitors.
Eur J Med Chem 160: 245-255 (2018)
Yonsei University
Pyrtriazoles, a Novel Class of Store-Operated Calcium Entry Modulators: Discovery, Biological Profiling, and in Vivo Proof-of-Concept Efficacy in Acute Pancreatitis.
J Med Chem 61: 9756-9783 (2018)
University of Eastern Piedmont
Highly Selective MERTK Inhibitors Achieved by a Single Methyl Group.
J Med Chem 61: 10242-10254 (2018)
Unc Eshelman School of Pharmacy
Characterization of Histone Deacetylase 8 (HDAC8) Selective Inhibition Reveals Specific Active Site Structural and Functional Determinants.
J Med Chem 61: 10000-10016 (2018)
University of Strasbourg
Discovery and Characterization of AZD6738, a Potent Inhibitor of Ataxia Telangiectasia Mutated and Rad3 Related (ATR) Kinase with Application as an Anticancer Agent.
J Med Chem 61: 9889-9907 (2018)
Astrazeneca
Development of Hybrid Phospholipid Mimics as Effective Agonists for Liver Receptor Homologue-1.
ACS Med Chem Lett 9: 1051-1056 (2018)
Emory University
Tuning the Dual Inhibition of Carbonic Anhydrase and Cyclooxygenase by Dihydrothiazole Benzensulfonamides.
ACS Med Chem Lett 9: 1045-1050 (2018)
University of Cagliari
Identification of Quinoline-Based RIP2 Kinase Inhibitors with an Improved Therapeutic Index to the hERG Ion Channel.
ACS Med Chem Lett 9: 1039-1044 (2018)
Glaxosmithkline
Famotidine, an Antiulcer Agent, Strongly Inhibits
ACS Med Chem Lett 9: 1035-1038 (2018)
University of Florence
Exploring Halogen Bonds in 5-Hydroxytryptamine 2B Receptor-Ligand Interactions.
ACS Med Chem Lett 9: 1019-1024 (2018)
National Institute of Biological Sciences
Synthesis and Biological Evaluation of an Indazole-Based Selective Protein Arginine Deiminase 4 (PAD4) Inhibitor.
ACS Med Chem Lett 9: 1013-1018 (2018)
Yale University
Synthesis and Evaluation of Aryl Quinolines as HIV-1 Integrase Multimerization Inhibitors.
ACS Med Chem Lett 9: 1007-1012 (2018)
University of Southern Mississippi
New Dopamine D3-Selective Receptor Ligands Containing a 6-Methoxy-1,2,3,4-tetrahydroisoquinolin-7-ol Motif.
ACS Med Chem Lett 9: 990-995 (2018)
City University of New York
NLRP3 Modulators for the Treatment of Autoinflammatory Disorders.
ACS Med Chem Lett 9: 965-966 (2018)
Usona Institute
Decision Making in Medicinal Chemistry: The Power of Our Intuition.
ACS Med Chem Lett 9: 956-958 (2018)
Gomez Consulting
Monosaccharide inhibitors targeting carbohydrate esterase family 4 de-N-acetylases.
Bioorg Med Chem 26: 5631-5643 (2018)
University of Toronto
Genetically-encoded fragment-based discovery of glycopeptide ligands for DC-SIGN.
Bioorg Med Chem 26: 5368-5377 (2018)
University of Alberta
Synthesis of aminopyrazole analogs and their evaluation as CDK inhibitors for cancer therapy.
Bioorg Med Chem Lett 28: 3736-3740 (2018)
Eppley Institute For Research In Cancer and Allied Diseases
Synthesis, nitric oxide release, and dipeptidyl peptidase-4 inhibition of sitagliptin derivatives as new multifunctional antidiabetic agents.
Bioorg Med Chem Lett 28: 3731-3735 (2018)
Xi'An Jiaotong University
Lysine demethylase 5B (KDM5B): A potential anti-cancer drug target.
Eur J Med Chem 161: 131-140 (2019)
Zhengzhou University
Quinoline and quinolone dimers and their biological activities: An overview.
Eur J Med Chem 161: 101-117 (2019)
Zhejiang Ocean University
Dihydropyrazothiazole derivatives as potential MMP-2/MMP-8 inhibitors for cancer therapy.
Bioorg Med Chem Lett 28: 3816-3821 (2018)
Nanjing Agricultural University
An investigation on 4-thiazolidinone derivatives as dual inhibitors of aldose reductase and protein tyrosine phosphatase 1B, in the search for potential agents for the treatment of type 2 diabetes mellitus and its complications.
Bioorg Med Chem Lett 28: 3712-3720 (2018)
University of Messina
An overview of Sirtuins as potential therapeutic target: Structure, function and modulators.
Eur J Med Chem 161: 48-77 (2019)
Sichuan University
Tau Tubulin Kinase 1 (TTBK1), a new player in the fight against neurodegenerative diseases.
Eur J Med Chem 161: 39-47 (2019)
Technical University of Madrid
Development of 2-amino-4-phenylthiazole analogues to disrupt myeloid differentiation factor 88 and prevent inflammatory responses in acute lung injury.
Eur J Med Chem 161: 22-38 (2019)
Wenzhou Medical University
Novel 5-(quinuclidin-3-ylmethyl)-1,2,4-oxadiazoles to investigate the activation of the ?7 nicotinic acetylcholine receptor subtype: Synthesis and electrophysiological evaluation.
Eur J Med Chem 160: 207-228 (2018)
University of Milan
Design, synthesis, cholinesterase inhibition and molecular modelling study of novel tacrine hybrids with carbohydrate derivatives.
Bioorg Med Chem 26: 5566-5577 (2018)
Universidade Federal Do Rio Grande Do Sul
Design, synthesis, and biological evaluation of novel aminopyrimidinylisoindolines as AXL kinase inhibitors.
Bioorg Med Chem Lett 28: 3761-3765 (2018)
Korea University
Semisynthesis of ent-norstrobane diterpenoids as potential inhibitor for factor Xa.
Bioorg Med Chem Lett 28: 3813-3815 (2018)
Guangdong-Macau Traditional Chinese Medicine Technology Industrial Park Development
Synthesis, in vitro and in vivo evaluation of 2-aryl-4H-chromene and 3-aryl-1H-benzo[f]chromene derivatives as novel ?-glucosidase inhibitors.
Bioorg Med Chem Lett 29: 119-123 (2019)
Volgograd State Medical University
Discovery of 5-(2-chloro-4'-(1H-imidazol-1-yl)-[1,1'-biphenyl]-4-yl)-1H-tetrazole as potent and orally efficacious S-nitrosoglutathione reductase (GSNOR) inhibitors for the potential treatment of COPD.
Bioorg Med Chem Lett 28: 3766-3773 (2018)
Glenmark Pharmaceuticals
Tetrazolylpropan-2-ones as inhibitors of fatty acid amide hydrolase: Studies on structure-activity relationships and metabolic stability.
Eur J Med Chem 160: 183-192 (2018)
University of M£Nster
Design, synthesis, and X-ray studies of potent HIV-1 protease inhibitors incorporating aminothiochromane and aminotetrahydronaphthalene carboxamide derivatives as the P2 ligands.
Eur J Med Chem 160: 171-182 (2018)
Purdue University
Discovery of Benzoazepinequinoline (BAQ) Derivatives as Novel, Potent, Orally Bioavailable Respiratory Syncytial Virus Fusion Inhibitors.
J Med Chem 61: 10228-10241 (2018)
Roche Pharma Research and Early Development
6-Benzhydryl-4-amino-quinolin-2-ones as Potent Cannabinoid Type 1 (CB
J Med Chem 61: 10276-10298 (2018)
Janssen Research & Development
Discovery of Orally Active Inhibitors of Brahma Homolog (BRM)/SMARCA2 ATPase Activity for the Treatment of Brahma Related Gene 1 (BRG1)/SMARCA4-Mutant Cancers.
J Med Chem 61: 10155-10172 (2018)
Novartis Institutes For Biomedical Research
Noncovalent Inhibitors of Mosquito Acetylcholinesterase 1 with Resistance-Breaking Potency.
J Med Chem 61: 10545-10557 (2018)
Umea University
Discovery and optimization of a novel series of pyrazolyltetrahydropyran N-type calcium channel (Ca
Bioorg Med Chem Lett 28: 3780-3783 (2018)
Janssen Research & Development
Identification of novel benzothiopyranone compounds against Mycobacterium tuberculosis through scaffold morphing from benzothiazinones.
Eur J Med Chem 160: 157-170 (2018)
Peking Union Medical College and Chinese Academy of Medical Sciences
Bioactive Pentacyclic Triterpenes from the Root Bark Extract of Myrianthus arboreus, a Species Used Traditionally to Treat Type-2 Diabetes.
J Nat Prod 81: 2169-2176 (2018)
Laval University
Discovery, Synthesis, and Evaluation of Oxynitidine Derivatives as Dual Inhibitors of DNA Topoisomerase IB (TOP1) and Tyrosyl-DNA Phosphodiesterase 1 (TDP1), and Potential Antitumor Agents.
J Med Chem 61: 9908-9930 (2018)
Sun Yat-Sen University
Discovery of Pyrrolidine Sulfonamides as Selective and Orally Bioavailable Antagonists of Transient Receptor Potential Vanilloid-4 (TRPV4).
J Med Chem 61: 9738-9755 (2018)
TBA
Computer-aided drug discovery of Myc-Max inhibitors as potential therapeutics for prostate cancer.
Eur J Med Chem 160: 108-119 (2018)
University of British Columbia
Antifungal benzo[b]thiophene 1,1-dioxide IMPDH inhibitors exhibit pan-assay interference (PAINS) profiles.
Bioorg Med Chem 26: 5408-5419 (2018)
The University of Queensland
Tryptophan 2,3-dioxygenase inhibitory activities of tryptanthrin derivatives.
Eur J Med Chem 160: 133-145 (2018)
Fudan University
Design and synthesis of a novel series of non-nucleoside HIV-1 inhibitors bearing pyrimidine and N-substituted aromatic piperazine.
Bioorg Med Chem Lett 28: 3491-3495 (2018)
Fudan University
Discovery of (E)-N-(4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)-3-((3-(2-(pyridin-2-yl)vinyl)-1H-indazol-6-yl)thio)propanamide (CHMFL-ABL-121) as a highly potent ABL kinase inhibitor capable of overcoming a variety of ABL mutants including T315I for chronic myeloid leukemia.
Eur J Med Chem 160: 61-81 (2018)
Chinese Academy of Sciences
Discovery, cocrystallization and biological evaluation of novel piperidine derivatives as high affinity Ls-AChBP ligands possessing ?7 nAChR activities.
Eur J Med Chem 160: 37-48 (2018)
Fudan University
Design of novel lipidated peptidomimetic conjugates for targeting EGFR heterodimerization in HER2?+?cancer.
Bioorg Med Chem Lett 28: 3506-3513 (2018)
University of Louisiana At Monroe
Design, synthesis, biological evaluation and cellular imaging of imidazo[4,5-b]pyridine derivatives as potent and selective TAM inhibitors.
Bioorg Med Chem 26: 5510-5530 (2018)
Psl Research University
Discovery of traditional Chinese medicine monomers and their synthetic intermediates, analogs or derivatives for battling P-gp-mediated multi-drug resistance.
Eur J Med Chem 159: 381-392 (2018)
Anhui University of Chinese Medicine
Discovery of a potent orally bioavailable retinoic acid receptor-related orphan receptor-gamma-t (ROR?t) inhibitor, S18-000003.
Bioorg Med Chem Lett 28: 3549-3553 (2018)
Shionogi
Identification of inhibitors of the E. coli chaperone SurA using in silico and in vitro techniques.
Bioorg Med Chem Lett 28: 3540-3548 (2018)
Oberlin College
1-(2-Hydroxybenzoyl)-thiosemicarbazides are promising antimicrobial agents targeting d-alanine-d-alanine ligase in bacterio.
Eur J Med Chem 159: 324-338 (2018)
University of Louvain
Discovery of a potent, low-absorbable sodium-dependent glucose cotransporter 1 (SGLT1) inhibitor (TP0438836) for the treatment of type 2 diabetes.
Bioorg Med Chem Lett 28: 3534-3539 (2018)
Taisho Pharmaceutical
Identification of steroidal derivatives inhibiting the transformations of allopregnanolone and estradiol by 17?-hydroxysteroid dehydrogenase type 10.
Bioorg Med Chem Lett 28: 3554-3559 (2018)
Laval University
Chemistry-driven glycoscience.
Bioorg Med Chem 26: 5229-5238 (2018)
Massachusetts Institute of Technology
Discovery and biological evaluation of thiobarbituric derivatives as potent p300/CBP inhibitors.
Bioorg Med Chem 26: 5397-5407 (2018)
Chinese Academy of Sciences
Hybrid compounds from chalcone and 1,2-benzothiazine pharmacophores as selective inhibitors of alkaline phosphatase isozymes.
Eur J Med Chem 159: 282-291 (2018)
University of Auckland
Design, synthesis, and biological evaluation of novel pan agonists of FFA1, PPAR? and PPAR?.
Eur J Med Chem 159: 267-276 (2018)
Guangdong Pharmaceutical University
Ligand-Based Fluorine NMR Screening: Principles and Applications in Drug Discovery Projects.
J Med Chem 62: 2218-2244 (2019)
Lavis
Nitro-Group-Containing Drugs.
J Med Chem 62: 2851-2893 (2019)
Taipei Medical University
Design, synthesis, and systematic evaluation of 4-arylpiperazine- and 4-benzylpiperidine napthyl ethers as inhibitors of monoamine neurotransmitters reuptake.
Bioorg Med Chem 26: 5538-5546 (2018)
Chonnam National University
Discovery and anti-inflammatory evaluation of benzothiazepinones (BTZs) as novel non-ATP competitive inhibitors of glycogen synthase kinase-3? (GSK-3?).
Bioorg Med Chem 26: 5479-5493 (2018)
Fudan University
Synthesis, in vitro and in vivo biological evaluation, COX-1/2 inhibition and molecular docking study of indole-N-acylhydrazone derivatives.
Bioorg Med Chem 26: 5388-5396 (2018)
Universidade Federal De Pernambuco (Ufpe)
Synthesis and structure-activity relationship study of arylsulfonamides as novel potent H5N1 inhibitors.
Eur J Med Chem 159: 206-216 (2018)
Wuhan University
Activity-guided development of potent and selective toll-like receptor 9 antagonists.
Eur J Med Chem 159: 187-205 (2018)
Csir-Indian Institute of Chemical Biology
Discovery of a novel series of pyridine and pyrimidine carboxamides as potent and selective covalent inhibitors of Btk.
Bioorg Med Chem Lett 28: 3419-3424 (2018)
Emd Serono Research & Development Institute
Synthesis, molecular docking and inhibition studies of novel 3-N-aryl substituted-2-heteroarylchromones targeting microtubule affinity regulating kinase 4 inhibitors.
Eur J Med Chem 159: 166-177 (2018)
Indian Institute of Technology Roorkee
Design, Synthesis, and Pharmacological Evaluation of Novel ?2/3 Subunit-Selective ?-Aminobutyric Acid Type A (GABA
J Med Chem 62: 317-341 (2019)
University of Vienna
Design and Activity of Specific Hypoxia-Inducible Factor-2? (HIF-2?) Inhibitors for the Treatment of Clear Cell Renal Cell Carcinoma: Discovery of Clinical Candidate ( S)-3-((2,2-Difluoro-1-hydroxy-7-(methylsulfonyl)-2,3-dihydro-1 H-inden-4-yl)oxy)-5-fluorobenzonitrile (PT2385).
J Med Chem 61: 9691-9721 (2018)
Peloton Therapeutics
Structurally Diverse Sesquiterpenoids from the Endangered Ornamental Plant Michelia shiluensis.
J Nat Prod 81: 2195-2204 (2018)
Chinese Academy of Sciences
GNE-371, a Potent and Selective Chemical Probe for the Second Bromodomains of Human Transcription-Initiation-Factor TFIID Subunit 1 and Transcription-Initiation-Factor TFIID Subunit 1-like.
J Med Chem 61: 9301-9315 (2018)
Genentech
Discovery of RG7834: The First-in-Class Selective and Orally Available Small Molecule Hepatitis B Virus Expression Inhibitor with Novel Mechanism of Action.
J Med Chem 61: 10619-10634 (2018)
TBA
A comprehensive review on xanthone derivatives as ?-glucosidase inhibitors.
Eur J Med Chem 157: 1460-1479 (2018)
Polytechnic Institute of Braganca
Synthesis and structure-activity relationship studies of cruzain and rhodesain inhibitors.
Eur J Med Chem 157: 1426-1459 (2018)
Universidade Federal Do Rio Grande Do Sul
Synthesis and Cytotoxic and Antiviral Profiling of Pyrrolo- and Furo-Fused 7-Deazapurine Ribonucleosides.
J Med Chem 61: 9347-9359 (2018)
Czech Academy of Sciences
Synthesis and evaluation of 2-substituted 4(3H)-quinazolinone thioether derivatives as monoamine oxidase inhibitors.
Bioorg Med Chem 26: 5531-5537 (2018)
North-West University
Development of high potent and selective Bcl-2 inhibitors bearing the structural elements of natural product artemisinin.
Eur J Med Chem 159: 149-165 (2018)
Shanghai Institute of Materia Medica (Simm)
A novel 2,4-diaminopyrimidine derivative as selective inhibitor of protein kinase C theta prevents allograft rejection in a rat heart transplant model.
Bioorg Med Chem 26: 5499-5509 (2018)
Astellas Pharma
Optimization of 8-Hydroxyquinolines as Inhibitors of Catechol O-Methyltransferase.
J Med Chem 61: 9647-9665 (2018)
Lieber Institute For Brain Development
4-epi-Isofagomine derivatives as pharmacological chaperones for the treatment of lysosomal diseases linked to ?-galactosidase mutations: Improved synthesis and biological investigations.
Bioorg Med Chem 26: 5462-5469 (2018)
Orleans University
Design, synthesis, and biological activity of substituted 2-amino-5-oxo-5H-chromeno[2,3-b]pyridine-3-carboxylic acid derivatives as inhibitors of the inflammatory kinases TBK1 and IKK? for the treatment of obesity.
Bioorg Med Chem 26: 5443-5461 (2018)
University of Michigan
A phenotypic approach to the discovery of compounds that promote non-amyloidogenic processing of the amyloid precursor protein: Toward a new profile of indirect ?-secretase inhibitors.
Eur J Med Chem 159: 104-125 (2018)
University of Lille
Discovery and lead identification of quinazoline-based BRD4 inhibitors.
Bioorg Med Chem Lett 28: 3483-3488 (2018)
National Institutes of Health
Design, synthesis and biological evaluation of (2S,3R,4R,5S,6R)-5-fluoro-6-(hydroxymethyl)-2-aryltetrahydro-2H-pyran-3,4-diols as potent and orally active SGLT dual inhibitors.
Bioorg Med Chem Lett 28: 3446-3453 (2018)
Janssen Research & Development
Design, synthesis, and evaluation of carboxyl-modified oseltamivir derivatives with improved lipophilicity as neuraminidase inhibitors.
Bioorg Med Chem Lett 28: 3477-3482 (2018)
Shenyang Pharmaceutical University
Clickable photoaffinity ligands for the human serotonin transporter based on the selective serotonin reuptake inhibitor (S)-citalopram.
Bioorg Med Chem Lett 28: 3431-3435 (2018)
Duquesne University
Dichloroacetophenones targeting at pyruvate dehydrogenase kinase 1 with improved selectivity and antiproliferative activity: Synthesis and structure-activity relationships.
Bioorg Med Chem Lett 28: 3441-3445 (2018)
University of Macau
Structural basis for potent inhibition of d-amino acid oxidase by thiophene carboxylic acids.
Eur J Med Chem 159: 23-34 (2018)
Tokushima University
Pyrrolidine nucleoside bisphosphonates as antituberculosis agents targeting hypoxanthine-guanine phosphoribosyltransferase.
Eur J Med Chem 159: 10-22 (2018)
The University of Queensland
Alkyl-guanidine Compounds as Potent Broad-Spectrum Antibacterial Agents: Chemical Library Extension and Biological Characterization.
J Med Chem 61: 9162-9176 (2018)
University of Siena
Synthesis and Antiviral Evaluation of Carbocyclic Nucleoside Analogs of Nucleoside Reverse Transcriptase Translocation Inhibitor MK-8591 (4'-Ethynyl-2-fluoro-2'-deoxyadenosine).
J Med Chem 61: 9218-9228 (2018)
Idenix An Msd
Rational Design, Synthesis, and Pharmacological Characterization of Novel Ghrelin Receptor Inverse Agonists as Potential Treatment against Obesity-Related Metabolic Diseases.
J Med Chem 61: 11039-11060 (2018)
Sib Swiss Institute of Bioinformatics
Development of Macrocyclic Peptides Containing Epoxyketone with Oral Availability as Proteasome Inhibitors.
J Med Chem 61: 9177-9204 (2018)
Zhejiang University
Efficient optimization of pyrazolo[3,4-d]pyrimidines derivatives as c-Src kinase inhibitors in neuroblastoma treatment.
Bioorg Med Chem Lett 28: 3454-3457 (2018)
University of Siena
Targeting heme Oxygenase-1 with hybrid compounds to overcome Imatinib resistance in chronic myeloid leukemia cell lines.
Eur J Med Chem 158: 937-950 (2018)
University of Catania
Heterocoumarins Are Selective Carbonic Anhydrase IX and XII Inhibitors with Cytotoxic Effects against Cancer Cells Lines.
ACS Med Chem Lett 9: 947-951 (2018)
University of Florence
Discovery of Quinazolines That Activate SOS1-Mediated Nucleotide Exchange on RAS.
ACS Med Chem Lett 9: 941-946 (2018)
Vanderbilt University School of Medicine
Selective PPAR? Modulators Improve Mitochondrial Function: Potential Treatment for Duchenne Muscular Dystrophy (DMD).
ACS Med Chem Lett 9: 935-940 (2018)
Mitobridge
Binding Motifs in the CBP Bromodomain: An Analysis of 20 Crystal Structures of Complexes with Small Molecules.
ACS Med Chem Lett 9: 929-934 (2018)
University of Zurich
SAR of 4-Alkoxybenzoic Acid Inhibitors of the Trypanosome Alternative Oxidase.
ACS Med Chem Lett 9: 923-928 (2018)
Instituto De Qu£Mica M£Dica
VU6007477, a Novel M
ACS Med Chem Lett 9: 917-922 (2018)
Vanderbilt Univercity
Deciphering Binding Interactions of IL-23R with HDX-MS: Mapping Protein and Macrocyclic Dodecapeptide Ligands.
ACS Med Chem Lett 9: 912-916 (2018)
Centro De Investigaci£N Lilly
A Series of Indole-Thiazole Derivatives Act as GPER Agonists and Inhibit Breast Cancer Cell Growth.
ACS Med Chem Lett 9: 901-906 (2018)
Saint Louis University
Peptidomimetics for Targeting Protein-Protein Interactions between DOT1L and MLL Oncofusion Proteins AF9 and ENL.
ACS Med Chem Lett 9: 895-900 (2018)
China Pharmaceutical University
Design, Synthesis, and Blood-Brain Barrier Transport Study of Pyrilamine Derivatives as Histone Deacetylase Inhibitors.
ACS Med Chem Lett 9: 884-888 (2018)
Kansai University
Reviving B-Factors: Retrospective Normalized B-Factor Analysis of c-ros Oncogene 1 Receptor Tyrosine Kinase and Anaplastic Lymphoma Kinase L1196M with Crizotinib and Lorlatinib.
ACS Med Chem Lett 9: 878-883 (2018)
Pfizer
GPR40 Receptor Agonists for the Treatment of Type 2 Diabetes and Related Diseases.
ACS Med Chem Lett 9: 870-871 (2018)
Therachem Research Medilab
Potential of PDE10A Inhibitors as Treatment for Schizophrenia and Other Neurological Disorders.
ACS Med Chem Lett 9: 866-867 (2018)
Therachem Research Medilab
Precedence and Promise of Covalent Inhibitors of EGFR and KRAS for Patients with Non-Small-Cell Lung Cancer.
ACS Med Chem Lett 9: 861-863 (2018)
Pfizer
Design of a True Bivalent Ligand with Picomolar Binding Affinity for a G Protein-Coupled Receptor Homodimer.
J Med Chem 61: 9335-9346 (2018)
Biomaterials and Nanomedicine (Ciber-Bbn)
Pyrrolone Derivatives as Intracellular Allosteric Modulators for Chemokine Receptors: Selective and Dual-Targeting Inhibitors of CC Chemokine Receptors 1 and 2.
J Med Chem 61: 9146-9161 (2018)
Leiden University
Antimalarial Lead-Optimization Studies on a 2,6-Imidazopyridine Series within a Constrained Chemical Space To Circumvent Atypical Dose-Response Curves against Multidrug Resistant Parasite Strains.
J Med Chem 61: 9371-9385 (2018)
University of Cape Town
N-Thiazolylamide-based free fatty-acid 2 receptor agonists: Discovery, lead optimization and demonstration of off-target effect in a diabetes model.
Bioorg Med Chem 26: 5169-5180 (2018)
Ogeda
Discovery of 4-(((4-(5-chloro-2-(((1s,4s)-4-((2-methoxyethyl)amino)cyclohexyl)amino)pyridin-4-yl)thiazol-2-yl)amino)methyl)tetrahydro-2H-pyran-4-carbonitrile (JSH-150) as a novel highly selective and potent CDK9 kinase inhibitor.
Eur J Med Chem 158: 896-916 (2018)
Chinese Academy of Sciences
The development of piperidinones as potent MDM2-P53 protein-protein interaction inhibitors for cancer therapy.
Eur J Med Chem 159: 1-9 (2018)
International Institute For Translational Chinese Medicine
Molecular Basis for the N-Terminal Bromodomain-and-Extra-Terminal-Family Selectivity of a Dual Kinase-Bromodomain Inhibitor.
J Med Chem 61: 9316-9334 (2018)
University of Minnesota
Novel Hypoxia-Inducible Factor 1? (HIF-1?) Inhibitors for Angiogenesis-Related Ocular Diseases: Discovery of a Novel Scaffold via Ring-Truncation Strategy.
J Med Chem 61: 9266-9286 (2018)
Seoul National University
Single Amino Acid Substitution in ?-Conotoxin TxID Reveals a Specific ?3?4 Nicotinic Acetylcholine Receptor Antagonist.
J Med Chem 61: 9256-9265 (2018)
Hainan University
Design, Synthesis, and Evaluation of Piperazinyl Pyrrolidin-2-ones as a Novel Series of Reversible Monoacylglycerol Lipase Inhibitors.
J Med Chem 61: 9205-9217 (2018)
Takeda Pharmaceutical
A truncated RHAMM protein for discovering novel therapeutic peptides.
Bioorg Med Chem 26: 5194-5203 (2018)
Western University
Identification of N-(5-(phenoxymethyl)-1,3,4-thiadiazol-2-yl)acetamide derivatives as novel protein tyrosine phosphatase epsilon inhibitors exhibiting anti-osteoclastic activity.
Bioorg Med Chem 26: 5204-5211 (2018)
Korea Research Institute of Bioscience and Biotechnology
Development of matrix metalloproteinase-13 inhibitors - A structure-activity/structure-property relationship study.
Bioorg Med Chem 26: 4984-4995 (2018)
Graz University of Technology
Discovery of potent and selective Spleen Tyrosine Kinase inhibitors for the topical treatment of inflammatory skin disease.
Bioorg Med Chem Lett 28: 3458-3462 (2018)
Glaxosmithkline R&D
Discovery of potent liver-selective stearoyl-CoA desaturase-1 (SCD1) inhibitors, thiazole-4-acetic acid derivatives, for the treatment of diabetes, hepatic steatosis, and obesity.
Eur J Med Chem 158: 832-852 (2018)
Japan Tobacco
Exploration of novel pyrrolo[2,1-f][1,2,4]triazine derivatives with improved anticancer efficacy as dual inhibitors of c-Met/VEGFR-2.
Eur J Med Chem 158: 814-831 (2018)
China Pharmaceutical University
Discovery of a Potent Thiazolidine Free Fatty Acid Receptor 2 Agonist with Favorable Pharmacokinetic Properties.
J Med Chem 61: 9534-9550 (2018)
University of Southern Denmark
Development of Inhibitors of the Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Signaling Pathway.
J Med Chem 62: 1715-1730 (2019)
China Pharmaceutical University
Discovery, Structure-Activity Relationship, and Biological Characterization of a Novel Series of 6-((1 H-Pyrazolo[4,3- b]pyridin-3-yl)amino)-benzo[ d]isothiazole-3-carboxamides as Positive Allosteric Modulators of the Metabotropic Glutamate Receptor 4 (mGlu
J Med Chem 62: 342-358 (2019)
Vanderbilt University
One-pot, multi-component synthesis and structure-activity relationships of peptoid-based histone deacetylase (HDAC) inhibitors targeting malaria parasites.
Eur J Med Chem 158: 801-813 (2018)
Heinrich-Heine-Universit£T D£Sseldorf
Multi-target-directed ligands for Alzheimer's disease: Discovery of chromone-based monoamine oxidase/cholinesterase inhibitors.
Eur J Med Chem 158: 781-800 (2018)
University of Porto
Discovery of furyl/thienyl ?-carboline derivatives as potent and selective PDE5 inhibitors with excellent vasorelaxant effect.
Eur J Med Chem 158: 767-780 (2018)
Shandong University
Synthesis, biological evaluation and structure-activity relationship of a novel class of PI3K? H1047R mutant inhibitors.
Eur J Med Chem 158: 707-719 (2018)
Chongqing University
HDAC as onco target: Reviewing the synthetic approaches with SAR study of their inhibitors.
Eur J Med Chem 158: 620-706 (2018)
Indian Csir-Central Drug Research Institute
Novel amide derivatives of 1,3-dimethyl-2,6-dioxopurin-7-yl-alkylcarboxylic acids as multifunctional TRPA1 antagonists and PDE4/7 inhibitors: A new approach for the treatment of pain.
Eur J Med Chem 158: 517-533 (2018)
Jagiellonian University Medical College
Design, synthesis, and biological evaluation of novel selective peptide inhibitors of 11?-hydroxysteroid dehydrogenase 1.
Bioorg Med Chem 26: 5128-5139 (2018)
Dsm Nutritional Products
Optimization of the efflux ratio and permeability of covalent irreversible BTK inhibitors.
Bioorg Med Chem Lett 28: 3307-3311 (2018)
Emd Serono Research & Development Institute
Methyl-containing pharmaceuticals: Methylation in drug design.
Bioorg Med Chem Lett 28: 3283-3289 (2018)
Xenon Pharmaceuticals
Design and synthesis of potent dual inhibitors of JAK2 and HDAC based on fusing the pharmacophores of XL019 and vorinostat.
Eur J Med Chem 158: 593-619 (2018)
National University of Singapore
DYRK1A kinase inhibition with emphasis on neurodegeneration: A comprehensive evolution story-cum-perspective.
Eur J Med Chem 158: 559-592 (2018)
Jamia Hamdard
Discovery of phenylalanine derivatives as potent HIV-1 capsid inhibitors from click chemistry-based compound library.
Eur J Med Chem 158: 478-492 (2018)
Shandong University
Donepezil-based multi-functional cholinesterase inhibitors for treatment of Alzheimer's disease.
Eur J Med Chem 158: 463-477 (2018)
China Pharmaceutical University
Discovery of DS-6930, a potent selective PPAR? modulator. Part I: Lead identification.
Bioorg Med Chem 26: 5079-5098 (2018)
Daiichi Sankyo
Branched pentapeptides as potent inhibitors of the vascular endothelial growth factor 165 binding to Neuropilin-1: Design, synthesis and biological activity.
Eur J Med Chem 158: 453-462 (2018)
University of Warsaw
Pyrazolo[4,3-b]pyrimido[4,5-e][1,4]diazepine derivatives as new multi-targeted inhibitors of Aurora A/B and KDR.
Eur J Med Chem 158: 428-441 (2018)
East China Normal University
Synthesis and Discovery of Arylpiperidinylquinazolines: New Inhibitors of the Vesicular Monoamine Transporter.
J Med Chem 61: 9121-9131 (2018)
Organix
Piperidinyl-embeded chalcones possessing anti PI3K? inhibitory properties exhibit anti-atopic properties in preclinical models.
Eur J Med Chem 158: 405-413 (2018)
Inserm 1052/Cnrs 5286/University of Lyon
How Selective Are Pharmacological Inhibitors of Cell-Cycle-Regulating Cyclin-Dependent Kinases?
J Med Chem 61: 9105-9120 (2018)
Palack£
Structure-Based Design of 1-Heteroaryl-1,3-propanediamine Derivatives as a Novel Series of CC-Chemokine Receptor 5 Antagonists.
J Med Chem 61: 9621-9636 (2018)
University of Chinese Academy of Sciences
Structure-activity relationship of novel (benzoylaminophenoxy)phenol derivatives as anti-prostate cancer agents.
Bioorg Med Chem 26: 5118-5127 (2018)
Ochanomizu University
Andrographolide derivative as STAT3 inhibitor that protects acute liver damage in mice.
Bioorg Med Chem 26: 5053-5061 (2018)
University of Macau
Discovery of 3-(4-sulfamoylnaphthyl)pyrazolo[1,5-a]pyrimidines as potent and selective ALK2 inhibitors.
Bioorg Med Chem Lett 28: 3356-3362 (2018)
National Center For Advancing Translational Sciences
Rationally designed divalent caffeic amides inhibit amyloid-? fibrillization, induce fibril dissociation, and ameliorate cytotoxicity.
Eur J Med Chem 158: 393-404 (2018)
Academia Sinica
Application of Virtual Screening to the Identification of New LpxC Inhibitor Chemotypes, Oxazolidinone and Isoxazoline.
J Med Chem 61: 9360-9370 (2018)
Novartis Institutes For Biomedical Research
Aiming to Miss a Moving Target: Bromo and Extra Terminal Domain (BET) Selectivity in Constrained ATAD2 Inhibitors.
J Med Chem 61: 8321-8336 (2018)
Glaxosmithkline
Advances in diarylpyrimidines and related analogues as HIV-1 nonnucleoside reverse transcriptase inhibitors.
Eur J Med Chem 158: 371-392 (2018)
Wuhan Institute of Technology
Identification of dual Sigma1 receptor modulators/acetylcholinesterase inhibitors with antioxidant and neurotrophic properties, as neuroprotective agents.
Eur J Med Chem 158: 353-370 (2018)
University of Pavia
Dual potent ALK and ROS1 inhibitors combating drug-resistant mutants: Synthesis and biological evaluation of aminopyridine-containing diarylaminopyrimidine derivatives.
Eur J Med Chem 158: 322-333 (2018)
Shenyang Pharmaceutical University
Design, synthesis, and biological evaluation of 2-(phenoxyaryl)-3-urea derivatives as novel P2Y
Eur J Med Chem 158: 302-310 (2018)
University of Chinese Academy of Sciences
Discovery of novel human inosine 5'-monophosphate dehydrogenase 2 (hIMPDH2) inhibitors as potential anticancer agents.
Eur J Med Chem 158: 286-301 (2018)
Shobhaben Pratapbhai Patel School of Pharmacy and Technology Management
Development of novel amide-derivatized 2,4-bispyridyl thiophenes as highly potent and selective Dyrk1A inhibitors. Part II: Identification of the cyclopropylamide moiety as a key modification.
Eur J Med Chem 158: 270-285 (2018)
German University In Cairo
Dinghupeptins A-D, Chymotrypsin Inhibitory Cyclodepsipeptides Produced by a Soil-Derived Streptomyces.
J Nat Prod 81: 1928-1936 (2018)
Chinese Academy of Sciences
Structure-Based Optimization of a Novel Class of Aldehyde Dehydrogenase 1A (ALDH1A) Subfamily-Selective Inhibitors as Potential Adjuncts to Ovarian Cancer Chemotherapy.
J Med Chem 61: 8754-8773 (2018)
Indiana University School of Medicine
Unexpected AChE inhibitory activity of (2E)?,?-unsaturated fatty acids.
Bioorg Med Chem Lett 28: 3315-3319 (2018)
Martin-Luther-University Halle-Wittenberg
Discovery of DS-6930, a potent selective PPAR? modulator. Part II: Lead optimization.
Bioorg Med Chem 26: 5099-5117 (2018)
Daiichi Sankyo
Synthesis of oxidative metabolites of CRA13 and their analogs: Identification of CRA13 active metabolites and analogs thereof with selective CB
Bioorg Med Chem 26: 5069-5078 (2018)
Kyung Hee University
Thiazole- and selenazole-comprising high-affinity inhibitors possess bright microsecond-scale photoluminescence in complex with protein kinase CK2.
Bioorg Med Chem 26: 5062-5068 (2018)
University of Tartu
In vitro and in vivo characterization of a novel, highly potent p53-MDM2 inhibitor.
Bioorg Med Chem Lett 28: 3404-3408 (2018)
Novartis Institutes For Biomedical Research
Discovery of DS42450411 as a potent orally active hepcidin production inhibitor: Design and optimization of novel 4-aminopyrimidine derivatives.
Bioorg Med Chem Lett 28: 3333-3337 (2018)
Daiichi Sankyo
Synthesis and antiproliferative activity of 6,7-disubstituted-4-phenoxyquinoline derivatives bearing the 1,8-naphthyridin-2-one moiety.
Eur J Med Chem 158: 201-213 (2018)
Jiangxi Science & Technology Normal University
Novel bisphosphonates with antiresorptive effect in bone mineralization and osteoclastogenesis.
Eur J Med Chem 158: 184-200 (2018)
University of Bari "A. Moro
Recent advances of RAF (rapidly accelerated fibrosarcoma) inhibitors as anti-cancer agents.
Eur J Med Chem 158: 144-166 (2018)
University of Science & Technology (Ust)
Structural alterations based on naproxen scaffold: Synthesis, evaluation of antitumor activity and COX-2 inhibition, and molecular docking.
Eur J Med Chem 158: 134-143 (2018)
Mansoura University
Design and Synthesis of Novel Amino-triazine Analogues as Selective Bruton's Tyrosine Kinase Inhibitors for Treatment of Rheumatoid Arthritis.
J Med Chem 61: 8917-8933 (2018)
Carna Biosciences
Targeting Cytochrome P450 (CYP) 1B1 Enzyme with Four Series of A-Ring Substituted Estrane Derivatives: Design, Synthesis, Inhibitory Activity, and Selectivity.
J Med Chem 61: 9229-9245 (2018)
Laval University
Discovery of ( S)-3-(3-(3,5-Dimethyl-1 H-pyrazol-1-yl)phenyl)-4-(( R)-3-(2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethyl)pyrrolidin-1-yl)butanoic Acid, a Nonpeptidic ?
J Med Chem 61: 8417-8443 (2018)
University of Strathclyde
Design, synthesis, and biological evaluations of phenylpropiolic acid derivatives as novel GPR40 agonists.
Eur J Med Chem 158: 123-133 (2018)
East China Normal University
Depsipeptides Featuring a Neutral P1 Are Potent Inhibitors of Kallikrein-Related Peptidase 6 with On-Target Cellular Activity.
J Med Chem 61: 8859-8874 (2018)
German Cancer Research Center (Dkfz)
Validation of Matrix Metalloproteinase-9 (MMP-9) as a Novel Target for Treatment of Diabetic Foot Ulcers in Humans and Discovery of a Potent and Selective Small-Molecule MMP-9 Inhibitor That Accelerates Healing.
J Med Chem 61: 8825-8837 (2018)
University of Notre Dame
Medermycin-Type Naphthoquinones from the Marine-Derived Streptomyces sp. XMA39.
J Nat Prod 81: 2120-2124 (2018)
Zhejiang University
A Molecular Hybridization Approach for the Design of Potent, Highly Selective, and Brain-Penetrant N-Myristoyltransferase Inhibitors.
J Med Chem 61: 8374-8389 (2018)
University of Dundee
Dihydrochalcone Glucosides from the Subaerial Parts of Thonningia sanguinea and Their in Vitro PTP1B Inhibitory Activities.
J Nat Prod 81: 2091-2100 (2018)
University of Innsbruck
BACE1 Inhibitory Meroterpenoids from Aspergillus terreus.
J Nat Prod 81: 1937-1945 (2018)
Huazhong University of Science and Technology
Allosteric Activation of Striatal-Enriched Protein Tyrosine Phosphatase (STEP, PTPN5) by a Fragment-like Molecule.
J Med Chem 62: 306-316 (2019)
Beckman Research Institute of The City of Hope
Discovery and Structure-Based Optimization of Benzimidazole-Derived Activators of SOS1-Mediated Nucleotide Exchange on RAS.
J Med Chem 61: 8875-8894 (2018)
Boehringer Ingelheim Rcv
Discovery of N-(4-{[5-Fluoro-7-(2-methoxyethoxy)quinazolin-4-yl]amino}phenyl)-2-[4-(propan-2-yl)-1 H-1,2,3-triazol-1-yl]acetamide (AZD3229), a Potent Pan-KIT Mutant Inhibitor for the Treatment of Gastrointestinal Stromal Tumors.
J Med Chem 61: 8797-8810 (2018)
Astrazeneca
b-Annulated 1,4-dihydropyridines as Notch inhibitors.
Bioorg Med Chem Lett 28: 3363-3367 (2018)
Human Biomolecular Research Institute
Discovery of selective urokinase plasminogen activator (uPA) inhibitors as a potential treatment for multiple sclerosis.
Bioorg Med Chem Lett 28: 3372-3375 (2018)
Abdulaziz University For Health Sciences
Role of p53 circuitry in tumorigenesis: A brief review.
Eur J Med Chem 158: 7-24 (2018)
Jss Academy of Higher Education and Research
Structure-activity relationship study of hypoxia-activated prodrugs for proteoglycan-targeted chemotherapy in chondrosarcoma.
Eur J Med Chem 158: 51-67 (2018)
University of Clermont Auvergne
Design, synthesis and identification of novel substituted 2-amino thiazole analogues as potential anti-inflammatory agents targeting 5-lipoxygenase.
Eur J Med Chem 158: 34-50 (2018)
Vellore Institute of Technology
The synthesis and kinetic evaluation of aryl ?-aminophosphonates as novel inhibitors of T. cruzi trans-sialidase.
Eur J Med Chem 158: 25-33 (2018)
University of Bath
A ?-glucuronidase-responsive albumin-binding prodrug for potential selective kinase inhibitor-based cancer chemotherapy.
Eur J Med Chem 158: 1-6 (2018)
University of Poitiers
LIT-001, the First Nonpeptide Oxytocin Receptor Agonist that Improves Social Interaction in a Mouse Model of Autism.
J Med Chem 61: 8670-8692 (2018)
Umr7200 Cnrs/Universit£
Optimization of a Series of Mu Opioid Receptor (MOR) Agonists with High G Protein Signaling Bias.
J Med Chem 61: 8895-8907 (2018)
The Scripps Research Institute
Identification of the First PPAR?/? Dual Agonist Able To Bind to Canonical and Alternative Sites of PPAR? and To Inhibit Its Cdk5-Mediated Phosphorylation.
J Med Chem 61: 8282-8298 (2018)
University of Bari Aldo Moro
Phosphonamidate Prodrugs of a Butyrophilin Ligand Display Plasma Stability and Potent V?9 V?2 T Cell Stimulation.
J Med Chem 61: 8658-8669 (2018)
University of Iowa
Introduction of a Methyl Group Curbs Metabolism of Pyrido[3,4- d]pyrimidine Monopolar Spindle 1 (MPS1) Inhibitors and Enables the Discovery of the Phase 1 Clinical Candidate N
J Med Chem 61: 8226-8240 (2018)
The Institute of Cancer Research
Synthesis and biological evaluation of novel 5,6-dihydropyrimido[4,5-f]quinazoline derivatives as potent CDK2 inhibitors.
Bioorg Med Chem Lett 28: 3385-3390 (2018)
Jiangnan University
( R)- N-(1-Methyl-2-hydroxyethyl)-13-( S)-methyl-arachidonamide (AMG315): A Novel Chiral Potent Endocannabinoid Ligand with Stability to Metabolizing Enzymes.
J Med Chem 61: 8639-8657 (2018)
Northeastern University
Structure-based drug design: Synthesis and biological evaluation of quinazolin-4-amine derivatives as selective Aurora A kinase inhibitors.
Eur J Med Chem 157: 1361-1375 (2018)
Sun Yat-Sen University
Boronic ester-linked macrocyclic lipopeptides as serine protease inhibitors targeting Escherichia coli type I signal peptidase.
Eur J Med Chem 157: 1346-1360 (2018)
Uppsala University
Design, synthesis and pharmacological evaluation of N4,N6-disubstituted pyrimidine-4,6-diamine derivatives as potent EGFR inhibitors in non-small cell lung cancer.
Eur J Med Chem 157: 1300-1325 (2018)
Wenzhou Medical University
ATP citrate lyase (ACLY) inhibitors: An anti-cancer strategy at the crossroads of glucose and lipid metabolism.
Eur J Med Chem 157: 1276-1291 (2018)
University of Pisa
Structure-based design of allosteric calpain-1 inhibitors populating a novel bioactivity space.
Eur J Med Chem 157: 1264-1275 (2018)
University of Cambridge
Recent developments of quinolone-based derivatives and their activities against Escherichia coli.
Eur J Med Chem 157: 1223-1248 (2018)
Medical School of Nanjing University
Discovery of new 2, 5-disubstituted 1,3-selenazoles as selective human carbonic anhydrase IX inhibitors with potent anti-tumor activity.
Eur J Med Chem 157: 1214-1222 (2018)
Department of University of Florence
Sulfonyl-containing phenyl-pyrrolyl pentane analogues: Novel non-secosteroidal vitamin D receptor modulators with favorable physicochemical properties, pharmacokinetic properties and anti-tumor activity.
Eur J Med Chem 157: 1174-1191 (2018)
China Pharmaceutical University
Small molecule-induced degradation of the full length and V7 truncated variant forms of human androgen receptor.
Eur J Med Chem 157: 1164-1173 (2018)
Vancouver Prostate Centre (Vpc)
Development of novel 2,4-bispyridyl thiophene-based compounds as highly potent and selective Dyrk1A inhibitors. Part I: Benzamide and benzylamide derivatives.
Eur J Med Chem 157: 1031-1050 (2018)
German University In Cairo
De Novo Design of ?-Helical Lipopeptides Targeting Viral Fusion Proteins: A Promising Strategy for Relatively Broad-Spectrum Antiviral Drug Discovery.
J Med Chem 61: 8734-8745 (2018)
Beijing Institute of Pharmacology and Toxicology
MEPicides: ?,?-Unsaturated Fosmidomycin Analogues as DXR Inhibitors against Malaria.
J Med Chem 61: 8847-8858 (2018)
George Washington University
Design, synthesis, and biological evaluation of selective and potent Carbazole-based butyrylcholinesterase inhibitors.
Bioorg Med Chem 26: 4952-4962 (2018)
Tehran University of Medical Sciences
5'-Chloro-2,2'-dihydroxychalcone and related flavanoids as treatments for prostate cancer.
Eur J Med Chem 157: 1143-1152 (2018)
Kanazawa University
Lowering Lipophilicity by Adding Carbon: One-Carbon Bridges of Morpholines and Piperazines.
J Med Chem 61: 8934-8943 (2018)
Astrazeneca
Insights into Current Tropomyosin Receptor Kinase (TRK) Inhibitors: Development and Clinical Application.
J Med Chem 62: 1731-1760 (2019)
University of Arkansas For Medical Sciences
Amino Acid Hot Spots of Halogen Bonding: A Combined Theoretical and Experimental Case Study of the 5-HT
J Med Chem 61: 8717-8733 (2018)
Polish Academy of Sciences
Colocynthenins A-D, Ring-A seco-Cucurbitane Triterpenoids from the Fruits of Citrullus colocynthis.
J Nat Prod 81: 2115-2119 (2018)
Xinjiang Technical Institute of Physics and Chemistry
Discovery of New Allosteric Modulators of the Urotensinergic System through Substitution of the Urotensin II-Related Peptide (URP) Phenylalanine Residue.
J Med Chem 61: 8707-8716 (2018)
Laval University
Novel multi-target compounds in the quest for new chemotherapies against Alzheimer's disease: An experimental and theoretical study.
Bioorg Med Chem 26: 4823-4840 (2018)
The City University of New York (Cuny)
Increasing C-Terminal Hydrophobicity Improves the Cell Permeability and Antiproliferative Activity of PACE4 Inhibitors against Prostate Cancer Cell Lines.
J Med Chem 61: 8457-8467 (2018)
University of Sherbrooke
Synthesis toward Bivalent Ligands for the Dopamine D
J Med Chem 61: 8212-8225 (2018)
Ghent University
HDAC3 is a potential validated target for cancer: An overview on the benzamide-based selective HDAC3 inhibitors through comparative SAR/QSAR/QAAR approaches.
Eur J Med Chem 157: 1127-1142 (2018)
Jadavpur University
Discovery of the bifunctional modulator of angiotensin II type 1 receptor (AT1R) and PPAR? derived from the AT1R antagonist, Fimasartan.
Bioorg Med Chem Lett 28: 3155-3160 (2018)
Boryung Pharmaceuticals
CD73 inhibition by purine cytotoxic nucleoside analogue-based diphosphonates.
Eur J Med Chem 157: 1051-1055 (2018)
Claude Bernard University Lyon 1
Elongation of the Hydrophobic Chain as a Molecular Switch: Discovery of Capsaicin Derivatives and Endogenous Lipids as Potent Transient Receptor Potential Vanilloid Channel 2 Antagonists.
J Med Chem 61: 8255-8281 (2018)
National Research Council (Cnr)
Trisubstituted thiazoles as potent and selective inhibitors of Plasmodium falciparum protein kinase G (PfPKG).
Bioorg Med Chem Lett 28: 3168-3173 (2018)
Lifearc
Histidine N(?)-cyclized macrocycles as a new genre of polo-like kinase 1 polo-box domain-binding inhibitors.
Bioorg Med Chem Lett 28: 3202-3205 (2018)
National Cancer Institute-Frederick
Synthesis of DNA interactive C3-trans-cinnamide linked ?-carboline conjugates as potential cytotoxic and DNA topoisomerase I inhibitors.
Bioorg Med Chem 26: 4916-4929 (2018)
Csir-Indian Institute of Chemical Technology
Discovery of benzothiazole amides as potent antimycobacterial agents.
Bioorg Med Chem Lett 28: 3177-3181 (2018)
Crestone
Design and synthesis of potent RSK inhibitors.
Bioorg Med Chem Lett 28: 3197-3201 (2018)
Novartis Institutes For Biomedical Research
Novel inhibitors of As(III) S-adenosylmethionine methyltransferase (AS3MT) identified by virtual screening.
Bioorg Med Chem Lett 28: 3231-3235 (2018)
Astrazeneca
Developing potential Helicobacter pylori urease inhibitors from novel oxoindoline derivatives: Synthesis, biological evaluation and in silico study.
Bioorg Med Chem Lett 28: 3182-3186 (2018)
Nanjing University
Discovery and development of substituted tyrosine derivatives as Bcl-2/Mcl-1 inhibitors.
Bioorg Med Chem 26: 4907-4915 (2018)
Shandong University
Design, synthesis and structure-activity relationship study of novel naphthoindolizine and indolizinoquinoline-5,12-dione derivatives as IDO1 inhibitors.
Bioorg Med Chem 26: 4886-4897 (2018)
Peking University
Design, synthesis and in vitro anti-Zika virus evaluation of novel Sinefungin derivatives.
Eur J Med Chem 157: 994-1004 (2018)
Chinese Academy of Medical Sciences and Peking Union Medical College
Novel selective thiadiazine DYRK1A inhibitor lead scaffold with human pancreatic ?-cell proliferation activity.
Eur J Med Chem 157: 1005-1016 (2018)
Icahn School of Medicine At Mount Sinai
Design, synthesis, and evaluation of cystargolide-based ?-lactones as potent proteasome inhibitors.
Eur J Med Chem 157: 962-977 (2018)
New Mexico Institute of Mining and Technology
Discovery of potent calpain inhibitors based on the azolo-imidazolidenone scaffold.
Eur J Med Chem 157: 946-959 (2018)
Universidad De Alcal£
Synthesis and SAR of 4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline derivatives as potent and selective CDK4/6 inhibitors.
Eur J Med Chem 157: 935-945 (2018)
Jiangnan University
Design and Characterization of Novel Covalent Bromodomain and Extra-Terminal Domain (BET) Inhibitors Targeting a Methionine.
J Med Chem 61: 8202-8211 (2018)
Zenith Epigenetics
Design, synthesis and biological evaluation of ring A modified 11-keto-boswellic acid derivatives as Pin1 inhibitors with remarkable anti-prostate cancer activity.
Bioorg Med Chem Lett 28: 3187-3193 (2018)
Shenyang Pharmaceutical University
Design, synthesis and in vitro study of densely functionalized oxindoles as potent ?-glucosidase inhibitors.
Bioorg Med Chem 26: 4996-5005 (2018)
Shiv Nadar University
Optimization of 5-arylidene barbiturates as potent, selective, reversible LSD1 inhibitors for the treatment of acute promyelocytic leukemia.
Bioorg Med Chem 26: 4871-4880 (2018)
Fudan University
Structure-Based Drug Design of Potent Pyrazole Derivatives against Rhinovirus Replication.
J Med Chem 61: 8402-8416 (2018)
Umr 7273 Cnrs
Synthesis, Evaluation, and Structure-Activity Relationship Study of Lanosterol Derivatives To Reverse Mutant-Crystallin-Induced Protein Aggregation.
J Med Chem 61: 8693-8706 (2018)
Zhejiang University
Structure-Based Design of MptpB Inhibitors That Reduce Multidrug-Resistant Mycobacterium tuberculosis Survival and Infection Burden in Vivo.
J Med Chem 61: 8337-8352 (2018)
University of Manchester
First SAR Study for Overriding NRAS Mutant Driven Acute Myeloid Leukemia.
J Med Chem 61: 8353-8373 (2018)
Korea University
Discovery of a non-toxic [1,2,4]triazolo[1,5-a]pyrimidin-7-one (WS-10) that modulates ABCB1-mediated multidrug resistance (MDR).
Bioorg Med Chem 26: 5006-5017 (2018)
Zhengzhou University
Discovery of Indole Derivatives as Novel and Potent Dengue Virus Inhibitors.
J Med Chem 61: 8390-8401 (2018)
Cistim Leuven
Discovery of TRPM8 Antagonist ( S)-6-(((3-Fluoro-4-(trifluoromethoxy)phenyl)(3-fluoropyridin-2-yl)methyl)carbamoyl)nicotinic Acid (AMG 333), a Clinical Candidate for the Treatment of Migraine.
J Med Chem 61: 8186-8201 (2018)
TBA
Stabilized ?-Hairpin Peptide Inhibits Insulin Degrading Enzyme.
J Med Chem 61: 8174-8185 (2018)
Peking University Shenzhen Graduate School
Optimization of Chromeno[2,3- c]pyrrol-9(2 H)-ones as Highly Potent, Selective, and Orally Bioavailable PDE5 Inhibitors: Structure-Activity Relationship, X-ray Crystal Structure, and Pharmacodynamic Effect on Pulmonary Arterial Hypertension.
J Med Chem 61: 8468-8473 (2018)
Sun Yat-Sen University
Overview of the Development of Glutaminase Inhibitors: Achievements and Future Directions.
J Med Chem 62: 1096-1115 (2019)
China Pharmaceutical University
Amelioration of PXR-mediated CYP3A4 induction by mGluR2 modulators.
Bioorg Med Chem Lett 28: 3194-3196 (2018)
Sanofi Us
Small-molecule compounds targeting the STAT3 DNA-binding domain suppress survival of cisplatin-resistant human ovarian cancer cells by inducing apoptosis.
Eur J Med Chem 157: 887-897 (2018)
Chinese Academy of Medical Sciences and Peking Union Medical College
Identification of novel inhibitors of histone acetyltransferase hMOF through high throughput screening.
Eur J Med Chem 157: 867-876 (2018)
Chinese Academy of Sciences
Natural products as inhibitors of Leishmania major dihydroorotate dehydrogenase.
Eur J Med Chem 157: 852-866 (2018)
University of S£O Paulo
Discovery and structural characterization of peficitinib (ASP015K) as a novel and potent JAK inhibitor.
Bioorg Med Chem 26: 4971-4983 (2018)
Astellas Pharma
Discovery of novel spiro[chromane-2,4'-piperidine] derivatives as potent and orally bioavailable G-protein-coupled receptor 119 agonists.
Bioorg Med Chem Lett 28: 3236-3241 (2018)
Kowa
[1,2,4]Triazolo[1,5-c]pyrimidines as adenosine receptor antagonists: Modifications at the 8 position to reach selectivity towards A
Eur J Med Chem 157: 837-851 (2018)
University of Trieste
Discovery of long-chain salicylketoxime derivatives as monoacylglycerol lipase (MAGL) inhibitors.
Eur J Med Chem 157: 817-836 (2018)
University of Pisa
Synthesis and evaluation of 4-cycloheptylphenols as selective Estrogen receptor-? agonists (SERBAs).
Eur J Med Chem 157: 791-804 (2018)
Marquette University
Design and synthesis of tetrahydropyridopyrimidine based Toll-Like Receptor (TLR) 7/8 dual agonists.
Bioorg Med Chem Lett 28: 3216-3221 (2018)
Janssen Infectious Diseases
Discovery of super soft-drug modulators of sphingosine-1-phosphate receptor 1.
Bioorg Med Chem Lett 28: 3255-3259 (2018)
University of Dundee
Discovery and optimization of novel benzothiophene-3-carboxamides as highly potent inhibitors of Aurora kinases A and B.
Bioorg Med Chem Lett 28: 3265-3270 (2018)
Mta-Se Pathobiochemistry Research Group
Identification of potent ROR? modulators: Scaffold variation.
Bioorg Med Chem Lett 28: 3210-3215 (2018)
The Scripps Research Institute
New piperidine-based derivatives as sigma receptor ligands. Synthesis and pharmacological evaluation.
Bioorg Med Chem Lett 28: 3206-3209 (2018)
University of Trieste
Design, synthesis and biological evaluation of lazabemide derivatives as inhibitors of monoamine oxidase.
Bioorg Med Chem 26: 4863-4870 (2018)
Hainan Normal University
Isoxazolo[3,4-d]pyridazinones positively modulate the metabotropic glutamate subtypes 2 and 4.
Bioorg Med Chem 26: 4797-4803 (2018)
University of Montana
Design of Gut-Restricted Thiazolidine Agonists of G Protein-Coupled Bile Acid Receptor 1 (GPBAR1, TGR5).
J Med Chem 61: 7589-7613 (2018)
Ardelyx
Structure-based design and synthesis of 1H-pyrazolo[3,4-d]pyrimidin-4-amino derivatives as Janus kinase 3 inhibitors.
Bioorg Med Chem 26: 4774-4786 (2018)
China Pharmaceutical University
Discovery of Asciminib (ABL001), an Allosteric Inhibitor of the Tyrosine Kinase Activity of BCR-ABL1.
J Med Chem 61: 8120-8135 (2018)
Novartis Institutes For Biomedical Research
Enthalpy-Driven Stabilization of Transthyretin by AG10 Mimics a Naturally Occurring Genetic Variant That Protects from Transthyretin Amyloidosis.
J Med Chem 61: 7862-7876 (2018)
University of The Pacific
Tetrahydroquinoline and tetrahydroisoquinoline derivatives as potential selective PDE4B inhibitors.
Bioorg Med Chem Lett 28: 3271-3275 (2018)
South China Agricultural University
Synthesis and bioactivity of 3,5-dimethylpyrazole derivatives as potential PDE4 inhibitors.
Bioorg Med Chem Lett 28: 3276-3280 (2018)
South China Agricultural University
Design, synthesis and biological evaluation of novel thiazolidinedione derivatives as irreversible allosteric IKK-? modulators.
Eur J Med Chem 157: 691-704 (2018)
Korea Institute of Science & Technology (Kist)
6-Substituted Hexamethylene Amiloride (HMA) Derivatives as Potent and Selective Inhibitors of the Human Urokinase Plasminogen Activator for Use in Cancer.
J Med Chem 61: 8299-8320 (2018)
University of Wollongong
Discovery of 3-Cyano- N-(3-(1-isobutyrylpiperidin-4-yl)-1-methyl-4-(trifluoromethyl)-1 H-pyrrolo[2,3- b]pyridin-5-yl)benzamide: A Potent, Selective, and Orally Bioavailable Retinoic Acid Receptor-Related Orphan Receptor C2 Inverse Agonist.
J Med Chem 61: 10415-10439 (2018)
Karo Pharma
Tariquidar-Related Chalcones and Ketones as ABCG2 Modulators.
ACS Med Chem Lett 9: 854-859 (2018)
Universidad Nacional De Colombia-Sede Bogot£
Lead Optimization of 5-Aryl Benzimidazolone- and Oxindole-Based AMPA Receptor Modulators Selective for TARP ?-8.
ACS Med Chem Lett 9: 821-826 (2018)
Janssen Research & Development
Structure-Guided Design and Procognitive Assessment of a Potent and Selective Phosphodiesterase 2A Inhibitor.
ACS Med Chem Lett 9: 815-820 (2018)
Merck
Discovery of a Series of 3-Cinnoline Carboxamides as Orally Bioavailable, Highly Potent, and Selective ATM Inhibitors.
ACS Med Chem Lett 9: 809-814 (2018)
Astrazeneca
Allosteric Modulators of the M4 Muscarinic Acetylcholine Receptor.
ACS Med Chem Lett 9: 783-784 (2018)
Usona Institute
Identification of Bivalent Ligands with Melatonin Receptor Agonist and Fatty Acid Amide Hydrolase (FAAH) Inhibitory Activity That Exhibit Ocular Hypotensive Effect in the Rabbit.
J Med Chem 61: 7902-7916 (2018)
University of Urbino
?-Carboline alkaloid monomers and dimers: Occurrence, structural diversity, and biological activities.
Eur J Med Chem 157: 622-656 (2018)
Northwest A&F University
Discovery of dual GyrB/ParE inhibitors active against Gram-negative bacteria.
Eur J Med Chem 157: 610-621 (2018)
Experimental Therapeutics Centre
Recent advances in small molecule based cancer immunotherapy.
Eur J Med Chem 157: 582-598 (2018)
Southern Medical University
Structure-Guided Design and Development of Potent and Selective Dual Bromodomain 4 (BRD4)/Polo-like Kinase 1 (PLK1) Inhibitors.
J Med Chem 61: 7785-7795 (2018)
University of Massachusetts-Boston
Structure-Based Optimization of Nonquaternary Reactivators of Acetylcholinesterase Inhibited by Organophosphorus Nerve Agents.
J Med Chem 61: 7630-7639 (2018)
Universite Grenoble Alpes
Oximes short-acting CB1 receptor agonists.
Bioorg Med Chem 26: 4963-4970 (2018)
Northeastern University
Design, synthesis and antibacterial properties of pyrimido[4,5-b]indol-8-amine inhibitors of DNA gyrase.
Bioorg Med Chem Lett 28: 2998-3003 (2018)
Redx Pharma
Squaramides as novel class I and IIB histone deacetylase inhibitors for topical treatment of cutaneous t-cell lymphoma.
Bioorg Med Chem Lett 28: 2985-2992 (2018)
Nestle Skin Health R&D
Discovery of potent, highly selective covalent irreversible BTK inhibitors from a fragment hit.
Bioorg Med Chem Lett 28: 2939-2944 (2018)
Emd Serono Research & Development Institute
Replacement of a Naphthalene Scaffold in Kelch-like ECH-Associated Protein 1 (KEAP1)/Nuclear Factor (Erythroid-derived 2)-like 2 (NRF2) Inhibitors.
J Med Chem 61: 8029-8047 (2018)
University of Illinois At Chicago
Characterization of crystal water molecules in a high-affinity inhibitor and hematopoietic prostaglandin D synthase complex by interaction energy studies.
Bioorg Med Chem 26: 4726-4734 (2018)
Riken Center For Biosystems Dynamics Research
Design, synthesis and structure-activity relationship of diaryl-ureas with novel isoxazol[3,4-b]pyridine-3-amino-structure as multi-target inhibitors against receptor tyrosine kinase.
Bioorg Med Chem 26: 4735-4744 (2018)
China Pharmaceutical University
In vitro and in vivo pharmacokinetic and pharmacodynamic study of MBRI-001, a deuterium-substituted plinabulin derivative as a potent anti-cancer agent.
Bioorg Med Chem 26: 4687-4692 (2018)
Ocean University of China
Pyrrole: An insight into recent pharmacological advances with structure activity relationship.
Eur J Med Chem 157: 527-561 (2018)
Jamia Hamdard
Histone Deacetylase 6-Selective Inhibitors and the Influence of Capping Groups on Hydroxamate-Zinc Denticity.
J Med Chem 61: 8054-8060 (2018)
University of Pennsylvania
Amelioration of mechanism-based inactivation of CYP3A4 by a H-PGDS inhibitor.
Bioorg Med Chem Lett 28: 3046-3049 (2018)
Sanofi Us
Design and synthesis of novel 6-hydroxy-4-methoxy-3-methylbenzofuran-7-carboxamide derivatives as potent Mnks inhibitors by fragment-based drug design.
Bioorg Med Chem 26: 4602-4614 (2018)
Shenyang Pharmaceutical University
A series of camptothecin prodrugs exhibit HDAC inhibition activity.
Bioorg Med Chem 26: 4706-4715 (2018)
East China Normal University
Pyrrolopyrimidines: An update on recent advancements in their medicinal attributes.
Eur J Med Chem 157: 503-526 (2018)
Indo-Soviet Friendship College of Pharmacy (Isfcp)
Recent advancement of piperidine moiety in treatment of cancer- A review.
Eur J Med Chem 157: 480-502 (2018)
Jamia Hamdard
Dual Inhibition of TYK2 and JAK1 for the Treatment of Autoimmune Diseases: Discovery of (( S)-2,2-Difluorocyclopropyl)((1 R,5 S)-3-(2-((1-methyl-1 H-pyrazol-4-yl)amino)pyrimidin-4-yl)-3,8-diazabicyclo[3.2.1]octan-8-yl)methanone (PF-06700841).
J Med Chem 61: 8597-8612 (2018)
Pfizer
In depth analysis of kinase cross screening data to identify chemical starting points for inhibition of the Nek family of kinases.
Medchemcomm 9: 44-66 (2018)
University of North Carolina At Chapel Hill
Synthesis and evaluation of 1,2,3,4-tetrahydro-1-acridone analogues as potential dual inhibitors for amyloid-beta and tau aggregation.
Bioorg Med Chem 26: 4693-4705 (2018)
Sun Yat-Sen University
Purple acid phosphatase inhibitors as leads for osteoporosis chemotherapeutics.
Eur J Med Chem 157: 462-479 (2018)
The University of Queensland
Allosteric Modulation of Class A GPCRs: Targets, Agents, and Emerging Concepts.
J Med Chem 62: 88-127 (2019)
TBA
Discovery of a Locally and Orally Active CXCL12 Neutraligand (LIT-927) with Anti-inflammatory Effect in a Murine Model of Allergic Airway Hypereosinophilia.
J Med Chem 61: 7671-7686 (2018)
Umr7200 Cnrs/Universit£
Synthesis, molecular docking, and biological activity of 2-vinyl chromones: Toward selective butyrylcholinesterase inhibitors for potential Alzheimer's disease therapeutics.
Bioorg Med Chem 26: 4716-4725 (2018)
Institute of Physiologically Active Compounds Russian Academy of Sciences
2,4-Diamino-6-methylpyrimidines for the potential treatment of Chagas' disease.
Bioorg Med Chem Lett 28: 3025-3030 (2018)
University of Dundee
Recent developments on synthesis and biological activities of ?-carboline.
Eur J Med Chem 157: 447-461 (2018)
Northwest A&F University
Design, synthesis and biological evaluation of novel naphthoquinone derivatives as IDO1 inhibitors.
Eur J Med Chem 157: 423-436 (2018)
Peking University
Identification of crizotinib derivatives as potent SHIP2 inhibitors for the treatment of Alzheimer's disease.
Eur J Med Chem 157: 405-422 (2018)
Korea Institute of Science and Technology
Pyridine bioisosteres of potent GluN2B subunit containing NMDA receptor antagonists with benzo[7]annulene scaffold.
Eur J Med Chem 157: 397-404 (2018)
Institut F£R Pharmazeutische Und Medizinische Chemie Der Westf£Lischen Wilhelms-Universit£T M£Nster
Design and synthesis of novel pyrimido[5,4-d]pyrimidine derivatives as GPR119 agonist for treatment of type 2 diabetes.
Bioorg Med Chem 26: 4080-4087 (2018)
Jiangxi University of Traditional Chinese Medicine
Design, synthesis, docking studies and biological screening of 2-thiazolyl substituted -2,3-dihydro-1H-naphtho[1,2-e][1,3]oxazines as potent HIV-1 reverse transcriptase inhibitors.
Eur J Med Chem 157: 310-319 (2018)
Solapur University
Design, synthesis and preclinical evaluation of 5-methyl-N
Bioorg Med Chem Lett 28: 3085-3093 (2018)
Duquesne University
Inhibition of the LOX enzyme family members with old and new ligands. Selectivity analysis revisited.
Bioorg Med Chem Lett 28: 3113-3118 (2018)
Hungarian Academy of Sciences
Novel, potent, selective and brain penetrant vasopressin 1b receptor antagonists.
Bioorg Med Chem Lett 28: 3260-3264 (2018)
Abbvie Deutschland
Identification of a novel series of potent and selective CCR6 inhibitors as biological probes.
Bioorg Med Chem Lett 28: 3067-3072 (2018)
Takeda Pharmaceutical
Pyrazinyl ureas revisited: 1-(3-(Benzyloxy)pyrazin-2-yl)-3-(3,4-dichlorophenyl)urea, a new blocker of A?-induced mPTP opening for Alzheimer's disease.
Eur J Med Chem 157: 268-278 (2018)
Korea Institute of Science & Technology (Kist)
Design, synthesis, and activity evaluation of novel erythropoietin mimetic peptides.
Bioorg Med Chem Lett 28: 3038-3041 (2018)
Beijing Institute of Pharmacology and Toxicology
Conversion of carbazole carboxamide based reversible inhibitors of Bruton's tyrosine kinase (BTK) into potent, selective irreversible inhibitors in the carbazole, tetrahydrocarbazole, and a new 2,3-dimethylindole series.
Bioorg Med Chem Lett 28: 3080-3084 (2018)
Bristol-Myers Squibb
Design, synthesis and biological evaluation of a series of novel GPR40 agonists containing nitrogen heterocyclic rings.
Bioorg Med Chem Lett 28: 3050-3056 (2018)
Peking Union Medical College and Chinese Academy of Medical Sciences
A novel synthesis of 2-arylbenzimidazoles in molecular sieves-MeOH system and their antitubercular activity.
Bioorg Med Chem 26: 4551-4559 (2018)
Csir-Central Institute of Medicinal and Aromatic Plants (Csir-Cimap)
Medicinal properties of terpenes found in Cannabis sativa and Humulus lupulus.
Eur J Med Chem 157: 198-228 (2018)
Univerisity of Eastern Finland (Uef)
Donepezil-butylated hydroxytoluene (BHT) hybrids as Anti-Alzheimer's disease agents with cholinergic, antioxidant, and neuroprotective properties.
Eur J Med Chem 157: 161-176 (2018)
China Pharmaceutical University
Discovery of a potent non-oxime reactivator of nerve agent inhibited human acetylcholinesterase.
Eur J Med Chem 157: 151-160 (2018)
Tno
Design, synthesis, antiproliferative activity, molecular docking and cell cycle analysis of some novel (morpholinosulfonyl) isatins with potential EGFR inhibitory activity.
Eur J Med Chem 156: 918-932 (2018)
Al-Azhar University
Rational Design and Structure Validation of a Novel Peptide Inhibitor of the Adenomatous-Polyposis-Coli (APC)-Rho-Guanine-Nucleotide-Exchange-Factor-4 (Asef) Interaction.
J Med Chem 61: 8017-8028 (2018)
Jinan University
Tailoring the Substitution Pattern on 1,3,5-Triazine for Targeting Cyclooxygenase-2: Discovery and Structure-Activity Relationship of Triazine-4-Aminophenylmorpholin-3-one Hybrids that Reverse Algesia and Inflammation in Swiss Albino Mice.
J Med Chem 61: 7929-7941 (2018)
TBA
Potent and Orally Bioavailable Inverse Agonists of ROR?t Resulting from Structure-Based Design.
J Med Chem 61: 7796-7813 (2018)
Astrazeneca
Novel Scaffolds for Dual Specificity Tyrosine-Phosphorylation-Regulated Kinase (DYRK1A) Inhibitors.
J Med Chem 61: 7560-7572 (2018)
Uit The Arctic University of Norway
Synthesis and biological evaluation of novel benzofuroxan-based pyrrolidine hydroxamates as matrix metalloproteinase inhibitors with nitric oxide releasing activity.
Bioorg Med Chem 26: 4363-4374 (2018)
Weifang Medical University
Decoy peptides derived from the extracellular domain of toll-like receptor 2 (TLR2) show anti-inflammatory properties.
Bioorg Med Chem 26: 4615-4623 (2018)
Medical University Innsbruck
Novel benzodiazepines derivatives as analgesic modulating for Transient receptor potential vanilloid 1.
Bioorg Med Chem 26: 4567-4573 (2018)
Chongqing Medical University
Evaluation of 4-phenylamino-substituted naphthalene-1,2-diones as tubulin polymerization inhibitors.
Bioorg Med Chem Lett 28: 3057-3063 (2018)
South China University of Technology
Novel spiroindoline HDAC inhibitors: Synthesis, molecular modelling and biological studies.
Eur J Med Chem 157: 127-138 (2018)
University of Siena
Discovery of a Potent and Selective Steroidal Glucocorticoid Receptor Antagonist (ORIC-101).
J Med Chem 61: 7767-7784 (2018)
Oric Pharmaceuticals
Development of Second-Generation CDK2 Inhibitors for the Prevention of Cisplatin-Induced Hearing Loss.
J Med Chem 61: 7700-7709 (2018)
TBA
A Fragment-Derived Clinical Candidate for Antagonism of X-Linked and Cellular Inhibitor of Apoptosis Proteins: 1-(6-[(4-Fluorophenyl)methyl]-5-(hydroxymethyl)-3,3-dimethyl-1 H,2 H,3 H-pyrrolo[3,2- b]pyridin-1-yl)-2-[(2 R,5 R)-5-methyl-2-([(3R)-3-methylmorpholin-4-yl]methyl)piperazin-1-yl]ethan-1-one
J Med Chem 61: 7314-7329 (2018)
Astex Pharmaceuticals
Identification of an Orally Bioavailable Chromene-Based Selective Estrogen Receptor Degrader (SERD) That Demonstrates Robust Activity in a Model of Tamoxifen-Resistant Breast Cancer.
J Med Chem 61: 7917-7928 (2018)
TBA
Novel Quinazolinone Inhibitors of ALK2 Flip between Alternate Binding Modes: Structure-Activity Relationship, Structural Characterization, Kinase Profiling, and Cellular Proof of Concept.
J Med Chem 61: 7261-7272 (2018)
Institute of Cancer Research
Nitric oxide donor-based FFA1 agonists: Design, synthesis and biological evaluation as potential anti-diabetic and anti-thrombotic agents.
Bioorg Med Chem 26: 4560-4566 (2018)
Guangdong Pharmaceutical University
Identification of influenza PA-Nter endonuclease inhibitors using pharmacophore- and docking-based virtual screening.
Bioorg Med Chem 26: 4544-4550 (2018)
Polo Universitario Ss. Annunziata
ROCK inhibitors 3: Design, synthesis and structure-activity relationships of 7-azaindole-based Rho kinase (ROCK) inhibitors.
Bioorg Med Chem Lett 28: 2622-2626 (2018)
Vertex Pharmaceuticals
An Affinity-Based Probe for the Human Adenosine A
J Med Chem 61: 7892-7901 (2018)
Astrazeneca
Discovery of Novel Aminotetralines and Aminochromanes as Selective and Competitive Glycine Transporter 1 (GlyT1) Inhibitors.
J Med Chem 61: 7503-7524 (2018)
Abbvie Deutschland
4-Aminophenyl acetamides and propanamides as potent transient receptor potential vanilloid 1 (TRPV1) ligands.
Bioorg Med Chem 26: 4509-4517 (2018)
Seoul National University
Incorporation of histone deacetylase inhibitory activity into the core of tamoxifen - A new hybrid design paradigm.
Bioorg Med Chem 26: 4428-4440 (2018)
Mcgill University
Discovery of novel Syk/PDGFR-?/c-Kit inhibitors as multi-targeting drugs to treat rheumatoid arthritis.
Bioorg Med Chem 26: 4375-4381 (2018)
East China University of Science & Technology
Asperidines A-C, pyrrolidine and piperidine derivatives from the soil-derived fungus Aspergillus sclerotiorum PSU-RSPG178.
Bioorg Med Chem 26: 4502-4508 (2018)
Prince of Songkla University
Tau-Centric Multitarget Approach for Alzheimer's Disease: Development of First-in-Class Dual Glycogen Synthase Kinase 3? and Tau-Aggregation Inhibitors.
J Med Chem 61: 7640-7656 (2018)
Alma Mater Studiorum-University of Bologna
Azulene-based compounds for targeting orexin receptors.
Eur J Med Chem 157: 88-100 (2018)
University of Helsinki
Iodine-mediated cyclization of cannabigerol (CBG) expands the cannabinoid biological and chemical space.
Bioorg Med Chem 26: 4532-4536 (2018)
University of Naples Federico II
Development of novel silanol-based human pregnane X receptor (PXR) agonists with improved receptor selectivity.
Bioorg Med Chem 26: 4493-4501 (2018)
The University of Tokyo
Synthesis and pharmacological characterization of functionalized 6-piperazin-1-yl-purines as cannabinoid receptor 1 (CB1) inverse agonists.
Bioorg Med Chem 26: 4518-4531 (2018)
Rti International
Design and synthesis of benzofuro[3,2-b]pyridin-2(1H)-one derivatives as anti-leukemia agents by inhibiting Btk and PI3K?.
Bioorg Med Chem 26: 4537-4543 (2018)
China Pharmaceutical University
Discovery of small molecule inhibitors of adenovirus by disrupting E3-19K/HLA-A2 interactions.
Bioorg Med Chem Lett 28: 2837-2841 (2018)
University of Illinois At Chicago
Synthesis and evaluation of aryliden- and hetarylidenfuranone derivatives of usnic acid as highly potent Tdp1 inhibitors.
Bioorg Med Chem 26: 4470-4480 (2018)
Siberian Branch of The Russian Academy of Sciences
Novel tertiary sulfonamides as potent anti-cancer agents.
Bioorg Med Chem 26: 4441-4451 (2018)
Human Biomolecular Research Institute
Design, Synthesis, and Biological Evaluation of 3-(Imidazo[1,2- a]pyrazin-3-ylethynyl)-4-isopropyl- N-(3-((4-methylpiperazin-1-yl)methyl)-5-(trifluoromethyl)phenyl)benzamide as a Dual Inhibitor of Discoidin Domain Receptors 1 and 2.
J Med Chem 61: 7977-7990 (2018)
Jinan University
2,4,6-Substituted Quinazolines with Extraordinary Inhibitory Potency toward ABCG2.
J Med Chem 61: 7952-7976 (2018)
University of Bonn
Discovery of a Potent and Orally Bioavailable Cyclophilin Inhibitor Derived from the Sanglifehrin Macrocycle.
J Med Chem 61: 9473-9499 (2018)
Gilead Sciences
Discovery of 4-Benzyloxybenzo[ d]isoxazole-3-amine Derivatives as Highly Selective and Orally Efficacious Human Sphingomyelin Synthase 2 Inhibitors that Reduce Chronic Inflammation in db/ db Mice.
J Med Chem 61: 8241-8254 (2018)
Fudan University
Difuran-substituted quinoxalines as a novel class of PI3K? H1047R mutant inhibitors: Synthesis, biological evaluation and structure-activity relationship.
Eur J Med Chem 157: 37-49 (2018)
Chongqing University
Novel hydrazido benzenesulfonamides-isatin conjugates: Synthesis, carbonic anhydrase inhibitory activity and molecular modeling studies.
Eur J Med Chem 157: 28-36 (2018)
Egyptian Russian University
Identification of ABX-1431, a Selective Inhibitor of Monoacylglycerol Lipase and Clinical Candidate for Treatment of Neurological Disorders.
J Med Chem 61: 9062-9084 (2018)
Abide Therapeutics
Enantiomeric Pairs of Meroterpenoids with Diverse Heterocyclic Systems from Rhododendron nyingchiense.
J Nat Prod 81: 1810-1818 (2018)
Fudan University
Design, Synthesis, and SAR of C-3 Benzoic Acid, C-17 Triterpenoid Derivatives. Identification of the HIV-1 Maturation Inhibitor 4-((1 R,3a S,5a R,5b R,7a R,11a S,11b R,13a R,13b R)-3a-((2-(1,1-Dioxidothiomorpholino)ethyl)amino)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-2,3,3a,4,5,5a,5b,6,7,7a,8,1
J Med Chem 61: 7289-7313 (2018)
TBA
2-Phenylquinoline S. aureus NorA Efflux Pump Inhibitors: Evaluation of the Importance of Methoxy Group Introduction.
J Med Chem 61: 7827-7848 (2018)
University of Perugia
Discovery of 3-Benzyl-1-( trans-4-((5-cyanopyridin-2-yl)amino)cyclohexyl)-1-arylurea Derivatives as Novel and Selective Cyclin-Dependent Kinase 12 (CDK12) Inhibitors.
J Med Chem 61: 7710-7728 (2018)
Takeda Pharmaceutical
In silico fragment-based drug design with SEED.
Eur J Med Chem 156: 907-917 (2018)
University of Z£Rich
Design, synthesis and evaluation of novel N-phenylbutanamide derivatives as KCNQ openers for the treatment of epilepsy.
Bioorg Med Chem Lett 28: 3004-3008 (2018)
Nanjing University of Technology
Sulfonamido-2-arylbenzoxazole GroEL/ES Inhibitors as Potent Antibacterials against Methicillin-Resistant Staphylococcus aureus (MRSA).
J Med Chem 61: 7345-7357 (2018)
Indiana University School of Medicine
Development of Kinase-Selective, Harmine-Based DYRK1A Inhibitors that Induce Pancreatic Human ?-Cell Proliferation.
J Med Chem 61: 7687-7699 (2018)
TBA
Cytotoxic and NF-?B and mitochondrial transmembrane potential inhibitory pentacyclic triterpenoids from Syzygium corticosum and their semi-synthetic derivatives.
Bioorg Med Chem 26: 4452-4460 (2018)
The Ohio State University
Synthesis and evaluation of camphor and cytisine-based cyanopyrrolidines as DPP-IV inhibitors for the treatment of type 2 diabetes mellitus.
Bioorg Med Chem 26: 4402-4409 (2018)
Siberian Branch of The Russian Academy of Sciences
Secondary carbamate linker can facilitate the sustained release of dopamine from brain-targeted prodrug.
Bioorg Med Chem Lett 28: 2856-2860 (2018)
University of Florida
Cyclic analogue of S-benzylisothiourea that suppresses kynurenine production without inhibiting indoleamine 2,3-dioxygenase activity.
Bioorg Med Chem Lett 28: 2846-2849 (2018)
Okayama University
Design and synthesis of novel thiadiazole-thiazolone hybrids as potential inhibitors of the human mitotic kinesin Eg5.
Bioorg Med Chem Lett 28: 2930-2938 (2018)
University of Kwazulu-Natal (Ukzn)
Structure-activity relationship and conformational studies of the natural product cyclic depsipeptides YM-254890 and FR900359.
Eur J Med Chem 156: 847-860 (2018)
University of Copenhagen
Synthesis, anticancer activity and molecular modeling studies of 1,2,4-triazole derivatives as EGFR inhibitors.
Eur J Med Chem 156: 774-789 (2018)
Nahda University
7?-Methyl substituent is a structural locus associated with activity cliff for nepenthone analogues.
Bioorg Med Chem 26: 4254-4263 (2018)
Fudan University
Synthesis and evaluation of an orally available "Y"-shaped biaryl peroxisome proliferator-activated receptor ? agonist.
Bioorg Med Chem 26: 4382-4389 (2018)
Daegu-Gyeongbuk Medical Innovation Foundation
Novel Hybrid Conjugates with Dual Suppression of Estrogenic and Inflammatory Activities Display Significantly Improved Potency against Breast Cancer.
J Med Chem 61: 8155-8173 (2018)
Wuhan University
Discovery of (S)-2-amino-N-(5-(6-chloro-5-(3-methylphenylsulfonamido)pyridin-3-yl)-4-methylthiazol-2-yl)-3-methylbutanamide (CHMFL-PI3KD-317) as a potent and selective phosphoinositide 3-kinase delta (PI3K?) inhibitor.
Eur J Med Chem 156: 831-846 (2018)
Chinese Academy of Sciences
Discovery of a benzenesulfonamide-based dual inhibitor of microsomal prostaglandin E
Eur J Med Chem 156: 815-830 (2018)
Goethe-University Frankfurt
Design, Synthesis, and Pharmacological Evaluation of Second-Generation Tetrahydroisoquinoline-Based CXCR4 Antagonists with Favorable ADME Properties.
J Med Chem 61: 7168-7188 (2018)
Emory University
Design, synthesis and biological evaluation of novel spiro-pentacylamides as acetyl-CoA carboxylase inhibitors.
Bioorg Med Chem 26: 3866-3874 (2018)
China Pharmaceutical University
Selective inhibition of human cathepsin S by 2,4,6-trisubstituted 1,3,5-triazine analogs.
Bioorg Med Chem 26: 4310-4319 (2018)
Orleans University
Terpenoids with vasorelaxant effects from the Chinese liverwort Scapania carinthiaca.
Bioorg Med Chem 26: 4320-4328 (2018)
Shandong University
3-(2-Carboxyethyl)indole-2-carboxylic Acid Derivatives: Structural Requirements and Properties of Potent Agonists of the Orphan G Protein-Coupled Receptor GPR17.
J Med Chem 61: 8136-8154 (2018)
Sultan Qaboos University
Allosteric Modulators of HSP90 and HSP70: Dynamics Meets Function through Structure-Based Drug Design.
J Med Chem 62: 60-87 (2019)
Istituto Di Chimica Del Riconoscimento Molecolare
Reevaluating the Substrate Specificity of the L-Type Amino Acid Transporter (LAT1).
J Med Chem 61: 7358-7373 (2018)
University of California
Novel series of 6-(2-substitutedacetamido)-4-anilinoquinazolines as EGFR-ERK signal transduction inhibitors in MCF-7 breast cancer cells.
Eur J Med Chem 155: 782-796 (2018)
Egyptian Russian University
Small Molecules Simultaneously Inhibiting p53-Murine Double Minute 2 (MDM2) Interaction and Histone Deacetylases (HDACs): Discovery of Novel Multitargeting Antitumor Agents.
J Med Chem 61: 7245-7260 (2018)
East China University of Science and Technology
Discovery of Risdiplam, a Selective Survival of Motor Neuron-2 ( SMN2) Gene Splicing Modifier for the Treatment of Spinal Muscular Atrophy (SMA).
J Med Chem 61: 6501-6517 (2018)
F. Hoffmann-La Roche
Indenone derivatives as inhibitor of human DNA dealkylation repair enzyme AlkBH3.
Bioorg Med Chem 26: 4100-4112 (2018)
Indian Institute of Technology Hyderabad
Surface Probing by Fragment-Based Screening and Computational Methods Identifies Ligandable Pockets on the von Hippel-Lindau (VHL) E3 Ubiquitin Ligase.
J Med Chem 61: 7387-7393 (2018)
University of Dundee
A Bioactive Resveratrol Trimer from the Stem Bark of the Sri Lankan Endemic Plant Vateria copallifera.
J Nat Prod 81: 1693-1700 (2018)
University of Colombo
Antiprotozoal and cysteine proteases inhibitory activity of dipeptidyl enoates.
Bioorg Med Chem 26: 4624-4634 (2018)
Universitat Jaume I
Synthetic molecules for disruption of the MYC protein-protein interface.
Bioorg Med Chem 26: 4234-4239 (2018)
The Scripps Research Institute
Small molecule scaffolds that disrupt the Rev1-CT/RIR protein-protein interaction.
Bioorg Med Chem 26: 4301-4309 (2018)
University of Connecticut
Acyl Glucuronide Metabolites of 6-Chloro-5-[4-(1-hydroxycyclobutyl)phenyl]-1 H-indole-3-carboxylic Acid (PF-06409577) and Related Indole-3-carboxylic Acid Derivatives are Direct Activators of Adenosine Monophosphate-Activated Protein Kinase (AMPK).
J Med Chem 61: 7273-7288 (2018)
Pfizer
Polypharmacology by Design: A Medicinal Chemist's Perspective on Multitargeting Compounds.
J Med Chem 62: 420-444 (2019)
Goethe University Frankfurt
Synergistic Multiresidue Substitutions of a Macrocyclic c[Pro-Arg-Phe-Phe-Asn-Ala-Phe-dPro] Agouti-Related Protein (AGRP) Scaffold Yield Potent and >600-Fold MC4R versus MC3R Selective Melanocortin Receptor Antagonists.
J Med Chem 61: 7729-7740 (2018)
University of Minnesota
Structural Optimization and Characterization of Potent Analgesic Macrocyclic Analogues of Neurotensin (8-13).
J Med Chem 61: 7103-7115 (2018)
University of Sherbrooke
MK-8353: Discovery of an Orally Bioavailable Dual Mechanism ERK Inhibitor for Oncology.
ACS Med Chem Lett 9: 761-767 (2018)
Merck
Discovery of AM-6226: A Potent and Orally Bioavailable GPR40 Full Agonist That Displays Efficacy in Nonhuman Primates.
ACS Med Chem Lett 9: 757-760 (2018)
Amgen Discovery Research
Optimization of 3-Pyrimidin-4-yl-oxazolidin-2-ones as Orally Bioavailable and Brain Penetrant Mutant IDH1 Inhibitors.
ACS Med Chem Lett 9: 746-751 (2018)
Novartis Institutes For Biomedical Research
Reverse Hydroxamate Inhibitors of Bone Morphogenetic Protein 1.
ACS Med Chem Lett 9: 736-740 (2018)
Glaxosmithkline Pharmaceuticals
Targeting Tumor Associated Carbonic Anhydrases IX and XII: Highly Isozyme Selective Coumarin and Psoralen Inhibitors.
ACS Med Chem Lett 9: 725-729 (2018)
University of Cagliari
Discovery of an Orally Bioavailable Dual PI3K/mTOR Inhibitor Based on Sulfonyl-Substituted Morpholinopyrimidines.
ACS Med Chem Lett 9: 719-724 (2018)
Shanghai Haiyan Pharmaceutical Technology
In Search of Selectivity in Inhibition of ADAM10.
ACS Med Chem Lett 9: 708-713 (2018)
University of Notre Dame
Inhibition of Connexin Hemichannels by New Amphiphilic Aminoglycosides without Antibiotic Activity.
ACS Med Chem Lett 9: 697-701 (2018)
Utah State University
Quinoxaline-Based Linear HCV NS3/4A Protease Inhibitors Exhibit Potent Activity against Drug Resistant Variants.
ACS Med Chem Lett 9: 691-696 (2018)
University of Massachusetts Medical School
Structure-Activity Relationship of Novel and Selective Biaryl-Chroman GPR40 AgoPAMs.
ACS Med Chem Lett 9: 685-690 (2018)
Merck
Discovery of MK-8318, a Potent and Selective CRTh2 Receptor Antagonist for the Treatment of Asthma.
ACS Med Chem Lett 9: 679-684 (2018)
Merck Research Laboratory
PK/PD Disconnect Observed with a Reversible Endothelial Lipase Inhibitor.
ACS Med Chem Lett 9: 673-678 (2018)
Bristol-Myers Squibb
Discovery of Natural Product Derived Labdane Appended Triazoles as Potent Pancreatic Lipase Inhibitors.
ACS Med Chem Lett 9: 662-666 (2018)
Csir - National Institute For Interdisciplinary Science and Technology (Csir-Niist)
Sweet Binders: Carbonic Anhydrase IX in Complex with Sucralose.
ACS Med Chem Lett 9: 657-661 (2018)
University of Florida
Novel Nonsteroidal Progesterone Receptor (PR) Antagonists with a Phenanthridinone Skeleton.
ACS Med Chem Lett 9: 641-645 (2018)
The University of Tokyo
Discovery of a First-in-Class Gut-Restricted RET Kinase Inhibitor as a Clinical Candidate for the Treatment of IBS.
ACS Med Chem Lett 9: 623-628 (2018)
Glaxosmithkline
LLY-283, a Potent and Selective Inhibitor of Arginine Methyltransferase 5, PRMT5, with Antitumor Activity.
ACS Med Chem Lett 9: 612-617 (2018)
Lilly Research Laboratories
Discovery of a Series of Indole-2 Carboxamides as Selective Secreted Phospholipase A
ACS Med Chem Lett 9: 594-599 (2018)
Astrazeneca
Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein.
ACS Med Chem Lett 9: 592-593 (2018)
Usona Institute
Covalent Inhibitors of the TEC Family of Kinases and Their Methods of Use.
ACS Med Chem Lett 9: 587-589 (2018)
Temple University
6-Biphenylmethyl-3-hydroxypyrimidine-2,4-diones potently and selectively inhibited HIV reverse transcriptase-associated RNase H.
Eur J Med Chem 156: 680-691 (2018)
University of Minnesota
6-Arylthio-3-hydroxypyrimidine-2,4-diones potently inhibited HIV reverse transcriptase-associated RNase H with antiviral activity.
Eur J Med Chem 156: 652-665 (2018)
University of Minnesota
Crystal structure of the Eg5 - K858 complex and implications for structure-based design of thiadiazole-containing inhibitors.
Eur J Med Chem 156: 641-651 (2018)
University College London
Design and synthesis of novel 1H-tetrazol-5-amine based potent antimicrobial agents: DNA topoisomerase IV and gyrase affinity evaluation supported by molecular docking studies.
Eur J Med Chem 156: 631-640 (2018)
Medical University of Warsaw
Multi-target-directed ligands for treating Alzheimer's disease: Butyrylcholinesterase inhibitors displaying antioxidant and neuroprotective activities.
Eur J Med Chem 156: 598-617 (2018)
University of Ljubljana
Design and synthesis of novel anti-hyperalgesic agents based on 6-prenylnaringenin as the T-type calcium channel blockers.
Bioorg Med Chem 26: 4410-4427 (2018)
University of Toyama
Design and biological evaluation of novel hybrids of 1, 5-diarylpyrazole and Chrysin for selective COX-2 inhibition.
Bioorg Med Chem 26: 4264-4275 (2018)
Nanjing University
New aziridine-based inhibitors of cathepsin L-like cysteine proteases with selectivity for the Leishmania cysteine protease LmCPB2.8.
Eur J Med Chem 156: 587-597 (2018)
Johannes Gutenberg-Universit£T Mainz
5-Aroylindoles Act as Selective Histone Deacetylase 6 Inhibitors Ameliorating Alzheimer's Disease Phenotypes.
J Med Chem 61: 7087-7102 (2018)
Taipei Medical University
Salicylic Acid Derivatives Inhibit Oxalate Production in Mouse Hepatocytes with Primary Hyperoxaluria Type 1.
J Med Chem 61: 7144-7167 (2018)
Universidad De Granada
Discovery of ?-Arrestin Biased Ligands of 5-HT
J Med Chem 61: 7218-7233 (2018)
Korea Institute of Science and Technology
Synthesis and anticancer activity of novel bisindolylhydroxymaleimide derivatives with potent GSK-3 kinase inhibition.
Bioorg Med Chem 26: 4209-4224 (2018)
University College Cork
Structural optimization and in vitro profiling of N-phenylbenzamide-based farnesoid X receptor antagonists.
Bioorg Med Chem 26: 4240-4253 (2018)
Goethe-University Frankfurt
New lead elements for histamine H
Bioorg Med Chem Lett 28: 2890-2893 (2018)
Pontificia Universidad Cat£Lica De Chile
Recent advances in peptidomimetics antagonists targeting estrogen receptor ?-coactivator interaction in cancer therapy.
Bioorg Med Chem Lett 28: 2827-2836 (2018)
Peking University Shenzhen Graduate School
Design, synthesis and screening of 1, 2, 4-triazinone derivatives as potential antitumor agents with apoptosis inducing activity on MCF-7 breast cancer cell line.
Eur J Med Chem 156: 563-579 (2018)
Port Said University
Synergistic inhibition of the Hedgehog pathway by newly designed Smo and Gli antagonists bearing the isoflavone scaffold.
Eur J Med Chem 156: 554-562 (2018)
Sapienza University of Rome
Neurogenic and neuroprotective donepezil-flavonoid hybrids with sigma-1 affinity and inhibition of key enzymes in Alzheimer's disease.
Eur J Med Chem 156: 534-553 (2018)
IQM-CSIC
Novel curcumin analogue hybrids: Synthesis and anticancer activity.
Eur J Med Chem 156: 493-509 (2018)
Anhui Medical University
Structure-Function Analysis of Immune Checkpoint Receptors to Guide Emerging Anticancer Immunotherapy.
J Med Chem 61: 10957-10975 (2018)
Universidade De Lisboa
Discovery of QCA570 as an Exceptionally Potent and Efficacious Proteolysis Targeting Chimera (PROTAC) Degrader of the Bromodomain and Extra-Terminal (BET) Proteins Capable of Inducing Complete and Durable Tumor Regression.
J Med Chem 61: 6685-6704 (2018)
TBA
Structure-based design, synthesis, and evaluation of structurally rigid donepezil analogues as dual AChE and BACE-1 inhibitors.
Bioorg Med Chem Lett 28: 2910-2913 (2018)
Mansoura University
Synthesis of 1,5-Anhydro-d-fructose derivatives and evaluation of their inflammasome inhibitors.
Bioorg Med Chem 26: 3763-3772 (2018)
The Noguchi Institute
Developing hybrid molecule therapeutics for diverse enzyme inhibitory action: Active role of coumarin-based structural leads in drug discovery.
Bioorg Med Chem 26: 3731-3762 (2018)
Abbottabad University of Science and Technology
Development of Novel Monoamine Oxidase-B (MAO-B) Inhibitors with Reduced Blood-Brain Barrier Permeability for the Potential Management of Noncentral Nervous System (CNS) Diseases.
J Med Chem 61: 7043-7064 (2018)
The University of British Columbia
Unraveling the Prenylation-Cancer Paradox in Multiple Myeloma with Novel Geranylgeranyl Pyrophosphate Synthase (GGPPS) Inhibitors.
J Med Chem 61: 6904-6917 (2018)
Mcgill University
Atropisomerism by Design: Discovery of a Selective and Stable Phosphoinositide 3-Kinase (PI3K) ? Inhibitor.
J Med Chem 61: 6858-6868 (2018)
Gilead Sciences
Discovery, Synthesis, Pharmacological Profiling, and Biological Characterization of Brintonamides A-E, Novel Dual Protease and GPCR Modulators from a Marine Cyanobacterium.
J Med Chem 61: 6364-6378 (2018)
University of Florida
Structure-Based Discovery of CF53 as a Potent and Orally Bioavailable Bromodomain and Extra-Terminal (BET) Bromodomain Inhibitor.
J Med Chem 61: 6110-6120 (2018)
TBA
Biosynthetic Baeyer-Villiger Chemistry Enables Access to Two Anthracene Scaffolds from a Single Gene Cluster in Deep-Sea-Derived Streptomyces olivaceus SCSIO T05.
J Nat Prod 81: 1570-1577 (2018)
South China Sea Institute of Oceanology
Structural insight into the optimization of ethyl 5-hydroxybenzo[g]indol-3-carboxylates and their bioisosteric analogues as 5-LO/m-PGES-1 dual inhibitors able to suppress inflammation.
Eur J Med Chem 155: 946-960 (2018)
University of Campania Luigi Vanvitelli
Exploration of carboxy pyrazole derivatives: Synthesis, alkaline phosphatase, nucleotide pyrophosphatase/phosphodiesterase and nucleoside triphosphate diphosphohydrolase inhibition studies with potential anticancer profile.
Eur J Med Chem 156: 461-478 (2018)
Quaid-I-Azam University
Discovery of potent anti-convulsant carbonic anhydrase inhibitors: Design, synthesis, in vitro and in vivo appraisal.
Eur J Med Chem 156: 430-443 (2018)
University of Delhi
Current progress on antioxidants incorporating the pyrazole core.
Eur J Med Chem 156: 394-429 (2018)
University of Aveiro
Synthesis and biological evaluation of magnolol derivatives as melatonergic receptor agonists with potential use in depression.
Eur J Med Chem 156: 381-393 (2018)
Chinese Academy of Sciences
Novel natural compounds from endophytic fungi with anticancer activity.
Eur J Med Chem 156: 316-343 (2018)
Beijing Normal University
Synthesis and anticancer activity of new dihydropyrimidinone derivatives.
Eur J Med Chem 156: 304-315 (2018)
Mansoura University
Chemoenzymatic Synthesis and Pharmacological Characterization of Functionalized Aspartate Analogues As Novel Excitatory Amino Acid Transporter Inhibitors.
J Med Chem 61: 7741-7753 (2018)
University of Groningen
De Novo Molecular Design of a Novel Octapeptide That Inhibits In Vivo Melanogenesis and Has Great Transdermal Ability.
J Med Chem 61: 6846-6857 (2018)
Dalian University of Technology
Discovery of a Potent, Selective, and Brain-Penetrant Small Molecule that Activates the Orphan Receptor GPR88 and Reduces Alcohol Intake.
J Med Chem 61: 6748-6758 (2018)
Research Triangle Institute
Novel Benzazole Derivatives Endowed with Potent Antiheparanase Activity.
J Med Chem 61: 6918-6936 (2018)
"Sapienza" Universit£
Combating Autoimmune Diseases With Retinoic Acid Receptor-Related Orphan Receptor-? (ROR? or RORc) Inhibitors: Hits and Misses.
J Med Chem 61: 10976-10995 (2018)
Cadila Healthcare
Activity of steroid 4 and derivatives 4a-4f as inhibitors of the enzyme 5?-reductase 1.
Bioorg Med Chem 26: 4058-4064 (2018)
Universidad Nacional Aut£Noma De M£Xico
Design, synthesis and docking study of 4-arylpiperazine carboxamides as monoamine neurotransmitters reuptake inhibitors.
Bioorg Med Chem 26: 4127-4135 (2018)
Chonnam National University
4-(Phenoxy) and 4-(benzyloxy)benzamides as potent and selective inhibitors of mono-ADP-ribosyltransferase PARP10/ARTD10.
Eur J Med Chem 156: 93-102 (2018)
University of Oulu
Optimization of the first small-molecule relaxin/insulin-like family peptide receptor (RXFP1) agonists: Activation results in an antifibrotic gene expression profile.
Eur J Med Chem 156: 79-92 (2018)
National Center For Advancing Translational Sciences
Design of two-tail compounds with rotationally fixed benzenesulfonamide ring as inhibitors of carbonic anhydrases.
Eur J Med Chem 156: 61-78 (2018)
Vilnius University
Discovery of a potent glucokinase activator with a favorable liver and pancreas distribution pattern for the treatment of type 2 diabetes mellitus.
Eur J Med Chem 156: 269-294 (2018)
Sanwa Kagaku Kenkyusho
Structure-activity relationships in fungal nucleobases transporters as dissected by the inhibitory effects of novel purine analogues.
Eur J Med Chem 156: 240-251 (2018)
National and Kapodistrian University of Athens
Synthesis, in vitro antiproliferative activity, and kinase inhibitory effects of pyrazole-containing diarylureas and diarylamides.
Eur J Med Chem 156: 230-239 (2018)
University of Sharjah
Thiodipeptides targeting the intestinal oligopeptide transporter as a general approach to improving oral drug delivery.
Eur J Med Chem 156: 180-189 (2018)
Keele University
Arylamino containing hydroxamic acids as potent urease inhibitors for the treatment of Helicobacter pylori infection.
Eur J Med Chem 156: 126-136 (2018)
Jishou University
Novel amino acid-substituted diphenylpyrimidine derivatives as potent BTK inhibitors against B cell lymphoma cell lines.
Bioorg Med Chem 26: 4179-4186 (2018)
Dalian Medical University
N-Acylhydrazones as drugs.
Bioorg Med Chem Lett 28: 2797-2806 (2018)
National Institute For Science and Technology On Innovation On Neglected Diseases (Inct/Idn)
Novel Modes of Inhibition of Wild-Type Isocitrate Dehydrogenase 1 (IDH1): Direct Covalent Modification of His315.
J Med Chem 61: 6647-6657 (2018)
TBA
Design and Synthesis of Tubulin and Histone Deacetylase Inhibitor Based on iso-Combretastatin A-4.
J Med Chem 61: 6574-6591 (2018)
Paris-Saclay University
Recent Advances in the Medicinal Chemistry of Liver X Receptors.
J Med Chem 61: 10935-10956 (2018)
Saint Louis University School of Medicine
Napabucasin and Related Heterocycle-Fused Naphthoquinones as STAT3 Inhibitors with Antiproliferative Activity against Cancer Cells.
J Nat Prod 81: 1636-1644 (2018)
Westphalian Wilhelms University
Curated by BindingDB
Curated by ChEMBL